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Polyacetylenic	  natural	  products,	   compounds	  containing	  multiple	   carbon-­‐carbon	  
triple	  bonds,	  have	  been	  found	  in	  a	  large	  collection	  of	  organisms.	  	  Radiochemical	  tracer	  
studies	  have	  indicated	  that	  these	  bioactive	  metabolites	  are	  synthesized	  from	  fatty	  acid	  
precursors	  through	  a	  series	  of	  uncharacterized	  desaturation	  and	  acetylenation	  steps.	  	  To	  
date,	   there	   are	   three	   main	   pathways	   believed	   to	   be	   involved	   in	   acetylenic	   natural	  
product	  biosynthesis.	   	  However,	   it	   is	  apparent	  that	  the	  crepenynic	  acid	  pathway	  is	  the	  
origin	  of	  a	  vast	  majority	  of	  the	  known	  plant	  and	  fungal	  acetylenic	  products.	  
This	   investigation	   provides	   concrete	   evidence	   that	   the	   polyacetylenic	   natural	  
products	   found	   in	   the	   fungus	   Fistulina	   hepatica	   and	   the	   medicinal	   plant	   species	  
Echinacea	   purpurea	   are	   biosynthesized	   from	   crepenynic	   acid.	   	   Through	   heterologous	  
expression	  in	  Yarrowia	  lipolytica,	  two	  acetylenases	  capable	  of	  producing	  crepenynic	  acid	  
were	   identified	   from	   E.	   purpurea.	   	   Furthermore,	   heterologous	   expression	   of	   two	  
diverged	  desaturases	   isolated	   from	  F.	   hepatica,	   uncovered	   a	  ∆12-­‐acetylenase	   and	   the	  






CHAPTER	  1. INTRODUCTION	  
Fatty	  acid	  desaturases	  are	  a	  family	  of	  enzymes	  capable	  of	  carrying	  out	  oxidative	  
dehydrogenation	   chemistry	   on	   established	   acyl	   chains.	   	   Over	   the	   years,	   a	   series	   of	  
diverged	  desaturases	  has	  emerged	  that	  have	  the	  ability	  to	  insert	  a	  variety	  of	  functional	  
groups	  into	  fatty	  acid	  acyl	  chains.	  	  One	  particular	  example	  of	  these	  diverged	  desaturases	  
is	   the	   alkyne-­‐forming	   subclass	   known	   as	   acetylenases.	   	   These	   enzymes	   further	  
desaturate	   pre-­‐existing	   double	   bonds	   in	   an	   acyl	   chain	   to	   produce	   the	   carbon-­‐carbon	  
triple-­‐bonded	  product.	  	  	  
	   Over	  the	  last	  several	  decades,	  polyacetylenic	  natural	  products	  from	  plants,	  fungi,	  
and	   aquatic	   organisms	   were	   discovered	   to	   possess	   a	   range	   of	   bioactivities.	   	   These	  
bioactivities	   include,	   but	   are	   not	   limited	   to,	   anti-­‐tumor,	   HIV-­‐inhibitory,	   and	  
immunosuppressive	   properties.	   	   The	   unique	   biological	   activities	   possessed	   by	  
polyacetylenic	   compounds	   have	   made	   them	   of	   great	   interest	   to	   the	   medical	   and	  
pharmaceutical	   industries.	   	   However,	   there	   is	   still	   much	   to	   be	   discovered	   about	   the	  
dehydrogenation	  pathways	  responsible	  for	  the	  biogenesis	  of	  these	  natural	  products.	  
This	  thesis	  describes	  investigations	  of	  polyacetylenic	  natural	  product	  biosynthesis	  
in	   Fistulina	   hepatica	   and	   Echinacea	   purpurea.	   	   Provided	   that	   many	   acetylenic	  
metabolites	  originate	  from	  fatty	  acids	  and	  fatty	  acid	  precursors,	  the	  introduction	  begins	  
with	   a	   brief	   overview	   of	   fatty	   acids.	   	   The	   fatty	   acid	   desaturase	   family	   is	   described,	  
highlighting	   the	   different	   classes	   of	   desaturases	   and	   their	   characteristics,	   as	   the	  
formation	   of	   the	   acetylenic	   bond	   is	   thought	   to	   undergo	   dehydrogenation	   in	   an	  
analogous	   fashion	   to	   that	  of	   integral	  membrane	  desaturases.	   	   Lastly,	   the	   introduction	  
concludes	   with	   a	   focus	   on	   acetylenase	   enzymes	   and	   provides	   the	   basis	   for	   why	  




1.1 Overview	  of	  Fatty	  Acids	  
	  
	  
1.1.1 What	  are	  Fatty	  Acids?	  
Fatty	  acids	   (FAs)	   are	  a	   cornerstone	  of	  existence	   since	   they	  play	   crucial	   roles	   in	  
the	   biological	   structures	   and	   functions	   that	   support	   life.	   	   Fatty	   acids	   are	   essential	  
biological	  components	  that	  make	  up	  the	  building	  blocks	  of	  all	  acyl	  lipids.	  	  FAs	  and	  their	  
complex	   lipid	   derivatives	   act	   as:	   1)	   energy	   storage	   reserves;	   2)	  major	   components	   of	  
membrane	   bilayers	   for	   both	   the	   cell	   and	   individual	   organelles;	   3)	   precursors	   of	  
biologically	   active	   compounds,	   such	   as	   hormones	   and	   secondary	   messengers;	   and	   4)	  
protein	   modifiers	   capable	   of	   imparting	   proper	   folding	   and	   anchoring	   of	   membrane	  
proteins	  through	  acylation	  [1,	  2]	  
A	  completely	  unmodified	  FA	  consists	  of	  two	  parts:	  1)	  a	  hydrocarbon	  chain	  with	  a	  
methyl	   group	   at	   one	   end	   and	   2)	   a	   carboxylic	   acid	   functional	   group	   at	   the	   other	   end	  
(Figure	  1).	  	  Saturated	  fatty	  acids	  contain	  acyl	  chains	  with	  only	  methylene	  groups,	  where	  
the	   hydrocarbon	   portion	   of	   the	   acyl	   chain	   is	   saturated	   with	   hydrogens.	   	   Fatty	   acid	  
modification	   pathways	   can	   introduce	   additional	   functional	   groups	   into	   the	   acyl	   chain,	  
however.	  	  These	  chemical	  modifications	  include	  a	  large	  number	  of	  functional	  groups,	  for	  
example	   fluoro,	   hydroxyl,	   double,	   and	   triple	   bonds	   to	   name	   a	   few.	   	  When	   functional	  
groups	   such	   as	   epoxides,	   alkenes,	   and	   alkynes	   are	   present,	   these	   fatty	   acids	   are	  
considered	   unsaturated	   because	   their	   hydrocarbon	   chains	   no	   longer	   contain	   the	  
maximum	  complement	  of	  hydrogens.	  	  
In	  plants,	  de	  novo	  FA	  biosynthesis	  largely	  occurs	  either	  in	  the	  chloroplasts	  or	  the	  
stroma	  of	  plastids,	  whereas	  in	  most	  other	  eukaryotes	  biosynthesis	  occurs	  in	  the	  cytosol	  
[3].	   	   The	   process	   of	   fatty	   acid	   biosynthesis	   is	   carried	   out	   by	   either	   a	   multisubunit	  
(prokaryotic)	  or	  a	  multifunctional	  (eukaryotic)	  fatty	  acid	  synthase	  complex	  that	  uses	  the	  
precursors	   acetyl-­‐CoA	   and	   malonyl-­‐CoA	   to	   generate	   saturated	   fatty	   acids	   with	   chain	  




products,	  through	  elongation	  and	  𝛽-­‐oxidation	  processes,	  can	  provide	  acyl	  chains	  ranging	  
from	  10-­‐30	  carbons	  in	  length.	  
	  
Figure	  1:	  Structure	  of	   fatty	  acids.	   	  Steric	  acid	   is	  a	  saturated	  fatty	  acid	  whereas	  oleic	  acid	   is	  unsaturated.	  	  
The	   installation	  of	   the	  double	  bond	   is	  carried	  out	  by	  a	  desaturase	  enzyme.	   	  The	  boxes	   in	   red	  and	  black	  
outline	  the	  carboxylic	  acid	  and	  hydrocarbon	  portions	  of	  the	  fatty	  acid,	  respectively.	  
	  
	  
1.1.2 Fatty	  Acid	  Naming	  and	  Nomenclature	  
Three	  types	  of	  names	  are	  regularly	  used	  to	   identify	  FAs:	  1)	  common	  names;	  2)	  
IUPAC	   nomenclature;	   and	   3)	   lipid	   shorthand	   notation.	   	   The	   most	   abundant	  
monounsaturated	  fatty	  acid	  found	  in	  nature	  is	  systematically	  named	  cis-­‐9-­‐octadecenoic	  
acid.	  	  However,	  the	  same	  fatty	  acid	  is	  frequently	  referred	  to	  by	  its	  common	  name	  oleic	  
acid	  or	  its	  lipid	  shorthand	  notation	  18:19.	  	  In	  the	  shorthand	  notation	  x:y:Z	  ,	  1)	  the	  number	  
of	  carbon	  atoms	  in	  the	  acyl	  chain	  are	  given	  by	  x;	  2)	  the	  number	  of	  double	  bonds	  present	  
are	  enumerated	  by	  y;	  and	  3)	   the	  position(s)	  of	  modifications	   in	  the	  acyl	  chain	  and	  the	  
geometric	   configuration	   of	   the	   double	   bond,	   when	   necessary,	   are	   designated	   by	   the	  
superscript	   ‘z’.	   	   By	   using	   the	   (∆)	   shorthand	  notation,	   oleic	   acid	   can	  be	   abbreviated	   as	  
18:1∆9c.	  	  When	  using	  the	  (∆)	  notation	  for	  more	  exotic	  fatty	  acids,	  such	  as	  (Z)-­‐octadec-­‐9-­‐
en-­‐12-­‐ynoic	  acid	  (Figure	  2),	  the	  notation	  is	  the	  same	  with	  one	  exception.	  	  Although	  the	  
acetylenic	   functional	   group	   contains	   two	   units	   of	   unsaturation	   and	   is	   annotated	   in	  
superscript	   form,	   it	   is	   not	   counted	   as	   a	   double	   bond.	   	   Consequently,	   the	   short	   hand	  
notation	  for	  (Z)-­‐octadec-­‐9-­‐en-­‐12-­‐ynoic	  acid	  is	  18:1∆9c,12a.	  	  Other	  shorthand	  notations	  will	  






Figure	   2:	   Shorthand	   notation	   for	   fatty	   acids.	   	   In	   this	   notation,	   the	   ∆	   represents	   the	   position	   of	  
unsaturation	  relative	  to	  the	  carboxyl	  end	  (∆-­‐	  end)	  of	  the	  acyl	  chain.	  	  In	  the	  case	  of	  the	  shorthand	  notation	  
for	   (Z)-­‐octadec-­‐9-­‐en-­‐12-­‐ynoic	   acid	   (18:1∆9c,12a)	   the	   cis	   double	   bond	   and	   the	   triple	   bond	   are	   located	   at	  
positions	   C9	   and	  C12	   relative	   to	   the	   carboxyl	   end	  of	   the	   acyl	   chain,	   respectively.	   	   An	   alternate	   naming	  
system	  counts	  from	  the	  methyl	  or	  𝜔-­‐end.	  
	  
	  
1.2 Fatty	  Acid	  Desaturases	  
Fatty	   acid	   desaturases	   are	   a	   family	   of	   enzymes	   capable	   of	   catalyzing	   the	  
dehydrogenation	   of	   pre-­‐existing	   fatty	   acyl	   chains.	   	   Sensu	   stricto	   this	   family	   acts	   to	  
remove	   adjacent	   hydrogen	   atoms	   from	   consecutive	   methylene	   groups	   in	   order	   to	  
generate	   a	   double	   bond	   in	   the	   acyl	   chain.	   	   Although	   the	   double	   bonds	   occur	   almost	  
exclusively	   in	   the	   cis	   configuration,	   trans	   isomers	   do	   exist	   in	   Nature	   as	   a	   minor	  
proportion	  of	   unsaturated	   species.	   	   The	   chemistry	   of	   double-­‐bond	   formation	   requires	  
two	   electrons,	   two	   protons,	   and	  molecular	   oxygen.	   	   The	   electrons	   serve	   as	   reducing	  
equivalents	  while	  activated	  O2	  helps	  facilitate	  the	  cleavage	  of	  the	  highly	  stable	  C-­‐H	  bond	  
and	  acts	  as	  the	  final	  electron	  acceptor,	  ultimately	  becoming	  reduced	  to	  water	  during	  the	  
process.	  	  
This	   family	   of	   enzymes	   is	   found	   in	   both	  prokaryotic	   and	   eukaryotic	   organisms,	  
and	   is	   known	   to	   be	   involved	   in	   the	   regulation	   of	   membrane	   fluidity.	   	   Furthermore,	  
desaturases	   are	   responsible	   for	   the	   formation	   of	   polyunsaturated	   fatty	   acids	   (PUFAs),	  
known	   precursors	   to	   a	   large	   number	   of	   biologically	   active	   molecules	   in	   plants	   and	  
animals.	   	   For	   example	   the	   eicosanoid,	   arachidonic	   acid	   (20:4∆5c,8c,11c,14c),	   is	   a	   highly	  




thromboxanes,	  and	  leukotrienes,	  as	  well	  as	  other	  biologically-­‐active	  compounds,	  such	  as	  
pheromones	  and	  growth	  regulators	  [1,	  4].	  	  	  
A	  survey	  of	  this	  enzymatic	  family	  has	  shown	  that	  desaturases	  carry	  out	  a	  broad	  
range	   of	   dehydrogenation	   chemistries	   using	   various	   substrates	   and	   producing	   a	  
multitude	  of	  unsaturated	  products.	   	  Desaturases	  are	  capable	  of	  modifying	  four	  distinct	  
classes	  of	  acyl	  substrates:	  acyl-­‐CoAs,	  acyl-­‐ACPs,	  complex	  acyl-­‐lipids,	  and	  sphingolipids	  [5].	  	  
In	   addition	   to	   substrate	   specificity,	   these	   desaturases	   have	   also	   been	   found	   to	   have	  
different	   regioselectivities.	   	   For	   example,	   front-­‐end	   desaturases	   only	   catalyze	  
dehydrogenation	  of	  C4-­‐C8,	  while	  other	  desaturases	   express	   regioselectivities,	   primarily	  
∆9-­‐,	  ∆12-­‐,	  and	  ∆15.	  
Many	   attempts	   have	   been	   made	   at	   categorizing	   the	   desaturase	   family	   into	  
further	  subclasses.	   	  Categorization	  has	  been	  done	  on	  the	  basis	  of	  substrate	  specificity,	  
regioselectivity,	  and	  cell	   location.	   	  However,	  a	  more	   specific	  approach	   is	   to	   categorize	  
desaturases	   based	   on	   their	   amino	   acid	   sequences.	   	   In	   using	   this	   approach,	   two	  
evolutionarily	  distinct	  groups	  of	  desaturase	  enzymes	  have	  emerged.	  	  	  
	  
	  
1.3 The	  Two	  Classes	  of	  Desaturases	  
The	  smaller	  of	  the	  two	  classes	  includes	  the	  soluble	  desaturases.	  	  To	  date,	  soluble	  
desaturases	  have	  only	  been	  identified	  in	  plants,	  and	  are	  exclusively	  located	  in	  the	  plastid,	  
where	  they	  have	  been	  shown	  to	  act	  solely	  on	  acyl	  substrates	  esterified	  to	  an	  acyl	  carrier	  
protein	  (ACP).	  	  Crystallographic	  and	  enzymological	  studies	  have	  been	  made	  possible	  by	  
the	  soluble	  nature	  and	  relative	  ease	  of	  isolation	  of	  this	  group	  of	  desaturases.	  	  In	  1993,	  
Fox	   et	   al.	   used	   optical	   and	   Mössbauer	   spectroscopies	   to	   study	   a	   stearoyl-­‐ACP	   ∆9-­‐
desaturase	   from	   castor	   (Ricinus	   communis).	   	   Based	   on	   the	   spectroscopic	   data	   and	  
sequence	   homology,	   this	   study	   defined	   the	   presence	   of	   a	   di-­‐iron	   cluster	   and	   a	   highly	  




structures	   of	   the	   castor	   and	   ivy	   ACP-­‐desaturases,	   the	   participation	   of	   two	   conserved	  
D/EXXH	   motifs	   in	   binding	   the	   catalytically	   essential	   non-­‐heme	   di-­‐iron	   complex	   was	  
confirmed	  [7-­‐9].	  	  	  
The	   second	   and	   much	   more	   widespread	   class	   of	   desaturases	   is	   comprised	   of	  
integral	   membrane	   proteins,	   which	   includes	   enzymes	   involved	   in	   the	   biosynthesis	   of	  
exotic	  fatty	  acids	  (see	  section	  on	  diverged	  FAD2s	  below)	  and	  biologically	  essential	  PUFAs.	  	  
Although	   the	   two	   conserved	   D/EXXH	  motifs	   found	   in	   soluble	   desaturases	   are	   absent,	  
three	  highly	  conserved	  histidine	  motifs	  (or	  boxes)	  have	  been	  identified	  and	  are	  thought	  
to	  be	  involved	  in	  catalysis.	  	  Similar	  to	  the	  soluble	  class,	  these	  His	  boxes	  are	  believed	  to	  
participate	   in	  a	  non-­‐heme	  di-­‐iron	  complex.	   	  These	   three	  histidine	  motifs	  contain	  eight	  
His	   residues	   that,	  upon	   individual	  mutation,	   resulted	   in	   the	   loss	  of	  desaturase	  activity	  
[10].	   	   These	   eight	   His	   residues	   form	   three	   highly	   conserved	   boxes	   of	   the	   sequences:	  
H(X)3-­‐4H,	   H(X)2-­‐3HH,	   and	   H/Q(X)2-­‐3HH.	   	   Additionally,	   membrane-­‐bound	   desaturases	  
contain	   4-­‐6	   conserved	   hydrophobic	   regions,	   which	   are	   proposed	   to	   include	   four	   α-­‐
helical	  transmembrane	  domains	  that	  act	  to	  anchor	  the	  enzyme	  to	  the	  membrane	  bilayer	  
and	  orient	   the	  His	  boxes	  on	  the	  cytosolic	  side	  of	   the	  membrane	   [9,	  11,	  12]	   (Figure	  3).	  	  
Further	   purification	   and	   characterization	   studies	   of	   this	   class	   of	   enzymes	   have	   been	  
significantly	   impeded	  by	  the	   inherent	   instability	  of	   these	  redox-­‐active	  proteins	  outside	  






Figure	  3:	  A	  proposed	  topological	  model	  for	  a	  FAD2	  enzyme.	  The	  membrane-­‐bound	  enzyme	  is	  anchored	  to	  
the	   ER	   by	   four	   transmembrane	   domains.	   	   Also	   illustrated	   are	   the	   highly	   conserved	   His	   boxes	   that	   are	  
thought	  to	  bind	  a	  non-­‐heme	  di-­‐iron	  cluster	  (shown	  in	  orange)	  on	  the	  cytosolic	  side	  of	  the	  bilayer.	  
	  
	  
A	   series	   of	   investigations	   on	   the	   phylogenetically	   unrelated	   Pseudomonas	  
oleovorans	   alkane	  𝜔-­‐hydroxylase	   (AlkB)	  may	  help	  provide	   insight	   into	   the	   relationship	  
between	   soluble	   and	   membrane-­‐bound	   desaturation	   chemistry.	   	   AlkB	   is	   a	   bacterial	  
integral	  protein	  that	  requires	  iron	  and	  molecular	  oxygen	  for	  the	  conversion	  of	  octane	  to	  
n-­‐octanol	  [13].	  	  Mössbauer	  spectroscopic	  studies	  demonstrated	  the	  presence	  of	  a	  non-­‐
heme	   di-­‐iron	   cluster	   similar	   to	   that	   found	   in	   the	   soluble	   stearoyl-­‐ACP	   ∆9-­‐desaturase	  
from	  castor,	  but	  with	  spectroscopic	  parameters	  consistent	  with	  multiple	  His	  Ligands	  [14].	  	  
Additionally	   it	   was	   discovered	   that	   the	   di-­‐iron	   cluster	   was	   reduced	   upon	   addition	   of	  
sodium	  dithionite,	  but	  was	  reoxidized	  by	  the	  addition	  of	  O2	  and	  substrate	  proving	  the	  di-­‐
iron	  cluster’s	  potential	  for	  involvement	  in	  catalysis	  [14].	  	  	  
Despite	   the	   general	   lack	   of	   AlkB	   sequence	   homology	   with	   known	  membrane-­‐




which	  are	  also	  positionally	  conserved	  relative	  to	  the	  hydrophobic	  regions	  [15].	  	  Studies	  
carried	  out	  by	  Shanklin	  demonstrated	  a	  complete	  loss	  of	  hydroxylase	  activity	  when	  each	  
of	  the	  eight	  conserved	  His	  residues	  was	  mutated	  to	  alanine	  [15].	  	  Taking	  the	  Mössbauer	  
and	  mutagenesis	  data	  together	  it	  becomes	  clear	  that	  AlkB	  contains	  a	  catalytically	  active	  
non-­‐heme	  di-­‐iron	  cluster	  similar	  to	  that	  found	  in	  the	  soluble	  class	  of	  desaturases.	  	  This	  
more	  robust	  enzyme	  may	  help	  bridge	   the	  gap	  between	  soluble	  and	  membrane-­‐bound	  
desaturase	   catalysis,	   and	   serve	   as	   an	   accessible	  mechanistic	   and	   structural	  model	   for	  
membrane-­‐bound	  desaturation.	  
In	   order	   to	   catalyze	   dehydrogenation	   chemistry,	   all	   desaturases	   require	   an	  
electron	   source,	   a	   flavoprotein,	   and	  a	   conjugating	  group,	  which	   is	   frequently	  a	   carrier	  
protein.	   The	   electron	   transport	   components	   required	   for	   catalysis	   are	   linked	   to	   the	  
cellular	   localization	   rather	   than	   the	   solubilization	   of	   the	   group	   [8].	   	   The	   reducing	  
electrons	   for	   plastidal-­‐based,	   soluble	   desaturation	   are	   provided	   by	  NADPH.	   	   Reducing	  
equivalents	   are	   then	   transferred	   to	   the	   flavoprotein	   ferredoxin-­‐NADP+	  oxidoreductase	  
and	   passed	   down	   the	   electron	   transport	   chain	   to	   the	   soluble	   desaturase	   through	   the	  
2Fe-­‐2S	   ferredoxin	   electron	   carrier.	   	   However,	   if	   the	   soluble	   desaturase	   is	   located	   in	  
photosynthetic	   tissue,	   the	   reducing	  equivalents	  eminate	   from	  photosystem	   I	   and	  pass	  
directly	   to	   ferredoxin	   thus	   negating	   the	   need	   for	   NADPH	   and	   the	   flavoprotein	  
ferredoxin-­‐NADP+	  oxidoreductase	  [16].	  
	  
Figure	  4:	  Electron	  transport	  system	  for	  soluble	  desaturases.	  	  This	  figure	  shows	  the	  flow	  of	  electrons	  in	  the	  






Conversely,	   in	   the	   case	  of	  microsomal	   systems,	   the	   reducing	  equivalents	   come	  
from	   NADH,	   which	   are	   shuttled	   through	   the	   transport	   system	   by	   the	   flavoprotein	  
cytochrome	  b5	  reductase.	  	  These	  electrons	  are	  passed	  through	  the	  cytochrome	  b5	  carrier	  
protein	   to	   the	   desaturase,	   from	   where	   they	   are	   ultimately	   transferred	   to	   the	   final	  
acceptor	  O2	  (Figure	  5).	  
	  
Figure	  5:	  Electron	  transport	  system	  for	  microsomal	  desaturation.	  	  This	  figure	  shows	  the	  flow	  of	  electrons	  




In	   plants	   and	   fungi,	   18:2	   fatty	   acids	   are	   generated	   by	   the	   membrane-­‐bound	  
desaturase	  FAD2.	  	  The	  archetypical	  fatty	  acid	  desaturase-­‐2	  (fad2)	  gene	  encodes	  a	  ∆12-­‐
desaturase	   located	   within	   the	   endoplasmic	   reticulum	   membrane	   that	   desaturates	  
18:1∆9c	   esterified	   to	   phosphatidylcholine	   (PC)	   to	   form	   the	   product	   18:2∆9c,12c.	   	   FAD2	  
generally	  modifies	  substrates	  of	  16-­‐18	  carbons	  in	  length	  and	  produces	  double	  bonds	  in	  
the	   cis	   configuration.	   The	   FAD2	   family	   has	   been	   shown	   to	   contain	   the	   characteristic	  
transmembrane	   domains	   and	   highly	   conserved	   His	   boxes	   that	   are	   indicative	   of	   the	  
membrane-­‐bound	  desaturases.	  	  
Kinetic	   isotope	  effect	   (KIE)	  studies	  have	  been	  conducted	  to	  try	  to	  elucidate	  the	  
mechanism	   of	   desaturation	   carried	   out	   by	   FAD2	   in	   converting	   18:1∆9c	   to	   18:1∆9c,12c.	  	  
Heterologous	  expression	  of	  A.	  thaliana	  FAD2	  in	  S.	  cerevisiae	  supplemented	  with	  [12,12-­‐	  
2H2]-­‐oleate	   and	   [13,13-­‐2H2]-­‐oleate	   demonstrated	   a	   large	   primary	   deuterium	   isotope	  




it	   was	   discovered	   that	   the	   C13-­‐H	   bond-­‐breaking	   step	   was	   insensitive	   to	   deuterium	  
substitution	  (kH/kD	  =	  1.05	  ±0.04).	   	  A	  second	   investigation	   into	  the	  mechanism	  of	  FAD2	  
desaturation	   was	   carried	   out	   by	   Behrouzian	   [18].	   	   The	   observed	   KIE	   of	   the	   Chlorella	  
vulgaris	  FAD2,	  where	  the	  values	  for	  C12-­‐H	  and	  C13-­‐H	  were	  kH/kD	  =	  7.4	  ±	  0.3	  and	  kH/kD	  =	  
1.08	  ±	  0.01,	   respectively,	  was	  nearly	   identical	   to	  the	  data	  obtained	  for	  the	  A.	  thaliana	  
homolog.	  	  By	  studying	  the	  KIE	  of	  stereospecifically	  labeled	  oleates,	  Stymne	  was	  able	  to	  
determine	   that	   the	   pro-­‐(R)	   hydrogen	   at	   C12	   is	   the	   proton	   abstracted	   first	   in	   the	  
formation	  of	  linoleate	  [19].	  	  Taken	  together,	  these	  data	  provide	  evidence	  for	  a	  stepwise	  
mechanism	  of	   desaturation,	   in	  which	   the	   rate-­‐limiting	   hydrogen	   abstraction	   occurs	   at	  
the	  pro-­‐(R)	  hydrogen	  on	  C12.	  	  This	  is	  followed	  by	  a	  rapid	  collapse	  of	  the	  highly	  unstable	  
intermediate	  and	  subsequent	  loss	  of	  a	  hydrogen	  attached	  to	  the	  C13	  atom.	  
	  
	  
1.5 Diverged	  FAD2s	  
Through	  broad	  efforts	  to	   identify	  and	  investigate	  FAD2s	  from	  plants,	  fungi,	  and	  
other	  organisms,	  it	  has	  been	  discovered	  that	  a	  range	  of	  FAD2	  subtypes	  exists.	  	  Many	  of	  
these	  enzymes	  are	  known	  as	  divergent	  FAD2s,	  FAD2-­‐like	  desaturases,	  or	  FAD2	  variants,	  
for	   their	   proficiency	   in	   carrying	   out	   a	   wide	   array	   of	   fatty	   acid	   modifications	   while	  
possessing	   a	   similar	   primary	   sequence	   to	   the	   prototypical	   enzymes.	   	   Diverged	   FAD2	  
desaturases	  have	   the	   ability	   to	   carry	   out	   hydroxylation,	   epoxidation,	   conjugation,	   and	  
acetylenation	  chemistry	  with	  unsaturated	  fatty	  acids	  (Figure	  6).	  	  These	  exotic	  fatty	  acids	  
are	   important	  commercial	  products.	   	  Hydroxy	   fatty	  acids	  can	  be	  used	  as	   lubricants,	   in	  
plastics,	   and	   in	   cosmetics,	   [20,	   21]	   whereas	   conjugated	   products	   are	   used	   as	   drying	  
agents,	  such	  as	  in	  paints	  and	  ink	  [22].	  	  
In	   1995,	   the	   first	   FAD2	   variant,	   a	   ∆12-­‐hydroxylase	   from	   castor	   (Ricinus	  
communis),	   was	   described.	   	   The	   hydroxylase	   was	   realized	   to	   have	   67%	   sequence	  
similarity	  with	  the	  well-­‐studied	  FAD2	  of	  Arabidopsis	  [23].	  	  When	  the	  gene	  was	  expressed	  
in	  transgenic	  tobacco,	  an	  accumulation	  of	  low	  levels	  of	  ricinoleic	  acid	  (18:1∆9c,12OH)	  was	  




	  ∆12-­‐hydroxylase	   has	   since	   been	   isolated	   from	   Lesquerella	   fendleri	   [24].	   	   This	   cDNA	  
showed	   71%	   and	   81%	   identity	   with	   the	   castor	   hydroxylase	   and	   Arabidopsis	   FAD2,	  
respectively.	   	   Upon	   expression	   of	   the	   L.	   fendleri	   hydroxylase	   in	   Arabidopsis,	   the	  
transgenic	   seeds	  were	  observed	   to	  accumulate	  18:1∆9c,12OH,	  18:1∆9c,12OH,15c,	  20:1∆11c,14OH	  
and	  trace	  amounts	  of	  20:2∆11c,14OH,17c.	  	  	  
	  
Figure	   6:	   FAD2	   and	   FAD2	   variant	   chemical	   modifications.	   	   The	   prototypical	   FAD2	   carries	   out	   the	   ∆12	  
desaturation	  step	   indicated	  by	   the	  blue	  arrow.	   	  Meanwhile,	  FAD2	  variants	  carry	  out	  manipulations	   that	  
result	  in	  hydroxyl,	  epoxy,	  conjugated,	  and	  acetylenic	  fatty	  acids	  represented	  by	  the	  green,	  pink,	  red,	  and	  
black	  arrows,	  respectively.	  
	  
	  
Research	   into	  the	  Crepis	  genus	  has	  established	  that	  C.	  alpina	  and	  C.	  palaestina	  
seed	   oils	   contain	   roughly	   70%	   crepenynic	   acid	   (18:1∆9c,12a)	   and	   60%	   vernolic	   acid	   (12-­‐
epoxy-­‐18:1∆9c),	   respectively	   [25].	   	   In	   1998,	   the	   Stymne	   lab	   characterized	   the	   enzymes	  




species	   [25].	   	   A	   full-­‐length	   cDNA	   designated	   Cpal2	   was	   obtained	   from	   C.	   palaestina	  
seeds	  and	  the	  deduced	  amino	  acid	  sequence	  was	  found	  to	  have	  58%	  identity	  with	  the	  
Arabidopsis	   FAD2	   and	   53%	   identity	   with	   the	   aforementioned	   castor	   ∆12-­‐hydroxylase.	  	  
Cpal2	  was	  transformed	  into	  A.	  thaliana	  and	  the	  total	  fatty	  acids	  from	  transgenic	  seeds	  
accrued	  up	  to	  15%	  of	  12-­‐epoxy-­‐18:1∆9c,	  indicating	  that	  Cpal2	  from	  C.	  palaestina	  is	  a	  ∆12-­‐
epoxygenase	  [25].	  	  
Similarly,	   a	   full-­‐length	   cDNA	   (Crep1)	   was	   obtained	   from	   C.	   alpina	   seeds	   that	  
coded	   for	   a	   protein	  with	   56%	   sequence	  homology	   to	  Arabidopsis	   thaliana	  FAD2,	   59%	  
with	  the	  castor	  ∆12-­‐hydroxylase,	  and	  81%	  identity	  with	  Cpal2.	  	  The	  fatty	  acid	  profile	  of	  
transgenic	  yeast	  expressing	  the	  Crep1	  cDNA	  revealed	  a	  0.3%	  accumulation	  of	  crepenynic	  
acid	   (18:1∆9c,12a).	   	   Upon	   expression	   of	   Crep1	   in	   Arabidopsis,	   the	   total	   fatty	   acids	   of	  
transgenic	  seeds	  contained	  as	  much	  as	  25%	  18:1∆9c,12a	  [25].	  	  This	  landmark	  study	  was	  the	  
first	  time	  that	  a	  ∆12-­‐acetylenase	  or	  ∆12-­‐epoxygenase	  had	  been	  cloned	  and	  functionally	  
characterized.	  
Another	   example	   of	   divergent	   FAD2	   activity	   can	   be	   viewed	   in	   the	   2002	  
investigation	  carried	  out	  by	  Dyer	  [22].	  	  In	  this	  study,	  it	  was	  discovered	  that	  two	  cDNAs,	  
designated	   FAD2	   and	   FADX,	   isolated	   from	   tung	   seeds	   (Aleurites	   fordii	   Hemsl)	   were	  
largely	  homologous	  to	  the	  Arabidopsis	  FAD2.	  	  The	  cDNA	  indicated	  as	  FAD2	  possessed	  78%	  
homology	   and	   carried	   out	   the	   quintessential	   FAD2	   ∆12	   desaturation.	   	   However,	   the	  
FADX	   cDNA	   was	   identified	   as	   a	   bifunctional,	   divergent	   FAD2	   with	   69%	   identity	   to	   A.	  
thaliana	  FAD2.	   	  The	  FADX	  gene	  displayed	  ∆12-­‐conjugase	  activity,	  acting	  to	  convert	  the	  
∆12	  bond	  of	  18:2∆9c,12c	  into	  the	  conjugated	  product	  18:3∆9c,11t,13t	  [22].	  
Many	  of	  the	  FAD2	  variants	  contain	  multifunctional	  activities.	  	  Beyond	  having	  ∆12	  
conjugation	   activity,	   FADX	   performed	   ∆12	   desaturation	   stereoselectively	   in	   the	   trans	  
configuration	  generating	  a	  multitude	  of	  desaturation	  products,	   ranging	   from	  16:2∆9c,12t	  
to	  18:2∆9c,12t	  to	  18:4∆6c,9c,11t,13t	  [22].	  	  Further	  investigation	  into	  Crep1	  and	  Cpal2	  exhibited	  
that	  Crep1	  has	  both	  ∆12	  cis	  and	  trans	  desaturation	  activity,	  as	  well	  as	  the	  acetylenase	  
activity	  described	  earlier,	  while	  the	  ∆12-­‐epoxygenase	  was	  uncovered	  to	  also	  possess	  a	  





A	  number	  of	  acetylenase	  genes	  have	  been	  isolated	  from	  various	  organisms	  and	  
functionally	  characterized.	  	  To	  date,	  acetylenases	  universally	  belong	  to	  the	  membrane-­‐
bound	  desaturase	  group.	  	  They	  harbor	  the	  same	  four	  hydrophobic	  regions	  characteristic	  
of	   other	   membrane	   desaturases	   and	   the	   three	   His	   motifs	   that	   are	   believed	   to	   be	  
involved	  in	  catalysis.	  	  	  
With	  many	  of	  the	  same	  structural	  features	  as	  membrane-­‐bound	  desaturases,	  it	  is	  
believed	  that	  the	  mechanism	  used	  for	  the	  formation	  of	  the	  alkyne	   is	  analogous	  to	  the	  
mechanism	   used	   in	   generating	   an	   alkene	   functional	   group	   (Figure	   7).	   	   Evidence	  
supporting	  this	  hypothesis	  was	  obtained	  through	  kinetic	  isotope	  studies.	  	  Deuterium	  KIE	  
experiments,	   conducted	   through	   heterologous	   expression	   of	   CREP1	   in	   S.	   cerevisiae,	  
uncovered	  a	  stepwise	  mechanism	  for	  the	  dehydrogenation	  of	   linoleate	  to	  crepenynate	  
[26].	  The	  C-­‐H	  bond	  at	  C12	  was	  very	  sensitive	  to	  labeled	  substitution	  (kH/kD	  =	  14.6	  ±	  3.0)	  
but,	   in	  contrast,	  the	  C13	  cleavage	  was	  relatively	  unaffected	  (kH/kD	  =	  1.25	  ±	  0.08).	   	  This	  
data	  provides	  evidence	  that	  the	  acetylenation	  reaction	  proceeds	  via	  initial	  breakage	  of	  
the	  C12-­‐H	  bond,	  and	  is	  followed	  by	  a	  rapid	  cleavage	  of	  the	  C13-­‐H	  bond	  analogous	  to	  the	  ∆12-­‐desaturation	  mechanism	  described	  earlier.	  
	  
Figure	  7:	  The	  proposed	  electron	  transport	  system	  and	  mechanism	  for	  acetylenation.	  
	  
	  
The	  isolation	  and	  functional	  characterization	  of	  several	  other	  plant	  acetylenases	  
has	   been	   made	   possible	   by	   their	   substantial	   sequence	   homology	   to	   FAD2	   and	   other	  




Arabidopsis	  FAD2,	  whereas	  the	  translation	  of	  the	  variant	  ELI12	  gene	  has	  61%	  [27].	  	  The	  
ELI12	  gene,	  whose	  expression	  is	  induced	  by	  fungal	  elicitation,	  demonstrated	  no	  activity	  
when	   expressed	   in	   S.	   cerevisiae.	   	   In	   contrast,	   expression	   of	   the	   gene	   in	   soybean	  
displayed	   the	   accumulation	   of	   both	   18:1∆9c,12a	   and	   (14Z)-­‐dehydrocrepenynic	   acid	  
(18:2∆9c,12a,14c)	  to	  a	  level	  of	  1.4	  and	  2.2%	  of	  the	  total	  FAMEs,	  respectively	  [28].	  	  This	  data	  
allowed	  for	  the	  ELI12	  gene	  to	  be	  redesignated	  PcACET.	  
The	   functionality	   of	   other	   divergent	   FAD2s	   from	   English	   ivy	   (Hedera	   helix),	  
sunflower	   (Helianthus	   annuus),	   and	   Calendula	   officinalis	  were	   also	   investigated	   [28].	  	  
The	   corresponding	   FAD2	   variant	   from	   ivy	   was	   found	   to	   contain	   90%	   identity	   with	  
PcACET,	   and	  upon	  expression	   in	   soybean	  embryos	   the	   accumulation	  of	   18:1∆9c,12a	   and	  
18:2∆9c,12a,14c	  was	  over	  6%	  of	  the	  total	  fatty	  acids,	  combined.	  	  The	  FAD2-­‐related	  EST	  from	  
sunflower	  has	  only	  57%	  homology	  to	  HhACET,	  but	  was	  shown	  to	  have	  approximately	  75%	  
amino	  acid	   identity	   to	   the	  Crepis	  acetylenase	  and	  epoxygenase.	   	  Again,	   the	   transgenic	  
soybean	   embryos	   expressing	   the	   diverged	   desaturase	   from	   sunflower	  was	   verified	   to	  
accumulate	   crepenynate	   and	   dehydrocrepenynate.	   	   Originally,	   Fritsche	   et	   al.	  
functionally	  characterized	  the	  divergent	  FAD2	  from	  C.	  officinalis	  as	  a	  ∆8,	  ∆11-­‐desaturase,	  
acting	   on	   the	   18:2∆9c,12c	   substrate	   and	   forming	   the	   conjugated	   fatty	   acid	   product,	  
calendic	   acid	   (18:2∆8t,10t,12c).	   	   However,	   the	   characterization	   was	   based	   on	   a	   flawed	  
interpretation	   of	   UV	   data	   of	   fatty	   acids	   isolated	   from	   recombinant	   yeast	   expression	  
cultures	  [29].	  	  As	  the	  Calendula	  enzyme	  possessed	  91%	  amino	  acid	  sequence	  identity	  to	  
the	  H.	  annuus	  ∆12-­‐acetylenase,	  it	  was	  reinvestigated	  and	  functionally	  determined	  to	  be	  
an	  acetylenase	  upon	  expression	  in	  somatic	  soybean	  embryos	  [28].	  
In	   addition	   to	   plant	   ∆12-­‐acetylenases,	   there	   are	   examples	   of	   ∆12-­‐acetylenases	  
from	  other	  eukaryotes,	  as	  well	  as,	  other	  acetylenases	  with	  different	  regioselectivities.	  	  A	  
fungal	  ∆12-­‐acetylenase	  from	  Cantharellus	  formosus,	  a	  moss	  bifunctional	  ∆6-­‐acetylenase,	  
and	  a	  multifunctional	  ∆11-­‐acetylenase	  from	  the	  moth	  Thaumetopoea	  pityocampa	  have	  
been	   reported	   [30-­‐32].	   These	   examples	   illuminated	   the	   potential	   for	   fatty	   acyl	  




desaturases.	  	  If	  so,	  this	  ever-­‐expanding	  variation	  in	  substrate	  specificity	  could	  contribute	  
to	  the	  large	  diversity	  of	  acetylenic	  natural	  products.	  
	  
	  
1.7 Acetylenic	  Natural	  Products	  
Acetylenic	  natural	  products	  are	  metabolites	  that	  contain	  a	  carbon-­‐carbon	  triple	  
bond,	  and	  have	  been	  unearthed	  in	  a	  variety	  of	  organisms	  ranging	  from	  terrestrial	  plants,	  
mammals,	   amphibians,	   and	   marine	   algae.	   	   As	   the	   most	   frequently	   encountered	  
acetylenic	   natural	   products	   are	   polyacetylenes,	   early	   research	   into	   these	   compounds	  
was	   limited	   by	   the	   inherent	   instability	   and	   seeming	   ease	   of	   in	   vivo	   degradation	   of	  
acetylenes.	   	   Starting	   in	   the	   1950’s	   and	   carrying	   through	   the	   1990’s,	   studies	   into	   the	  
synthesis,	   isolation,	   and	   biogenesis	   of	   acetylenic	   natural	   products	   were	   pioneered	   by	  
the	  labs	  of	  Sir	  E.H.R.	  Jones,	  F.	  Bohlmann,	  and	  J.	  D.	  Bu’Lock	  [33,	  34].	  	  	  
The	   first	   real	   insight	   into	   the	   biosynthesis	   of	   acetylenic	   secondary	  metabolites	  
came	  when	   [1-­‐14C]acetate	   feedings	   in	   the	   fungus,	   Polyporus	   anthracophilus,	   revealed	  
the	   labeling	   of	   the	   odd-­‐numbered	   carbons	   in	  matricaria	   ester	   (Figure	   8)	   [33,	   35].	   	   In	  
addition,	   labeled	   acetylenic	   natural	   products	   have	   been	   observed	   in	   feeding	  
experiments	  with	   [2-­‐14C]-­‐malonate	   [33,	  34].	   	  Given	  these	  results,	   it	  was	  proposed	  that	  
naturally	   occurring	   acetylenes	   are	   mainly	   derived	   from	   fatty	   acids,	   although	   many	  
details	  of	  simple	  fatty	  acid	  synthesis	  was	  unknown	  at	  the	  time	  [33].	  
The	   formation	   of	   acetylenic	   natural	   products	   is	   thought	   to	   proceed	   by	   one	   of	  
three	   major	   biosynthetic	   pathways:	   the	   crepenynic	   acid	   pathway,	   the	   stearolic	   acid	  
pathway,	  and	  the	  tariric	  acid	  pathway.	  	  These	  pathways	  differ	  from	  one	  another	  based	  
on	  the	  regioselectivities	  of	  desaturation	  and/or	  acetylenation	  of	  the	  precursor	  oleic	  acid,	  
leading	   to	   the	   formation	   of	   crepenynic	   acid	   (18:1∆9c,12a),	   stearolic	   acid	   (18:0∆9a),	   and	  
tariric	  acid	  (18:0∆6a),	  respectively.	  	  A	  survey	  of	  the	  literature	  appears	  to	  suggest	  that	  the	  
vast	  majority	  of	  acetylenic	  metabolites	  are	  synthesized	  via	  the	  crepenynic	  acid	  pathway	  




metabolites	   (ranging	   from	  C8-­‐C18)	   are	   primarily	   derived	   from	  C18	   fatty	   acids	   that	   have	  
their	   chain	   length	   altered	   through	   oxidative	   processes	   as	   they	   are	   processed	   into	   the	  
secondary	  metabolite.	  
Over	  the	  years,	  feeding	  experiments	  with	  labeled	  fatty	  acid	  precursors,	  as	  well	  as,	  
labeled	   fatty	  acids	  have	   led	   to	  a	  model	  of	  acetylenic	  metabolite	  production	  beginning	  
with	  basic	   fatty	  acids	   [33-­‐35].	   	  One	  of	   the	  most	  notable	  biochemical	  advancements	   in	  
the	   field	   came	   in	   1998	  when	   the	   Stymne	   lab	   cloned	   and	   characterized	   the	   first	   ∆12-­‐
acetylenase,	   Crep1	   [25].	   	   Stymne	   showed	   that	   Crep1	   uses	   linoleate	   as	   a	   substrate	   to	  
form	  the	  branchpoint	  metabolite	  crepenynic	  acid	  by	  further	  desaturating	  the	  cis	  double	  
bond	   at	   the	   ∆12	   position,	   establishing	   the	   relationship	   between	   desaturases	   and	  
acetylenases.	  
	  
Figure	  8:	  Biologically	  active	  acetylenic	  natural	  products.	  
	  
	  
On	   several	   occasions,	   these	   naturally	   occurring	  metabolites	   have	   been	   found	   to	  
contain	   biological	   activities	   including:	   anti-­‐fungal,	   anti-­‐bacterial,	   anti-­‐viral,	   and	   anti-­‐




finding	   that	   the	   Carthamus	   tinctorius	   metabolite	   safynol	   inhibited	   the	   growth	   of	   the	  
fungus	  Phytophthora	   drechsleri	   [36].	   	   Additionally,	   three	   classes	   of	   polyacetylenes	   from	  
Rudbeckia	   hirta	   have	   been	   shown	   to	   have	   photoinduced	   insecticidal	   properties	   toward	  
mosquito	  larvae	  and	  the	  tobacco	  hornworm	  [37].	   	  Furthermore,	  the	  acetylenic	  fatty	  acid	  
dehydrocrepenynate	  is	  an	  inhibitor	  of	  bacterial	  conjugation,	  which	  plays	  a	  key	  role	  in	  the	  
spread	  of	  bacterial	  antibiotic	  resistance	  [38].	   	   It	  has	  also	  been	  determined	  that	  at	   lower,	  
dietary	   concentrations	   (–)-­‐falcarinol,	   a	   polyacetylene	   isolated	   from	   carrots	   and	   ginseng,	  
has	  chemoprotective	  effects,	  as	  verified	  in	  a	  murine	  colon	  cancer	  model	  [39].	  	  
	  




Many	  other	  examples	  of	  polyacetylene	  bioactivity	  have	  been	  identified	  over	  the	  
past	  couple	  of	  decades	  [34,	  41].	   	  However,	  specific	  cases	  are	  beyond	  the	  scope	  of	   the	  
current	  work	  and	  therefore,	  interested	  readers	  are	  directed	  to	  the	  above	  literature	  for	  a	  
more	  detailed	  background	  of	  these	  interesting	  properties.	  	  Nevertheless,	  the	  biological	  
activities	  of	  this	  class	  of	  compounds	  indicate	  the	  significance	  for	  research	  in	  the	  area	  of	  
acetylenic	  natural	  products,	  while	  there	   is	  still	  much	   investigation	  needed	  to	  elucidate	  
whether	  a	  general	  mechanism	  is	  involved	  in	  the	  biosynthesis	  of	  these	  molecules.	  
This	  thesis	  investigates	  the	  dehydrogenation	  pathways	  involved	  in	  the	  formation	  
of	   polyacetylenes	   found	   in	   the	   fungus	   Fistulina	   hepatica	   and	   the	   plant	   Echinacea	  
purpurea.	   	   Heterologous	   expression	   in	   yeast	   of	   gene	   targets	   isolated	   from	   both	   F.	  
hepatica	  and	  E.	  purpurea	  have	  led	  to	  the	  production	  of	  crepenynic	  acid,	  verifying	  their	  
ability	   to	   execute	   the	   first	   step	   in	   the	   formation	   of	   polyacetylenic	   natural	   products.	  	  
Additionally,	   a	   second	   gene	   isolated	   from	   F.	   hepatica	   encoded	   the	   ability	   to	   perform	  
multiple	   dehydrogenation	   steps	   beyond	   the	   formation	   of	   crepenynic	   acid,	   that	   are	  
consistent	  with	  the	  hypothetical	  crepenynate	  pathway	  proposed	  by	  Bu’Lock.	  	  These	  two	  
studies	  have	  provided	  concrete	  evidence	  supporting	  the	  hypothesis	  that	  the	  crepenynic	  
acid	   pathway	   is	   involved	   in	   the	   biogenesis	   of	   natural	   acetylenes	   accumulated	   by	   F.	  












CHAPTER	  2. 	  FISTULINA	  HEPATICA	  
2.1 Background	  
Basidiomycete	   (club)	   fungi	   are	   known	   to	   biosynthesize	   an	   array	   of	   mostly	  
lipophilic	  acetylenic	  natural	  products	  (Figure	  10).	  	  Although	  acetylenic	  natural	  products	  
have	   also	   been	   isolated	   from	   plants,	   acetylenic	   fatty	   acids	   rarely	   accumulate	   to	  
substantial	   levels	   in	   green	   tissue.	   	   In	   contrast,	   it	   is	   more	   common	   to	   see	   the	  
accumulation	   of	   acetylenic	   fatty	   acids	   in	   fungi	   [34].	   The	   acetylenic	   fatty	   acid	  
dehydrocrepenynic	  acid	  (18:2∆9c,12a,14c)	  has	  been	  shown	  to	  accumulate	  to	  between	  60-­‐70%	  
of	  the	  fatty	  acyl	  content	  in	  the	  ectomycorrhyzial	  fungi	  of	  the	  family	  Cantharellaceae	  [42,	  
43].	  
A	  previous	   study	  on	   the	   fungus	  Cantharellus	   formosus	  was	  able	   to	   functionally	  
characterize	  two	  putative	  FAD2s	  through	  heterologous	  expression	   in	  S.	  cerevisiae	   [30].	  	  
The	   first	   gene	   target	  was	   identified	   as	   a	   ∆12-­‐desaturase	   (CfDES),	   producing	   16:2∆9c,12c	  
and	  18:2∆9c,12c	  as	  7.6%	  and	  18.9%	  of	  the	  total	  fatty	  acids,	  respectively.	  	  The	  second	  of	  the	  
putative	  FAD2s	  was	  revealed	  to	  accumulate	  0.52%	  18:1∆9c,12a	  upon	  supplementation	  of	  
linoleate,	  allowing	  this	  gene	  to	  be	  designated	  as	  a	  ∆12-­‐acetylenase	  (CfACET).	  	  Upon	  co-­‐
expression	  of	  CfDES	  and	  CfACET,	  the	  formation	  of	  dehydrocrepenynic	  acid	  was	  detected,	  
likely	   implicating	  a	  substrate-­‐dependent	  perturbation	  of	  the	  ∆12-­‐desaturase	  activity	  as	  
being	  responsible	  for	  the	  formation	  of	  18:2∆9c,12a,14c	  in	  C.	  formosus.	  This	  study	  is	  the	  first	  
and	   only	   time	   a	   fungal	   acetylenase	   has	   been	   isolated,	   to	   date,	   and	   provides	   the	   first	  
enzymatic	   evidence	   for	   the	   involvement	   of	   the	   crepenynic	   acid	   pathway	   in	   fungal	  





Figure	  10:	  Examples	  of	  acetylenic	  natural	  products	  isolated	  from	  fungal	  species.	  
	  
	  
Another	   polyalkyne-­‐producing	   basidiomycete	   is	   Fistulina	   hepatica.	   	   This	   edible	  
mushroom	  is	  commonly	  referred	  to	  as	  beefsteak	  fungus,	  a	  moniker	  that	  is	  derived	  from	  
its	  similarities	  in	  appearance	  of	  the	  fungus	  to	  that	  of	  raw	  meat.	  	  Fistulina	  is	  a	  brown-­‐rot	  
fungus	  that	  can	  typically	  be	  found	  living	  on	  the	  wood	  of	  oak	  and	  chestnut	  trees	  and	  has	  
been	   investigated	   for	   its	   phenolic	   and	   volatile	   compounds	   [44,	   45].	   	   However,	   what	  
sparked	  these	  studies	  was	  the	  isolation	  by	  Jones	  of	  five	  polyacetylenic	  natural	  products	  
from	   liquid	   cultures	   of	   F.	   hepatica	   (Figure	   11)	   [46].	   	   The	   tetrayne-­‐tetraol	   (5)	   was	  
determined	  to	  possess	  modest	  antibacterial	  activity	  against	  Staphylococcus	  aureus	  and	  
Salmonella	   typhi	   [46].	   	   Since	   this	   initial	   study,	   other	   examples	   of	   bioactive	  






Figure	  11:	  Polyacetylenes	  identified	  in	  Fistulina	  hepatica	  by	  Jones	  [46].	  
	  
	  
	   	  Radiolabeled	   tracer	   studies	   with	   oleic,	   linoleic,	   crepenynic,	   and	  
dehydrocrepenynic	  acids	  have	  validated	  their	   incorporation	  into	  fungal	  polyacetylenes,	  
including	  dehydromatricaria	  acid,	  odyssic	  acid,	  and	  nemotinic	  acid	   [40,	  49,	  50].	   	  Taken	  
together	  with	  the	  array	  of	  acetylenic	  metabolites	  produced	  by	  beefsteak	  fungus	  and	  the	  
recent	   identification	   of	   the	   first	   crepenynate-­‐producing	   fungal	   acetylenase	   from	  
Cantharellus,	  it	  is	  hypothesized	  that	  the	  crepenynic	  acid	  pathway	  is	  active	  in	  F.	  hepatica.	  	  
In	   this	   chapter,	  we	   investigate	   the	   involvement	  of	   the	  crepenynic	  acid	  pathway	   in	   the	  
formation	  of	   alkyne-­‐containing	  natural	   products	   in	  F.	   hepatica.	   This	   chapter	   describes	  
the	   functional	   characterization	  of	   two	   fungal	   diverged	  desaturases:	   a	  ∆12-­‐acetylenase	  
and	   the	   initial	   example	   of	   a	  multifunctional	   fatty	   acid	   diacetylenase,	   capable	   of	   ∆14-­‐	  




supports	   that	   this	   pathway	   does	   indeed	   contribute	   to	   polyacetylenic	   natural	   product	  
synthesis	   in	   Fistulina.	   	   This	   work	   therefore	   provides	   the	   first	   evidence	   of	   enzymatic	  
participants	  involved	  in	  the	  formation	  of	  intermediates	  beyond	  dehydrocrepenynate	  en	  
route	  to	  polyacetylenes	  and	  supports	  the	  original	  crepenynic	  acid	  pathway	  outlined	  by	  
Bu’Lock	  [40].	  	  
	  
	  
2.2 Materials	  and	  Methods	  
	  
	  
2.2.1 Preparation	  of	  Genomic	  DNA	  Library	  for	  Fistulina	  hepatica	  
F.	  hepatica	  (ATCC	  strain	  64428)	  was	  grown	  on	  solid	  YM	  media	  at	  22	  °C-­‐26	  °C	  to	  
reach	  confluence	  (approximately	  6	  weeks).	  	  The	  isolation	  of	  gDNA	  was	  adapted	  from	  the	  
general	  method	  of	  Möller	  et	  al.,	  and	  included	  the	  optional	  RNase	  A	  treatment	  step	  [51].	  	  
Using	   a	   chilled	  mortar	   and	   pestle,	   1.3	   g	   of	   fresh	   Fistulina	  mycelia	   and	   fruiting	   bodies	  
were	   frozen	   in	   liquid	   N2	   and	   ground	   to	   a	   fine	   powder	   in	   the	   presence	   of	   an	   equal	  
amount	  of	  glass	  beads.	  	  The	  large-­‐scale	  extraction	  of	  gDNA	  was	  performed	  as	  described	  
by	  Möller	  with	  the	  volumes	  increased	  approximately	  100	  fold.	   	  The	  isolated	  gDNA	  was	  
further	   purified	   by	   using	   Qiagen	   genomic	   tip-­‐100	   (Qiagen,	   Valencia,	   CA).	   	   Using	   the	  
purified	   F.	   hepatica	   gDNA	   a	   21.8-­‐Mb	   Roche	   454	   shotgun	   sequence	   library	   was	  




2.2.2 Cloning	  and	  Sequencing	  of	  Putative	  Desaturases	  from	  Fistulina	  
Total	   RNA	  was	   isolated	   from	   Fistulina	  mycelia	   and	   fruiting	   bodies	   using	   TRIzol	  
(Invitrogen,	  Carlsbad,	  CA)	  following	  the	  manufacturer’s	  instructions.	  	  The	  poly	  (A)+	  RNA	  
was	  isolated	  from	  total	  RNA	  using	  the	  Dynabeads	  mRNA	  Purification	  Kit	  (Invitrogen)	  and	  
was	   converted	   to	   rapid	   amplification	   of	   cDNA	   ends	   (RACE)-­‐ready	   cDNA’s	   with	   the	  
SMARTer	   RACE	   cDNA	  Amplification	   Kit	   (Clontech,	  Mountain	   View,	   CA).	   	   To	   determine	  




were	  used	  in	  a	  RACE	  approach	  to	  obtain	  partial	  cDNA’s	  for	  both	  Fhe04128	  and	  Fhe10752	  
genes	  (Table	  14,	  Appendix	  A).	   	  Using	  the	  RACE-­‐ready	  cDNA’s	  and	  the	  Advantage	  2	  PCR	  
kit	   (Clontech),	   5’-­‐	   and	   3’-­‐	   RACE	   products	  were	   obtained	   and	   T/A	   cloned	   into	   pCR2.1-­‐
TOPO	   vector	   (Invitrogen).	   	   The	   RACE	   constructs	   were	   then	   transformed	   into	   DH5α	  
chemically	  competent	  E.	  coli.	  	  Insert-­‐containing	  plasmids	  were	  purified	  with	  Wizard	  DNA	  
spin	  columns	  (Promega,	  Madison,	  WI)	  and	  bidirectionally	  sequenced.	  
The	  collected	  data	  was	  used	  to	  develop	  full-­‐length	  primers	  containing	  a	  His6	  tag	  
and	   5’-­‐BamHI	   and	   3’-­‐NotI	   restriction	   sites	   (Table	   14,	   Appendix	   A).	   	   The	   full-­‐length	  
transcripts	  were	  obtained	  by	  Vent	  PCR	  and	  cloned	   into	  pYES2	  expression	  vector	  using	  
the	  aforementioned	  restriction	  sites	  and	  T4	  DNA	  ligase	  (Gibco	  BRL,	  San	  Francisco,	  CA).	  	  
The	   full-­‐length,	   His6	   fusion-­‐	   tagged	   constructs	  were	   transformed	   into	   competent	   XL1-­‐
Blue	  E.	  coli	  and	  sequenced	  to	  verify	  their	  integrity.	  
	  
	  
2.2.3 Expression	  of	  Fhe04128	  and	  Fhe10752	  
The	   activities	   of	   the	   putative	   desaturases	   Fhe04128	   and	   Fhe10752	   were	  
characterized	  using	  the	  Saccharomyces	  cerevisiae	  strain	  InvSc1.	  	  Constructs	  of	  Fhe04128	  
and	   Fhe10752	   were	   transformed	   into	   baker’s	   yeast	   using	   a	   standard	   lithium	   acetate-­‐
polyethylene	  glycol	  method	  of	  Gietz	   [52]	  with	  selection	  on	  complete	  minimal	  medium	  
lacking	  uracil	  and	  containing	  dextrose	  (CM-­‐ura+dex)	  for	  3	  days	  at	  30	  °C	  [53].	  	  YPD	  liquid	  
starter	  cultures	  (1%	  yeast	  extract,	  2%	  peptone,	  and	  2%	  dextrose)	  of	  single	  transformants	  
were	  grown	  at	  30	  °C	  overnight	  with	  240	  rpm	  shaking.	  	  For	  expression	  cultures,	  50	  μl	  of	  
fresh	  YPD	  starter	  culture	  was	  inoculated	  into	  5-­‐mL	  CM-­‐ura+2%	  galactose	  and	  grown	  at	  
22	   °C	  with	   240	   rpm	   for	   24	   h	   followed	  by	   expression	   at	   15	   °C	  with	   240	   rpm	   for	   72	   h.	  	  
When	  exogenous	  fatty	  acids	  were	  fed,	  the	  5-­‐mL	  expression	  culture	  contained	  0.1%	  (w/v)	  






2.2.4 GC/MS	  Analysis	  of	  Yeast	  Lipids	  
Fatty	   acid	   methyl	   ester	   (FAME),	   pyrrolidide	   (FAPy),	   and	   dimethyloxazoline	  
(DMOX)	  derivatives	  from	  yeast	  cultures	  were	  prepared	  as	  previously	  described	  [54,	  55].	  	  
In	  preparation	   for	  DMOX	  synthesis,	   the	  dried	  FAMEs	  were	   initially	   reacted	  with	  0.5	  M	  
NaOH	  in	  90%	  aqueous	  MeOH	  at	  80	  °C	  for	  1	  h,	  followed	  by	  acidification	  with	  1	  M	  HCl	  to	  
generate	  the	  free	  fatty	  acids.	  	  The	  free	  fatty	  acid	  mixture	  was	  diluted	  with	  1	  mL	  of	  water	  
and	  extracted	  with	  2	  mL	  of	  1	  :	  1	  hexane	  :	  diethyl	  ether.	  	  The	  organic	  layer	  containing	  the	  
fatty	  acids	  was	  dried	  down	  under	  a	  stream	  of	  N2	  and	  the	  concentrated	  sample	  was	  used	  
for	  DMOX	  derivatization.	  However,	   as	   derivatization	   of	   higher	   unsaturated	   fatty	   acids	  
was	  performed,	  this	  step	  was	  carried	  out	  for	  15-­‐18	  h	  at	  room	  temperature.	  	  
The	  prepared	   FAMEs	  were	   separated	   and	   analyzed	  by	   an	  Agilent	   Technologies	  
GC-­‐MS	  (7890A	  GC/	  5975C	  MS)	  using	  a	  VF-­‐23	  column	  (30	  m	  x	  250	  μm	  x	  0.25	  μm).	   	  For	  
“FAMEshort”,	   the	   oven	   program	  was:	   60	   °C	   starting	   temperature,	   ramp	   10	   °C/min	   to	  
150	  °C	  ,	  hold	  5	  min;	  ramp	  10	  °C/min	  to	  220	  °C,	  hold	  1	  min;	  and	  ramp	  50	  °C/min	  to	  250	  °C,	  
hold	   2	   min.	   	   Similarly,	   the	   pyrrolidides	   and	   DMOX	   derivatives	   were	   analyzed	   on	   the	  
same	  GC-­‐MS	  instrument	  and	  column.	  	  The	  pyrrolidide	  oven	  program	  “FAPy”	  consisted	  of:	  
initial	   temperature	   of	   150	   °C,	   ramp	   10	   °C/min	   to	   220	   °C,	   holding	   5	   min;	   and	   ramp	  
50	  °C/min	  to	  250	  °C,	  hold	  20	  min.	   	  The	  “DMOX”	  oven	  program	  was	  the	  same	  program	  
used	  to	  analyze	  FAMEs	  with	  the	  exception	  that	  the	  hold	  time	  for	  the	  250	  °C	  step	  was	  12	  
min.	   	   An	   alternate	   FAME	   program,	   “FAMElong”,	   used	   to	   analyze	   the	   18:2∆9c,12a,14c	  	  
supplemented	  expressions	  was:	  60	  °C	  starting	  temperature,	  ramp	  10	  °C/min	  to	  150	  °C,	  
hold	  5	  min;	  ramp	  5	  °C/min	  to	  180	  °C,	  hold	  5	  min;	  ramp	  1	  °C/min	  to	  210	  °C,	  hold	  5	  min;	  
and	  ramp	  10	  °C/min	  to	  250	  °C,	  hold	  3	  min.	  Although,	  in	  all	  cases,	  the	  injector	  was	  set	  to	  









2.2.5 Isolation	  and	  NMR	  Analysis	  of	  Fatty	  Acid	  Natural	  Products	  	  
	  
	  
2.2.5.1 Purification	  of	  Natural	  Products	  
FAMEs	  were	  purified	  from	  7	  L	  of	  culture,	  supplemented	  with	  0.3	  mM	  crepenynic	  
acid.	  	  The	  extracted	  FAMEs	  were	  purified	  using	  flash	  column	  chromatography	  followed	  
by	  reversed-­‐phase	  thin	  layer	  chromatography.	  The	  flash	  column	  was	  loaded	  with	  a	  5.1	  
cm	  (diameter)	  x	  17.8	  cm	  (length)	  pad	  of	  SiO2	  covered	  by	  a	  2.5-­‐cm	  layer	  of	  sand.	  	  Initially	  
the	  column	  was	  equilibrated	  with	  hexane.	  The	  mobile	  phase	  consisted	  of	  a	  step-­‐down	  
gradient	   from	   100:1	   hexane	   :	   ethyl	   acetate	   (300	   mL)	   to	   50:1	   (200	   mL)	   with	   an	  
intermediate	  step	  of	  75:1	  (150	  mL).	  	  A	  set	  of	  2-­‐mL	  fractions	  was	  collected	  over	  50	  tubes.	  
This	  method	  was	  used	  predominantly	  to	  remove	  the	  saturated	  fatty	  acid	  methyl	  esters.	  	  
The	   fractions	   containing	   mainly	   unsaturated	   fatty	   acids	   were	   pooled	   together	   and	  
concentrated	  under	  reduced	  pressure.	  
Reversed-­‐phase	   TLC	  was	   carried	   out	   using	   a	  method	   adapted	   from	  Marquardt	  
and	  Wilson	   [56].	   The	   pooled	   FAMEs	   from	   column	   chromatography	  were	   loaded	   on	   a	  
Whatman	  KC18	  reversed-­‐phase	  TLC	  plate	  (20	  cm	  x	  20	  cm	  x	  200	  μm).	   	  The	  plates	  were	  
developed	  using	  10	  %	  (w/v)	  AgNO3	  in	  acetonitrile	  :	  1,4-­‐dioxane	  :	  acetic	  acid	  (80:20:1)	  at	  
room	  temperature	  for	  1	  h.	   	  After	  air-­‐drying,	  the	  plates	  were	  sprayed	  with	  0.03%	  (w/v)	  
1,6-­‐	  diphenyl-­‐2,3,5-­‐hexatriene	  in	  chloroform,	  air-­‐dried	  and	  FAMEs	  visualized	  under	  long	  
range	  UV	   light.	   	  The	  Rf	  values	  were	  determined	  and	   the	  bands	  were	  excised	   from	  the	  
silica	   plate.	   	   The	   FAMEs	   were	   extracted	   from	   the	   excised	   silica	   bands	   using	   4	   mL	   of	  
chloroform	   and	   the	   solvent	   was	   removed	   using	   a	   rotary	   evaporator.	   	   Samples	   were	  
redissolved	  in	  hexanes	  and	  analyzed	  by	  GC-­‐MS.	  
	  
	  
2.2.5.2 Structural	  Determination	  of	  Natural	  Products	  by	  NMR	  
Proton	   (500	  MHz),	  gsCOSY,	  and	  gsHSQC	  NMR	  spectroscopic	  data	  was	  collected	  




500-­‐MHz	   Bruker	   Avance-­‐III	   NMR	   spectrometer.	   The	   data	  was	   recorded	  with	   standard	  
pulse	  sequences	  in	  CDCl3	  at	  298	  K	  with	  the	  chemical	  shifts	  reported	  as	  ppm	  referenced	  




Transmembrane	  predictions	  were	  performed	  using	  the	  “TopPred	  0.01”	  program	  
from	   the	   Mobyle	   server	   (http://mobyle.pasteur.fr/cgi-­‐bin/portal.py?#forms::toppred).	  	  
The	  multisequence	  alignments	  and	  phylogenetic	  analysis	  were	  performed	  as	  previously	  
described	   by	   Minto	   [54].	   Percent	   amino	   acid	   identity	   was	   determined	   using	   the	  






2.3.1 Isolation	  and	  Cloning	  of	  Fistulina	  Sequences	  
Using	   the	   known	   desaturase	   and	   acetylenase	   sequences	   of	   Cantharellus	  
formosus	   and	   Phanerochaete	   chrysosporium,	   a	   BlastX	   search	   through	   our	   21.8-­‐Mb	  
Roche	   454	   shotgun	   sequence	   database	   yielded	   a	   list	   of	   gDNA	   contigs	   for	   Fistulina	  
hepatica.	   	   Starting	  with	   the	   gDNA	   sequence	   of	   the	   resultant	   possible	   acetylenases,	   a	  
BlastX	  search	  was	  performed	  to	  identify	  gene	  homologs	  from	  other	  organisms	  and	  the	  
search	  results	  were	  used	  to	  hand-­‐parse	  the	  gDNA	  contigs	  of	  F.	  hepatica.	  	  The	  introns	  of	  
the	   gDNA	   sequence	   were	   verified	   as	   the	   non-­‐conserved	   portions	   of	   the	   contigs	   (by	  
comparison	  to	  known	  desaturases)	  and	  through	  pattern	  recognition	  of	  the	  5’-­‐	  GTRNGT	  
and	  3’-­‐	  YAG	  splice	  motifs	  [54].	  
This	  series	  of	  steps	  was	  performed	  for	  two	  Fistulina	  FAD2	  homologs,	  Fhe04128	  
and	  Fhe10752.	   	  Once	   introns	  were	  delineated	   and	   removed,	   a	  mass	   alignment	  of	   the	  
edited	  contigs	  and	  13	  homologs	  from	  GenBank™	  was	  prepared	  to	  aid	  in	  the	  generation	  




verified	  the	  extent	  of	  full-­‐length	  transcripts	  as	  indicated	  by	  the	  presence	  of	  a	  stop	  codon	  
preceding	  the	  ATG	  start	  codon	  from	  the	  anticipated	  fad2	  sequence	  alignment	  at	  the	  5’	  
end	  of	  the	  ORF	  and	  stop	  codon	  at	  the	  3’	  end	  of	  the	  ORF	  followed	  by	  the	  poly	  (A)+	  tail	  for	  
each	  homolog.	  
Through	  prior	  work,	  the	  use	  of	  an	  N-­‐terminal	  His6	  tag	  has	  been	  found	  to	  increase	  
activity	  in	  comparison	  to	  untagged	  proteins	  when	  expressing	  diverged	  desaturases	  [30,	  
54].	   	   Therefore,	   the	   collected	   RACE	   data	   was	   used	   to	   develop	   full-­‐length	   primers	  
containing	   BamHI-­‐ATG-­‐(CAT)6	   (sense)	   and	  NotI	   (antisense)	   restriction	   sites.	   	   The	   full-­‐
length	  transcripts	  were	  obtained	  by	  Vent	  PCR	  and	  cloned	  into	  pYES2	  expression	  vector	  
using	  the	  aforementioned	  restriction	  sites.	  	  Bidirectional	  sequencing	  was	  performed	  on	  




Figure	   12:	   Schematic	   for	   gene	   constructs.	   	   The	   putative	   desaturase	   is	   flanked	   by	   either	   a	  BamHI-­‐ATG-­‐




The	  putative	  FAD2	  cDNA’s	  for	  Fhe04128	  and	  Fhe10752	  contained	  1257	  and	  1242	  
nucleotides	   coding	   for	   418	   and	   413	   aa,	   respectively.	   	   Given	   that	   the	   F.	   hepatica	  
mycelium	  was	  from	  a	  dikaryon,	  two	  alleles	  for	  both	  genes	  were	   identified	  and	  cloned.	  	  
Analysis	   of	   the	   nucleic	   acid	   sequences	   for	   the	   two	   Fhe04128	   alleles	   indicated	   the	  
presence	   of	   16	   SNPs,	   while	   only	   three	   were	   identified	   in	   the	   Fhe10752	   alleles.	  	  
Comparison	   of	   the	   Fhe04128	   and	   Fhe1075	   DNA	   sequences	   revealed	   54%	   sequence	  
identity.	   	   In	   contrast	   to	   their	   intron-­‐free	   desaturase	   and	   diverged	   desaturase	  
counterparts	   in	   plants,	   the	   putative	   fungal	   desaturases,	   Fhe04128	   and	   Fhe10752	  
possessed	  six	  and	  12	  introns,	  respectively,	  ranging	  49-­‐63	  nt	  in	  length.	  	  	  
Primary	   sequence	   analysis	   identified	   two	   residue	   and	   four	   residue	   differences	  




acid	   sequence	   for	   Fhe10752	   had	   approximately	   70%	   sequence	   homology	   with	   the	  
chanterelle	   ∆12-­‐acetylenase,	   whereas	   Fhe04128	   possessed	   a	   meager	   41%	   sequence	  
identity	   to	   both	   the	   ∆12-­‐acetylenase	   and	   Fhe10752.	   	   Bioinformatic	   experiments	  
indicated	  the	  presence	  of	   four	  putative	  transmembrane	  domains	  and	  three	  trademark	  
histidine	  boxes	   (Figure	  13),	  which	  are	  expected	   to	  participate	   in	   the	  binding	  of	  a	  non-­‐
heme	   di-­‐iron	   cluster	   required	   for	   catalysis	   [10].	   	   From	   the	   local	   alignment	   of	   the	  
conserved	   His	   boxes,	   it	   appears	   that	   most	   diverged	   desaturases	   contain	   a	   glycine	  
residue	  at	  the	  position	  immediately	  preceding	  the	  first	  His	  box	  (Blue	  arrow).	  	  However,	  
this	   residue	   is	   found	   to	   be	   an	   alanine	   in	   the	   case	   of	   standard	   desaturases.	   	   Similarly,	  
most	   diverged	   desaturases	   contain	   a	   glycine	   immediately	   following	   His	   box	   Ia,	   while	  
glutamine	  is	  found	  in	  functionally	  characterized	  desaturases	  (Green	  arrow).	  	  The	  second	  
His	   box	   has	   the	   sequence	   H(H/A)(R/K)HH	   in	   known	   desaturases,	   acetylenases,	   and	  
Fhe10752	  but	  Fhe04128	  has	  the	  sequence	  HHAHH.	  	  Lastly,	  a	  similar	  observation	  to	  that	  
of	  Blacklock	  was	   found	  for	   the	  third	  His	  box	   [30].	   	  The	  sequence	  starting	   five	  residues	  
prior	   to	   the	   initial	   His	   residue	   of	   the	   last	   His	   box	   (Black	   arrow)	   for	   acetylenases	   is	  
(D/N)VX(H/N)X.	   	   This	   same	   sequence	   was	   found	   to	   be	   present	   in	   both	   alleles	   of	  
Fhe10752	  and	  Fhe04128.	  
	  
	  
2.3.3 GC-­‐MS	  Analysis	  of	  Fistulina	  Tissue	  
Using	   ≈	   0.5	   g	   of	   fresh	   F.	   hepatica	  mycelial	   tissue,	   FAMEs	   were	   prepared	   and	  
analyzed	   by	   standard	   methods	   (Figure	   14).	   	   The	   GC-­‐MS	   lipid	   analysis	   of	   the	   tissue	  
indicated	   the	   accumulation	   of	   0.14%	   crepenynate	   (18:1∆9c,12a)	   and	   0.49%	  
dehydrocrepenynate	  (18:2∆9c,12a,14c).	  No	  evidence	  of	  polyacetylenic	  fatty	  acids	  was	  found	  
in	  the	  mycelial	   lipid	  pool.	   	  FAMEs	  of	  F.	  hepatica	   fruiting	  bodies	  (≈	  0.2	  g;	  a	  gracious	  gift	  
from	  Professor	  D.	   Job	  at	   the	  University	  of	  Neuchâtel,	  Switzerland)	  were	  also	  prepared	  
and	  analyzed,	  but	   lipid	  analysis	  of	  Fistulina	   fruiting	  bodies	  showed	  no	  accumulation	  of	  





Figure	  13:	  Local	  sequence	  alignment	  of	  the	  conserved	  His	  boxes	  for	  putative	  and	  functionally	  
characterized	  diverged	  desaturases.	  	  
	  
Figure	  14:	  GC/MS	  total	  ion	  chromatogram	  of	  FAMEs	  prepared	  from	  Fistulina	  hepatica	  mycelial	  lipids.	  	  
Separation	  of	  the	  FAMES	  was	  achieved	  using	  the	  “FAMEshort”	  oven	  program.	  	  FAMEs	  analysis	  indicated	  
the	  accumulation	  of	  both	  crepenynic	  and	  dehydrocrepenynic	  acids	  to	  detectable	  levels.	  
	  
	  
2.3.4 Expression	  of	  Putative	  FAD2	  Homologs	  
To	   functionally	   characterize	   the	   Fhe04128	   and	   Fhe10752	   genes,	   FAMEs	   of	  
transgenic	   S.	   cerevisiae	   expressions	   were	   analyzed	   by	   GC-­‐MS.	   	   Analysis	   of	   FAMEs	  




by	   Fhe04128	   but	   illustrated	   that	   both	   Fhe10752	   alleles	   possessed	   ∆12	   desaturase	  
activity,	   as	   established	   by	   the	   presence	   of	   16:2∆9,12	   and	   18:2∆9,12	   (Figure	   15).	   	   The	  
16:2∆9,12	  product	  contributed	  1.79%	  of	   the	  total	   fatty	  acid	  pool	  while	   the	  two	  18:2∆9,12	  
diunsaturated	   fatty	   acids	   made	   up	   1.32%	   of	   the	   total	   FAMEs,	   combined	   (Table	   1).	  	  
Collectively,	   the	  diunsaturated	   fatty	  acid	  products	  made	  up	  3.11%	  of	   total	  FAMEs	  and	  
illustrates	  that	  Fhe10752	  has	  a	  regioselectivity	  consistent	  with	  the	  FAD2	  desaturases.	  	  	  
Previous	   studies	   on	   the	   fungal	   ∆12-­‐acetylenase	   CfACET	   have	   confirmed	   this	  
enzyme’s	  ability	  to	  generate	  16:2∆9,12t	  and	  18:2∆9,12t	  in	  the	  absence	  of	  linoleate	  substrate	  
[30].	   	   Comparison	   of	   the	  GC-­‐MS	   traces	   for	   FAMEs	   isolated	   from	  unfed	   Fhe10752	   and	  
CfACET	   yeast	   expression	   cultures	   revealed	   that	   the	   16:2∆9,12	   diunsaturated	   product	  
contained	   double	   bonds	   solely	   in	   the	   trans	   configuration	   at	   the	   12th	   position.	   The	  
18:2∆9,12	   fatty	  acids	  generated	  by	  both	  Fhe10752	  alleles	  occurred	  approximately	   three	  
times	  as	  often	  in	  the	  trans	  configuration	  versus	  the	  cis	  isomer	  (Table	  1).	  	  
To	   investigate	   potential	   ∆12-­‐acetylenase	   activity,	   expressions	   of	   the	   Fistulina	  
constructs	  were	  supplemented	  with	  the	  substrate	  18:2∆9c,12c.	   	   In	  all	  cases,	  the	  fed	  fatty	  
acid	  was	  determined	  to	  accumulate	  to	  >30%	  of	   the	  total	  FAMEs.	   	  Lipid	  analysis	  of	   the	  
Fhe04128	   construct	   indicated	   no	   new	   desaturase	   activity	   providing	   an	   identical	   lipid	  
profile	   to	   the	   control	   expression.	   	   Conversely,	   analysis	   of	   GC-­‐MS	   data	   for	   Fhe10752	  
indicated	  the	  presences	  of	  a	  newly	  synthesized	  fatty	  acid	  with	  a	  retention	  time	  of	  18.3	  
min	  that	  was	  absent	  in	  empty	  vector	  (Figure	  16).	  	  
This	  new	  fatty	  acid	  was	  discovered	  to	  accumulate	  up	  to	  1.83%	  (Table	  1),	  and	  had	  
MS	   fragmentation	  consistent	  with	   that	  of	  crepenynic	  acid	   (18:1∆9c,12a).	   	  The	   identity	  of	  
this	   Fhe10752-­‐derived	   FA	  was	   later	   confirmed	   by	   comparing	   the	   retention	   time	   (18.3	  
min)	   and	   fragmentation	   pattern	   with	   an	   authentic	   methyl	   crepenynate	   standard	  
prepared	  from	  C.	  alpina	  seed	  oil	  and	  comparison	  of	  pyrrolidide	  derivatives	  synthesized	  
from	  both	   the	  Fhe10752	  expression	   (Figure	  17)	  and	   the	  methyl	   crepenynate	   standard	  
(Appendix	  A).	  	  Additional	  inspection	  indicated	  that	  no	  other	  acetylenic	  natural	  products	  
were	   formed,	   and	   there	   was	   no	   significant	   difference	   in	   activity	   between	   the	   two	  







Figure	   15:	   Demonstration	   of	   Δ12-­‐desaturase	   activity.	   Overlay	   of	   total	   ion	  
chromatographs	   of	   the	   total	   FAMEs	   extracted	   from	   unfed	   yeast	   expression	  
cultures	   and	   analyzed	   using	   the	   ‘FAMEshort”	   program.	   	   The	   traces	   on	   the	   left	  
colored	  in	  black,	  red,	  blue	  and	  green	  represent	  pYES2-­‐(His)6CfACET	  ,	  empty	  pYES2,	  







Table	  1:	  Fatty	  acid	  profile	  for	  unfed	  and	  18:2∆9c,12c-­‐supplemented	  yeast	  expression	  cultures.	  	  Results	  are	  expressed	  as	  the	  mean	  %	  ±	  sd,	  n=3-­‐6;	  ND	  =	  not	  detected.	  
(a)Fatty	  acid	  supplemented	  to	  expression	  cultures	  
	   Fatty	  Acids	  














Δ9c,12a	   26:0	  
Constructs	   	   	   	   	   	   	   	   	   	   	  
Unfed	   	   	   	   	   	   	   	   	   	   	  
pYES2	   20.5±0.1	   39.0±1.2	   ND	   4.55±0.04	   29.8±0.5	   1.89±0.05	   ND	   ND	   ND	   4.35±0.61	  
Fhe04128	   18.2±0.9	   36.5±0.7	   ND	   5.46±0.16	   35.0±1.4	   1.26±0.06	   ND	   ND	   ND	   3.51±1.66	  
Fhe10752	   19.6±0.2	   38.0±0.7	   1.79±0.12	   5.31±0.10	   26.6±0.4	   1.41±0.07	   0.98±0.01	   0.34±0.02	   ND	   5.90±0.29	  
	  	  +18:2∆9c,12c	  (a)	   	   	   	   	   	   	   	   	   	   	  
pYES2	   18.5±0.8	   24.9±0.9	   ND	   5.45±0.21	   17.4±0.4	   0.47±0.02	   ND	   30.7±0.4	   ND	   2.69±0.25	  
Fhe04128	   16.6±0.4	   16.1±0.8	   ND	   7.18±0.22	   15.5±0.4	   0.17±0.01	   ND	   41.8±0.2	   ND	   2.69±0.32	  
Fhe10752	   19.0±0.2	   21.8±0.4	   1.15±0.05	   5.55±0.29	   15.1±0.5	   0.39±0.02	   ND	   32.4±0.7	   1.83±0.02	   2.75±0.23	  
	   	   	   	   	   	  
	  















Figure	   16:	   Demonstration	   of	   Δ12-­‐acetylenase	   activity.	   Overlay	   of	   GC-­‐MS	   analysis	   for	   total	   FAMEs	  
extracted	  from	  18:2∆9c,12c-­‐supplemented	  yeast	  expression	  cultures.	  	  The	  “FAMEshort”	  GC-­‐MS	  program	  was	  
used	  for	  analysis.	  	  The	  traces	  on	  the	  left	  colored	  in	  black,	  red,	  blue	  and	  green	  represent	  crepenynic	  acid,	  








Figure	   17:	   Analysis	   of	   mass	   spectra	   for	   crepenynoyl	   pyrrolidides.	   Figure	   (A)	   displays	   the	   diagnostic	  
fragment	   ion	  sites	   for	   the	  crepenynic	  acid	  pyrrolidide,	  while	   figure	   (B)	   corresponds	   to	   the	  mass	   spectra	  




In	  order	  to	  accumulate	  dehydrocrepenynic	  acid	  (18:2∆9c,12a,14c),	  F.	  hepatica	  must	  
contain	   the	  enzymatic	  machinery	   to	  desaturate	   the	  endogenous	  18:1∆9c,12a	   at	   the	  C14	  
position,	   and	   to	   test	   this,	   yeast	   expression	   cultures	  were	   supplemented	  with	   0.5	  mM	  
18:1∆9c,12a.	   	   The	   Fhe10752	   construct	   was	   found	   to	   possess	   no	   new	   activity,	  
demonstrating	  the	  gene’s	  regiospecificity	  for	  desaturating	  C16-­‐C18	  acyl	  chains	  at	  the	  C12	  
position.	  	  Interestingly,	  the	  presence	  of	  two	  new	  fatty	  acids	  was	  detected	  upon	  feeding	  
18:1∆9c,12a	   to	   yeast	   expressing	   Fhe04128	   (Figure	   18).	   	   Through	   comparison	   of	   relative	  
retention	  times	  and	  mass	  spectra	  of	  authentic	  FAMEs	  and	  dimethyloxazoline	  standards	  
isolated	   from	  Cantharellus,	   the	  peak	  at	  18.9	  min	  was	   identified	  as	  dehydrocrepenynic	  
acid	  and	  was	  shown	  to	  accumulate	  to	  4.59%	  (Table	  2;	  Figure	  19).	  	  The	  production	  of	  this	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Mass	  spectra	   for	  all	   FAME,	  pyrrolidine,	  and	  DMOX	  derivatives	  are	   located	   in	  Appendix	  A.	  Additionally,	  












Figure	  18:	  Demonstration	  of	  diacetylenase	  activity.	  	  The	  overlaid	  traces	  colored	  in	  black,	  
red,	   blue	   and	   green	   correspond	   to	   total	   FAMES	   analyzed	   by	   GC-­‐MS	   (“FAMEshort”	  
program)	  for	  an	  authentic	  dehydrocrepenynate	  standard	  and	  yeast	  expression	  cultures	  of	  
pYES2	   empty	   vector,	   pYES2-­‐(His)6Fhe10752,	   and	   pYES2-­‐(His)6Fhe04128,	   respectively,	  





Table	   2:	   Fatty	   acid	   profile	   of	   18:1∆9c,12a	  -­‐	   and	   18:2∆9c,12a,14c	   -­‐	   supplemented	   yeast	   expression	   cultures.	   Results	   are	   expressed	   as	   the	  mean	   ±	   sd,	   n=3-­‐6;	  ND	   =	   not	  
detected.	  (a)Fatty	  acid	  supplemented	  to	  expression	  culture.	  	  	  
Fatty	  
Acids	  à	  






















Constructs	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
+18:1	  
Δ9c,12a	  	  (a)	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
pYES2	   11.5±0.4	   10.9±0.2	   ND	   8.60±0.37	   15.6±0.6	   0.10±0.02	   0.20±0.02	   2.18±0.08	   49.1±	  1.5	   ND	   ND	   1.80±0.24	   ND	   ND	  
Fhe04128	   14.0±0.5	   10.4±0.4	   ND	   10.5±0.4	   12.2±0.4	   ND	   0.22±0.01	   2.51±0.03	   38.4±1.5	   4.59±0.19	   7.24±0.21	   ND	   ND	   ND	  
Fhe10752	   11.6±0.3	   13.0±2.3	   0.49±0.06	   8.33±0.22	   16.2±0.7	   ND	   0.33±0.05	   2.12±0.05	   46.0±3.4	   ND	   ND	   1.84±0.19	   ND	   ND	  
	  
+18:2	  
Δ9c,12a,14c	  	  (a)	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	  
pYES2	   13.6±0.4	   33.5±1.5	   ND	   6.11±0.44	   30.8±1.3	   0.61±0.05	   ND	   2.23±0.18	   ND	   9.23±1.00	   ND	   3.87±0.46	   ND	   ND	  
Fhe04128	   18.6±1.0	   31.8±0.5	   ND	   6.51±0.45	   21.9±0.2	   0.21±0.19	   ND	   4.87±0.30	   ND	   5.42±0.41	   3.91±0.48	   5.43±0.30	   0.97±0.04	   0.39±0.04	  






Figure	  19:	  Mass	  spectral	  identification	  of	  the	  18:2∆9c,12a,14c	  DMOX	  derivative	  prepared	  from	  a	  crepenynate-­‐
fed	  Fhe04128	  expression	   culture.	   	   Figure	   (A)	  displays	   the	  diagnostic	   fragments	   for	  dehydrocrepenynate	  
DMOX,	  while	  (B)	  is	  the	  compound’s	  mass	  spectra.	  The	  molecular	  ion	  is	  m/z	  329.	  
	  
	  
acetylenic	   fatty	   acid	   has	   previously	   only	   been	   shown	   to	   result	   from	   desaturation	   of	  
18:1∆9c,12a	   at	   the	  C14	  position	  by	   FAD2	   [30].	   	  As	  S.	   cerevisiae	   is	   known	   to	   lack	   a	  FAD2	  
gene,	   any	   desaturation	   occurring	   on	   the	   18:1∆9c,12a	   substrate	   is	   a	   direct	   result	   of	  
Fhe04128	  activity.	  
The	   second	   fatty	  acid	  product	  was	   found	   to	   co-­‐elute	  with	  26:0	   (21.7	  min),	  but	  
closer	  inspection	  of	  the	  FAME	  MS	  fragmentation	  revealed	  a	  parent	  ion	  of	  m/z	  288.	  	  This	  
parent	  ion	  was	  indicative	  of	  further	  dehydrogenation	  of	  18:2∆9c,12a,14c,	  potentially	  to	  the	  
diacetylene	   18:1∆9c,12a,14a.	   	   Evidence	   supporting	   this	   was	   gained	   by	   comparison	   of	  
relative	   retention	   times	   and	   FAMEs	   mass	   spectra	   with	   a	   synthetic	   standard	   of	  









the	   identity	   of	   the	   diacetylene,	   DMOX	   derivatives	   were	   produced	   from	   the	   FAMEs,	  
which	  were	  compared	  to	  derivatized	  standards	  (Figure	  20,	  Appendix	  A).	  	  
The	  diacetylenic	  product	  accumulated	  up	  to	  7.24%	  (Table	  2);	  however,	  some	  of	  
this	  7.24%	  may	  have	  arose	  from	  co-­‐elution	  of	  26:0,	  because	  the	  two	  fatty	  acid	  methyl	  
esters	   had	   similar	   retention	   times	   with	   the	   GC-­‐MS	   oven	   program	   used.	   	   For	   all	  
crepenynic	   acid-­‐supplemented	   expressions,	   18:1∆9c,12a	   accumulated	   above	   38%	   of	   the	  
transgenic	   yeast	   lipid	   pool.	   GC-­‐MS	   analysis	   shows	   that	   the	   buildup	   of	   18:1∆9c,12a	   in	  
Fhe04128	   was	   38.4%	   compared	   to	   46.3%	   and	   49.2%	   in	   Fhe10752	   and	   empty	   vector	  
control,	  respectively.	  	  Also,	  acetylenic	  fatty	  acids	  were	  shown	  to	  accumulate	  up	  to	  50.2%	  
of	   the	   total	   fatty	  acids	   in	   the	  Fhe04128	  expressions,	  and	  of	   this,	  23.6%	   is	   the	  product	  
resulting	  from	  Fhe04128	  activity.	  	  
	  
Figure	  20:	  Mass	  spectrum	  for	  18:1∆9c,12a,14a	  DMOX	  derivative	  synthesized	  from	  a	  18:1∆9c,12a-­‐supplemented	  
Fhe04128	  expression	  culture.	  	  (A)	  Diagnostic	  fragments	  for	  diacetylenic	  DMOX	  with	  the	  exception	  of	  the	  











In	  an	  attempt	  to	  uncover	  any	  further	  activities	  that	  Fhe04128	  and	  Fhe10752	  may	  
possess,	   expressions	   of	   the	   InvSc1	   transformants	   with	   0.5	   mM-­‐supplementation	   of	  
18:2∆9c,12a,14c	  were	   carried	  out.	   	   Intriguingly,	   the	   incorporation	  of	  18:2∆9c,12a,14c	   into	   the	  
heterologous	   yeast	   was	   found	   to	   be	   <12%,	   only	   1/3	   of	   the	   accumulation	   seen	   with	  
crepenynic	  acid	   (Table	  2).	   	  Also,	   the	  density	  of	   the	  cell	   cultures	  appeared	   to	  be	   lower	  
than	   previous	   supplementation	   studies.	   	   Therefore,	   dehydrocrepenynic	   acid	   may	   be	  
toxic	  to	  yeast.	  	  	  
For	  lipid	  analysis	  of	  the	  18:2∆9c,12a,14c	  supplemented	  expressions,	  the	  FAMEs	  were	  
analyzed	   using	   a	   different	   GC-­‐MS	   oven	   program	   in	   effort	   to	   obtain	   better	   separation	  
between	   the	   diacetylenic	   natural	   product	   and	   26:0.	   	   GC-­‐MS	   analysis	   of	   the	   Fhe04128	  
FAMEs	  indicated	  the	  accumulation	  of	  dehydrocrepenynate	  and	  the	  diacetylene	  to	  levels	  
of	   5.42%	   and	   3.91%,	   respectively	   (Table	   2).	   	   Conversely,	   the	   accumulation	   of	  
dehydrocrepenynate	  was	  almost	  double	  that	  of	  Fhe04128	  in	  the	  Fhe10752	  and	  control	  
expression	  cultures.	  	  Although	  Fhe10752	  transgenic	  yeast	  displayed	  no	  new	  fatty	  acids,	  
FAMEs	  analysis	  of	  Fhe04128	  also	  demonstrated	  the	  production	  of	  two	  additional	   fatty	  
acids	  (Figure	  21).	  	  The	  first	  of	  these	  peaks,	  with	  a	  retention	  time	  of	  33.5	  min,	  made	  up	  
0.97%	  of	  the	  total	  lipid	  content.	  	  The	  second	  peak	  at	  37.3	  min	  was	  found	  to	  accumulate	  
up	  to	  0.39%.	  The	  mass	  spectra	  of	  these	  two	  new	  fatty	  acids	  show	  a	  parent	  peak	  of	  m/z	  
286	   (Figure	   22).	   	   This	   is	   two	   mass	   units	   less	   than	   the	   diacetylene,	   leading	   to	   the	  
conclusion	   that	   these	   two	   products	   may,	   in	   fact,	   be	   cis	   and	   trans	   stereoisomers	   of	  
18:2∆9c,12a,14a,16.	  	  	  
In	   an	   effort	   to	   conclusively	   identify	   these	   fatty	   acids,	   DMOX	   derivatives	   were	  
made	  and	  analyzed	  by	  GC-­‐MS.	   	  However,	   the	  derivatization	  of	   this	  highly	  unsaturated	  
and	   conjugated	   fatty	   acid	   proved	   to	   be	   extremely	   challenging.	   	   The	   poor	   conversion	  
from	   the	   FAME	   to	   the	   DMOX	   derivative,	   in	   addition	   to	   breakdown	   and	   isomerization	  
seen	   in	   the	   derivatization	   process	   of	   this	   relatively	   unstable	   compound,	   lowered	   the	  
signal-­‐to-­‐noise	   ratio	   in	   the	   mass	   spectral	   data	   and	   limited	   the	   interpretation	   of	   the	  









Figure	  21:	  Demonstration	  of	   stereoselective	  ∆16-­‐desaturase	  activity.	   	   (A)	  The	  overlaid	   traces	   colored	   in	  
red,	  blue	  and	  green	  correspond	  to	  TICs	  of	  total	  FAMES	  analyzed	  by	  GC-­‐MS,	  using	  the	  “FAMElong”	  program,	  
for	   yeast	   expression	   cultures	   of	   empty	   pYES2,	   pYES2-­‐(His)6Fhe10752,	   and	   pYES2-­‐(His)6Fhe04128,	  
respectively,	  supplemented	  with	  0.5	  mM	  18:2∆9c,12a,14c.	  	  Figure	  (B)	  is	  an	  expansion	  of	  the	  30-­‐40	  min	  portion	  











Figure	  22:	  Mass	  spectrum	  of	  methyl	  dehydrodiacetylenes.	  	  (A)	  Spectra	  for	  (16Z)-­‐dehydrodiacetylenic	  and	  
(B)	   (16E)-­‐dehydrodiacetylenic	   fatty	   acid	   methyl	   esters	   isolated	   from	   Fhe04128	   transgenic	   yeast	  











Figure	  23:	  Mass	  spectra	  of	  18:2∆9c,12a,14a,16	  DMOX	  derivatives.	  	  Shown	  are	  the	  mass	  fragmentation	  patterns	  










Furthermore,	   the	   dehydrodiacetylenic	   natural	   products	   are	   further	   conjugated	  
than	  either	  C14	  unsaturated	  product,	  and	  the	  last	  unsaturation	  is	  occurring	  closer	  to	  the	  
end	  of	  the	  molecule.	  	  Taken	  together,	  the	  increase	  in	  conjugation	  and	  closer	  proximity	  
of	  the	  ∆16	  double	  bond	  to	  the	  methyl	  end	  has	  convoluted	  the	  mass	  spectra	  analysis	  of	  
the	  dehydrodiacetylenic	  natural	  products.	  	  It	  appears	  that	  with	  increasing	  unsaturation	  
toward	   the	  methyl	   end,	   the	   diagnostic	   peaks	   of	  m/z	   236,	   246,	   and	   260	   become	   less	  
prominent.	  	  Nevertheless,	  many	  of	  the	  expected	  peaks	  corresponding	  to	  fragments	  for	  a	  
C18	   chain	   containing	   the	   16-­‐ene-­‐12,14-­‐diyne	   are	   present	   for	   both	   of	   the	  
dehydrodiacetylenic	  species,	  even	  if	  at	  lower	  abundances.	  	  	  	  
	  
	  
2.3.5 Natural	  Product	  Purification	  
An	  alternative	   approach	   to	   identifying	   the	  diacetylene	  and	  dehydrodiacetylene	  
was	   to	   isolate	   sufficient	   amounts	   of	   the	   natural	   products	   to	   use	   nuclear	   magnetic	  
resonance	   (NMR)	   spectroscopy	   for	   structural	   analysis.	   	   Crepenynic	   acid-­‐supplemented	  
expression	  cultures	  were	  grown	  under	  the	  same	  expression	  conditions	  as	  were	  used	  for	  
the	   screening	   cultures.	   	   FAMEs	   were	   generated	   by	   acidic	   methanolysis	   and	   isolated	  
using	   a	   combination	   of	   flash	   column	   and	   reversed-­‐phase	   thin-­‐layer	   chromatography.	  	  
After	   spraying	   the	   TLC	   plate	   with	   0.03%	   (w/v)	   1,6-­‐diphenyl-­‐2,3,5-­‐hexatriene	   in	  
chloroform	  and	  visualizing	  under	  long-­‐wavelength	  UV	  light,	  the	  observable	  FAME	  bands	  
were	   excised	   (Figure	   24).	   	   Once	   the	   FAMEs	  were	   extracted	   from	   the	   silica	   stationary	  
phase	   and	   analyzed	   by	   GC-­‐MS,	   it	   was	   clear	   that	   the	   diacetylenic	   and	  
dehydrodiacetylenic	   natural	   products	   were	   separated	   from	   the	   fatty	   acid	   pool.	  	  
However,	  the	  diacetylenic	  and	  dehydrodiacetylenic	  natural	  products	  were	  incapable	  of	  








Table	  3:	  Tabulated	  distances	  for	  select	  FAMEs	  from	  reversed-­‐phase	  TLC	  purification.	  
Component	   Rf	  value	  
Dioctyl	  Phthalate	   0.85	  
Diacetylene	  and	  
Dehydrodiacetylenes	   0.75	  
Crepenynate	  and	  
Dehydrocrepenynate	   0.7	  
	  
	  
Figure	   24:	   Reversed-­‐phase	   TLC	   separtion	   of	   Fistulina	   natural	   products.	   	   Clear	   separation	   of	   the	  
diacetylenic	  and	  dehydrodiacetylenic	  natural	  products	  was	  effected	  from	  the	  remaining	  FA	  pool	  using	  C18-­‐
bonded	   silica	   plates	   developed	   in	   10%	   (w/v)	   AgNO3	   in	   acetonitrile	   :	   1,4-­‐dioxane	   :	   acetic	   acid	   (80:20:1).	  	  
The	   bands	   were	   excised,	   FAMEs	   extracted,	   and	   analyzed	   by	   GC-­‐MS.	   	   Bands	   below	   the	  





Two	   subsequent	   purifications	   by	   reversed-­‐phase	   TLC	   yielded	   a	   FAMEs	   pool	  
containing	   only	   the	   diacetylenic,	   dehydrodiacetylenic	   acids,	   and	   a	   phthalate	  
contaminant,	  as	  determined	  by	  GC-­‐MS	  analysis.	   	  It	  was	  later	  concluded	  that	  TLC	  plates	  
used	  for	  purification	  were	  responsible	  for	  the	  introduction	  of	  phthalate	  into	  the	  sample.	  
Proton	  NMR	  of	  the	  diacetylenic	  acid	  mixture	   indicated	  two	  minor	  components,	  
each	  comprising	  approximately	  1%	  of	  the	  sample.	  	  Proton	  data	  for	  the	  major	  component	  
was	   consistent	   with	   the	   assignment	   of	   the	   compound	   being	   the	   diacetylenic	   acid,	  
18:19c,12a,14a	   (Table	  4;	  Figure	  25).	   	  For	  the	  minor	   fatty	  acids,	  vinylic	  multiplets	  at	  δ	  6.11	  
and	  δ 6.27	  and	  multiplets	  at	  δ	  1.79	  and	  δ	  1.90	  were	  observed	  by	  proton	  NMR	  (Figure	  26).	  	  
Through	  COSY,	  a	  correlation	  between	  the	  multiplet	  at	  δ	  6.11	  and	  the	  multiplet	  at	  δ	  1.90	  
was	   observed,	   and	   is	   consistent	   with	   the	   structure	   of	   18:2∆9c,12a,14a,16c	   (Figure	   27).	   	   A	  
second	   coupling	   was	   observed	   between	   protons	   at δ	   6.27	   and	   δ	   1.79,	   which	   is	  
consistent	   with	   18:2∆9c,12a,14a,16t.	   	   Coupled	   with	   the	   MS	   data,	   this	   data	   conclusively	  
identifies	  the	  major	  acetylene	  as	  18:1∆9c,12a,14a	  which	  is	  produced	  with	  lesser	  quantities	  
of	  (16Z)-­‐	  and	  (16E)-­‐	  isomers	  of	  18:2∆9c,12a,14a,16	  during	  Fhe04128	  expression.	  
	  
Table	  4:	  Tabulated	  proton	  NMR	  data	  for	  diacetylenic	  methyl	  ester	  mixture.	  
Proton(s)	   Multiplicity	   J,	  Hz	  
2	   t,	  2H	   7.4	  
8	   dt,	  2H	   6.8,	  7.1	  
9	   m,	  1H	   –	  
10	   dt,	  1H	   6.7,	  10.4	  
11	   d,	  2H	   6.7	  
16	   t,	  2H	   7.0	  
16E/Z	   m,	  1H	   –	  
17E	   m,	  1H	   –	  
17Z	   m,	  1H	   –	  
18	   t,	  3H	   7.4	  
18E	   m,	  3H	   –	  
18Z	   m,	  3H	   –	  




















Figure	  27:	  COSY	  of	  acetylenic	  natural	  product	  mixture.	  (A)	  is	  the	  full	  spectrum	  for	  the	  diacetylenic	  FAME	  
mixture,	   which	   shows	   the	   identifiable	   correlations	   for	   the	   (16Z)-­‐	   and	   (16E)-­‐	   isomers	   of	   18:2∆9c,12a,14a,16	  









Numerous	  examples	  of	  acetylenic	  secondary	  metabolites	  have	  been	  discovered	  
throughout	  the	  eukaryotic	  domain,	  yet	  the	  full	  synthetic	  scheme	  for	  the	  biosynthesis	  of	  
these	  natural	  products	  has	  remained	  poorly	  defined.	  Based	  on	  the	  structures	  of	  known	  
plant	  and	  fungal	  polyacetylenes	  and	  incorporation	  experiments	  with	  isotopically	  labeled	  
compounds,	  the	  crepenynate	  pathway	  has	  been	  implicated	  in	  most	  cases	  of	  polyalkyne	  
biogenesis.	  	  Because	  the	  brown-­‐rot	  fungus	  Fistulina	  hepatica	  manufactures	  a	  wide	  array	  
of	  polyacetylenic	  natural	  products	  [46-­‐48],	  this	  fungus	  offered	  a	  clear-­‐cut	  opportunity	  to	  
probe	  the	  crepenynic	  acid	  pathway	  (Figure	  28).	  	  
	  
Figure	  28:	  Proposed	  crepenynic	  acid	  pathway	  in	  Fistulina	  hepatica.	  	  The	  steps	  in	  the	  pathway	  known	  prior	  
to	   this	   study	   are	   indicated	   by	   black	   bold	   arrows,	   steps	   proven	   through	   this	   study	   are	   marked	   by	   red	  
arrows,	  and	  the	  theoretical	  steps	  are	  indicated	  by	  dashed	  arrows.	  	  Fhe04128	  and	  Fhe10752	  are	  capable	  of	  






FAMEs	   analysis	   of	   F.	   hepatica	   mycelia	   confirmed	   the	   accumulation	   of	   both	  
18:1∆9c,12a	  and	  18:2∆9c,12a,14c.	  	  To	  accumulate	  18:2∆9c,12a,14c,	  Fistulina	  must	  contain	  at	  least	  
one	  FAD2	  ∆12-­‐desaturase	  and	  one	  FAD2-­‐like	  ∆12-­‐acetylenase	  responsible	  for	  ∆12-­‐/∆14-­‐
desaturation	   and	   ∆12-­‐acetylenation,	   respectively.	   	   Our	   investigation	   began	   with	  
identifying	   FAD2	   desaturase	   homologs	   within	   the	   F.	   hepatica	   genome.	   	   Two	   of	   the	  
cloned	  putative	  desaturases,	   Fhe04128	  and	  Fhe10752	  were	  discovered	   to	   contain	   the	  
typical	   characteristics	  of	  membrane-­‐bound	  desaturases.	   	   Sequence	  analysis	  uncovered	  
the	   presence	   of	   the	   three	   catalytically	   essential	   His	   boxes	   and	   four	   transmembrane	  
domains	   that	  act	   to	  orient	   the	  His	  boxes	  on	   the	  cytosolic	   side	  of	   the	  membrane.	   	  The	  
deduced	   amino	   acid	   sequence	   for	   Fhe10752	   had	   substantial	   sequence	   homology	   to	  
known	  FAD2	  desaturase	  homologs,	  in	  particular	  the	  ∆12-­‐acetylenase	  CfACET;	  while,	  the	  
Fhe04128	   polypetide	   was	   found	   to	   have	   significantly	   less	   sequence	   homology	   to	  
previously	  characterized	  desaturases.	  	  	  
The	   demonstration	   of	   ∆12-­‐desaturase	   activity	   by	   Fhe10752,	   under	   unfed	  
expression	   conditions,	   supported	   the	   enzyme	   being	   placed	   in	   the	   FAD2	   desaturase	  
family.	   	   However,	   the	   formation	   of	   C16	   diunsaturated	   products	   preferentially	   in	   the	  
trans	   configuration	   at	   C-­‐12,	   and	   a	   mixture	   of	   C18	   isomers	   at	   the	   12th	   position	   was	  
reminiscent	  of	  the	  activity	  seen	  from	  characterized	  ∆12-­‐acetylenases	  [19,	  30].	  	  
The	   formation	   of	   18:1∆9c,12a	   upon	   supplementation	   of	   18:2∆9c,12c	   to	   Fhe10752	  
expressions	   (as	   validated	   by	   pyrrolidides),	   demonstrated	   this	   protein	   possesses	   the	  
anticipated	   ∆12-­‐acetylenase	   activity.	   	   A	   closer	   look	   at	   the	   conversion	   percentage	  
[(product	   /	   sum	  of	   direct	   substrate	   and	   product)	   x100]	   for	   the	   formation	   of	   16:2∆9c,12t	  
and	   18:1∆9c,12a	   in	   Fhe10752	   when	   18:2∆9c,12c	   was	   supplemented	   demonstrated	   that	  
Fhe10752	  preferentially	  acts	  on	  the	  linoleate	  substrate	  to	  form	  crepenynic	  acid	  (Table	  5).	  	  
No	  activity	  other	  than	  the	  ∆12-­‐desaturase/∆12-­‐acetylenase	  activities	  were	  displayed	  by	  
Fhe10752	   and	   is	   indicative	   of	   the	   enzyme’s	   specificity	   for	   ∆12-­‐dehydrogenation	   on	  
16:1∆9c,	   18:1∆9c,	   and	   18:2∆9c,12c	   substrates.	   	   This	   multifunctional	   enzymatic	   activity	  
displayed	   in	   Fhe10752	   is	   not	   unique	   to	   ∆12-­‐acetylenases,	   but	   rather	   has	   become	   a	  




background	   section	   of	   this	   chapter.	   This	   is	   the	   first	   time	   a	   ∆12-­‐acetylenase	   has	   been	  
isolated	  and	   functionally	   characterized	   from	  F.	  hepatica,	   and	  provides	   support	   for	   the	  
hypothesis	   that	   polyacetylenes	   located	   in	   Fistulina	   are	   being	   biosynthesized	   via	   the	  
crepenynic	  acid	  pathway.	  	  
	  
	  
Table	  5:	  Tabulated	  conversion	  ratios	  for	  Fhe04128	  and	  Fhe10752	  constructs.	  	  A	  Values	  are	  estimates	  due	  
to	  the	  presence	  of	  18:2∆9c,12c	  in	  the	  crepenynic	  and	  dehydrocrepenynic	  acid	  feedstocks.	  
	  
Construct	   Product	   Conversion	  Percent	  
Fhe10752	  Unfed	   16:2∆9c,12t	   4.5	  
Fhe10752	  Linoleate	  Feeding	   16:2∆9c,12t	   5.0	  
Fhe10752	  Crepenynate	  Feeding	   16:2∆9c,12t	   3.6	  
Fhe10752	  Dehydrocrepenynate	  Feeding	   16:2∆9c,12t	   5.0	  
Fhe10752	  Unfed	   18:2∆9c,12t	   3.5	  
Fhe10752	  Crepenynate	  Feeding	   18:2∆9c,12t	   1.8A	  
Fhe10752	  Dehydrocrepenynate	  Feeding	   18:2∆9c,12t	   1.9A	  
Fhe10752	  Unfed	   18:2∆9c,12c	   1.3	  
Fhe10752	  Crepenynate	  Feeding	   18:2∆9c,12c	   11.4A	  
Fhe10752	  Dehydrocrepenynate	  Feeding	   18:2∆9c,12c	   9.3A	  
Fhe10752	  Linoleate	  Feeding	   18:1∆9c,12a	   5.3	  
Fhe10752	  Dehydrocrepenynate	  Feeding	   18:1∆9c,12a	   11.1	  
Fhe04128	  Crepenynate	  Feeding	   18:2∆9c,12a,14c	   9.1	  
Fhe04128	  Crepenynate	  Feeding	   18:1∆9c,12a,14a	   14.4	  
Fhe04128	  Dehydrocrepenynate	  Feeding	   18:1∆9c,12a,14a	   36.6	  
Fhe04128	  Dehydrocrepenynate	  Feeding	   18:2∆9c,12a,14a,16c	   9.1	  
Fhe04128	  Dehydrocrepenynate	  Feeding	   18:2∆9c,12a,14a,16t	   3.6	  
	  
	  
Through	   comparison	  with	   sequence	  databases,	   Fhe04128	  was	  distantly	   related	  
to	   the	   known	   FAD2	   desaturases.	   	   Initial	   expressions	   of	   Fhe04128	   in	   the	   presence	   or	  
absence	  of	  exogenous	   linoleate	  did	  not	  result	   in	  detectable	  desaturase	  activity.	   	  Given	  
that	  Fistulina	  is	  capable	  of	  producing	  highly	  unsaturated	  acetylenic	  compounds	  beyond	  




Fhe04128.	   	   Crepenynic	   acid-­‐supplemented	   expressions	   began	   to	   reveal	   the	  
unprecedented	  cascade	  of	  desaturation	  activities	  possessed	  by	  Fhe04128.	   	  This	   super-­‐
desaturase	  contains	  the	  catalytic	  capacity	  to	  carry	  out	  a	  multitude	  of	  desaturation	  steps	  
never	  seen	  before.	  	  	  
Fhe04128	   is	  a	   tri-­‐functional	  enzyme	  capable	  of	  ∆16-­‐desaturation	   in	  addition	   to	  
∆14	   desaturation/acetylenation.	   	   The	   desaturase	   was	   able	   to	   produce	  
dehydrocrepenynic	   acid,	   18:1∆9c,12a,14a,	   and	   the	   (16Z)-­‐	   and	   (16E)-­‐	   isomers	   of	  
18:1∆9c,12a,14a,16	   when	   supplemented	   18:1∆9c,12a	   and	   18:2∆9c,12a,14c.	   	   Although	   the	  
dehydrodiacetylenic	   natural	   products	   were	   initially	   only	   observed	   when	   18:2∆9c,12a,14c	  
was	   supplemented,	  partial	   purification	  of	   the	  ∆16-­‐unsaturated	  products	  was	  achieved	  
through	   reversed-­‐phase	   TLC	   of	   crepenynic	   acid-­‐supplemented	   expressions.	   	   This	  
demonstrates	   the	   first	   time	  an	  acetylenase	  has	  possessed	  enough	  activity	   to	  generate	  
its	   own	   substrate	   for	   two	   consecutive	   desaturation	   steps;	   the	   formation	   of	   the	  
diacetylene	  from	  the	  dehydrocrepenynate	  product,	  and	  its	  use	  as	  the	  substrate	  for	  the	  
formation	  of	  18:2∆9c,12a,14c,16c/t.	  	  However,	  a	  closer	  look	  at	  the	  conversion	  ratios	  for	  both	  
18:1∆9c,12a	   and	   18:2∆9c,12a,14c	   supplementation	   studies	   demonstrates	   that	   Fhe04128	  
preferentially	  dehydrogenates	  dehydrocrepenynic	  acid	  to	  form	  the	  18:1∆9c,12a,14a	  product	  
(Table	  5).	  	  	  
Although	  the	  formation	  of	  the	  tri-­‐acetylene	  was	  not	  detected,	  the	  cis/trans	  ratio	  
of	   dehydrodiacetylenic	   products	   generated	   by	   Fhe04128	   was	   nearly	   identical	   to	   the	  
trans/cis	   ratio	   of	   C18	   diunsaturated	   products	   generated	   by	   Fhe10752.	   	   The	   unfed	  
Fhe10752	   expressions	   revealed	   that	   18:2∆9c,12t	   was	   produced	   2.88	   times	   more	  
frequently	   than	   18:2∆9c,12c.	   	   Additionally,	   it	   was	   found	   that	   the	   dehydrocrepenynate	  
supplemented	   expression	   of	   Fhe04128	  produced	   the	   18:2∆9c,12a,14a,16c	   2.49	   times	  more	  
frequently	   than	   the	   trans	   isomer.	   	   Coupled	   with	   the	   formation	   of	   cis/trans	   isomers	  
found	   in	   other	   acetylenases,	   the	   close	   proximity	   of	   these	   ratios	   may	   suggest	   ∆16-­‐
acetylenase	  activity	   is	  within	  the	  catalytic	  abilities	  of	  Fhe04128,	  but	  was	  too	  low	  to	  be	  




Previous	  expressions	  of	  ∆12-­‐acetylenases	  in	  soybean	  and	  yeast	  have	  shown	  the	  
production	   of	   18:2∆9c,12a,14c.	   	   The	   origin	   of	   formation	   for	   dehydrocrepenynate	   was	  
originally	  believed	  to	  be	  carried	  out	   in	  one	  of	  two	  ways	  [28].	   	  The	  first	  hypothesis	  was	  
crepenynate	   desaturation	   by	   a	   FAD3	   (∆15-­‐desaturase)	   at	   the	   14th	   position	   due	   to	   the	  
triple-­‐bonded,	   altered	   substrate	   fitting	   into	   the	   desaturase	   active	   site.	   	   The	   second	  
hypothesis	  speculated	  that	  the	  ∆12-­‐acetylenase	  could	  use	  𝛼-­‐linolenic	  acid	  (18:3∆9c,12c,15c)	  
as	  a	  substrate	  to	  form	  the	  ∆12-­‐acetylenic	  bond	  with	  concomitant	  rearrangement	  of	  the	  
∆15-­‐double	   bond	   to	   the	   14th	   position.	   	   However,	   a	   co-­‐expression	   of	   the	  Cantharellus	  
∆12-­‐desaturase	   and	   ∆12-­‐acetylenase	   in	   yeast	   revealed	   the	   formation	   of	  
dehydrocrepenynic	  acid	  [30].	  	  This	  is	  consistent	  with	  an	  alternative	  theory	  that	  the	  ∆12-­‐
desaturase	  is	  responsible	  for	  the	  desaturation	  of	  crepenynic	  acid	  at	  the	  ∆14	  position	  to	  
form	   dehydrocrepenynate	   in	   C.	   formosus	   and	   is	   most	   likely	   the	   origin	   in	   other	  
expression	  systems.	  	  	  
In	  contrast,	  Fhe04128	  expressions	  demonstrate	  the	  accumulation	  of	  18:2∆9c,12a,14c,	  
but	   Fhe04128	   indicated	  no	  ∆12-­‐desaturase	  activity	  when	  expressed	   in	   the	  absence	  of	  
exogenous	  fatty	  acids.	  	  It	  is	  also	  known	  that	  Saccharomyces	  lacks	  an	  oleate	  desaturase;	  
hence,	   the	   formation	   of	   dehydrocrepenynic	   acid	   is	   a	   direct	   result	   of	   ∆14-­‐desaturase	  
activity	  exhibited	  by	  Fhe04128.	  	  Since	  the	  conversion	  ratios	  for	  Fhe04128	  demonstrate	  
that	   this	   enzyme	   preferentially	   acts	   as	   a	   ∆14-­‐acetylenase,	   the	   larger	   accumulation	   of	  
dehydrocrepenynic	   acid	   over	   18:1∆9c,12a	   in	   Fistulina	   mycelia	   may	   result	   from	   a	  
combination	  of	   FAD2	  and	   Fhe04128	  activities.	   	   The	   lack	  of	   accumulation	  of	   Fhe04128	  
products	  beyond	  18:2∆9c,12a,14c	   in	  mycelia	  may	  demonstrate	  either	  a	  degradation	  of	  the	  
dehydrocrepenynate	  product	  within	  the	  tissue,	  or	  a	  rapid	  conversion	  of	  the	  18:1∆9c,12a,14a	  
and	   18:2∆9c,12a,14a,16c/t	   compounds	   into	   other	   natural	   products	   along	   the	   polyacetylene	  
biosynthesis	  pathway.	  
Validation	   of	   the	   membrane-­‐bound	   fatty	   acyl	   desaturation	   mechanisms	   has	  
remained	  elusive	  over	  the	  years	  due	  to	  a	   lack	  of	  structural	  and	  enzymological	  data	  on	  
purified	  enzymes.	  	  However,	  kinetic	  isotope	  effect	  studies	  have	  confirmed	  that	  fatty	  acyl	  




all	   proceed	   by	   initial	   pro-­‐(R)	   hydrogen	   abstraction	   at	   the	   carbon	   atom	   nearest	   the	  
carboxyl	   end	   [17,	   18,	   26,	   32,	   57].	   	   It	   is	   generally	   accepted	   that	   the	   formation	   of	   cis	  
double	  bonds	  at	  these	  positions	  results	  from	  abstraction	  of	  the	  pro-­‐(R)	  hydrogen	  at	  their	  
respective	  carbon	  atom,	  followed	  by	  a	  rapid	  collapse	  of	  the	  unstable	  intermediate	  and	  
ultimately	  resulting	  in	  the	  loss	  of	  the	  pro-­‐(R)	  hydrogen	  located	  on	  the	  adjacent	  carbon	  
[19,	  30,	  57].	  	  It	  is	  theorized	  that	  the	  unstable	  intermediate	  formed	  during	  desaturation	  
eliminates	   far	   to	   quickly	   for	   a	   substrate	   conformational	   change	   to	   occur	   within	   the	  
active	   site.	   	   Therefore,	   it	   is	   conceivable	   that	   the	  desaturation	   reactions	   performed	  by	  
Fhe04128	   would	   be	   carried	   out	   with	   proton	   abstraction	   occurring	   first	   at	   the	   C14	  
position	   for	  both	  desaturation	   [pro-­‐(R)]	   and	  acetylenation	  and	  at	   the	  C16	  position	   for	  
desaturation.	   	  However,	  the	  pro-­‐(R)	  abstraction	  at	  C17	  would	  most	   likely	  take	  place	   in	  
the	  formation	  of	  18:2∆9c,12a,14a,16c	  and	  pro-­‐(S)	  for	  the	  formation	  of	  the	  18:2∆9c,12a,14a,16t	  [19]	  
(Figure	  29).	  
The	   reason	   for	   switching	   the	   fatty	   acid	   natural	   product	   derivatization	   from	  
pyrrolidides	   to	   oxazolines	   merits	   discussion.	   As	   the	   natural	   products	   became	   more	  
unsaturated,	   greater	   susceptibility	   to	   derivatization	   problems	   was	   observed.	   This	   is	  
consistent	   with	   several	   studies	   investigating	   the	   derivatization	   of	   other	   highly	  
unsaturated	   fatty	   acids.	   	   Crepenynic	   acid	   has	   been	   shown	   to	   undergo	   rearrangement	  
and	   isomerization	   in	   the	   presences	   of	   both	   high	   temperature	   and	   basic	   conditions,	  
together	   [58].	   	   More	   recently,	   isomerization	   and	   cyclization	   of	   trans-­‐3-­‐hexadecenoic	  
acid	   and	   crepenynic	   acid,	   respectively,	   has	   been	   seen	   in	   preparation	   of	   DMOX	  
derivatives	  using	  the	  one-­‐pot	  method	  at	  180	  °C	  [55,	  59].	  	  
The	   one-­‐pot	   derivatization	   method	   for	   converting	   FAMEs,	   through	   free	   fatty	  
acids,	   to	   pyrrolidides	   under	  mildly	   basic	   conditions	   at	   100	   °C	   was	   successful	   only	   for	  
methyl	  crepenynate.	  	  Conversely,	  attempts	  to	  extend	  the	  method	  to	  the	  pyrrolidides	  of	  
the	   desaturation	   products	   of	   Fhe04128	   proved	   unsuccessful.	   	   It	   is	   presumed	   that	   the	  
polyacetylenes	  are	  breaking	  down	  under	  the	  high	  heat	  and	  mildly	  basic	  conditions	  used	  
for	   pyrrolidide	   formation.	   	   After	   several	   failed	   attempts,	   DMOX	   derivatives	   were	  






Figure	   29:	   Predicted	   model	   for	   Fhe04128	   dehydrogenation	   reactions.	   	   Experimental	   data	   has	  
demonstrated	  that	  membrane-­‐bound	  desaturation	  occurs	  with	  an	  initial	  removal	  of	  the	  pro-­‐(R)	  hydrogen	  
closest	   to	   the	   carboxyl	   end.	   	   It	   is	   generally	   accepted	   that	   the	   short	   lifespan	   of	   the	   highly	   unstable	  
intermediate	  does	  not	  allow	  for	  a	  substrate	  conformational	  change	  within	  the	  active	  site,	  and	  the	  reaction	  
would	  therefore	  proceed	  via	  syn	  stereochemistry.	  	  The	  hydrogen	  atoms	  labeled	  in	  red	  correspond	  to	  the	  
second	  hydrogen	  atom	  removed	  during	  each	  desaturation	  step.	  
	  
	  
appears	   to	  be	  comparable	   in	  basicity	   to	   the	  pyrrolidide	  method,	   the	  ability	   to	   run	   the	  
milder	  derivatization	  at	  a	  lower	  temperature	  seemed	  advantageous	  [60].	  	  
The	   FAMEs	   must	   be	   converted	   to	   their	   free	   acids	   before	   generating	   the	   acid	  
chlorides	  required	  for	  DMOX	  derivatization.	   	  The	  free	  acids	  were	  prepared	  by	  a	  simple	  
incubation	  of	  the	  FAMEs	  with	  0.5	  M	  NaOH	  at	  80	  °C	  for	  1	  h,	  followed	  by	  acidification	  with	  




characterization	  of	   dehydrocrepenynate	   but	   turned	  out	   unfruitful	   for	   the	   diacetylene.	  
Through	   further	  examination	  of	   the	   total	   ion	   chromatograms,	   it	  was	   realized	   that	   the	  
crepenynate/dehydrocrepenynate	   ratio	  was	   lower	   in	   the	   starting	   FAMEs	   sample	   than	  
the	   ratio	   in	   the	   resulting	   DMOX	   product	   pool.	   This	   was	   a	   clear	   sign	   of	  
dehydrocrepenynate	  degradation	  under	  mildly	  basic	  conditions	  at	  high	  temperature	  and	  
is	  again	  consistent	  with	   the	   literature	   [58-­‐60]	   	  From	  this,	   it	  was	  anticipated	   that	  more	  
highly	  unsaturated	  products	  than	  dehydrocrepenynate	  were	  much	  more	  susceptible	  to	  
isomerization	  under	  the	  current	  conditions.	  	  	  
Ultimately,	  hydrolysis	  of	  the	  diacetylenic	  lipids	  were	  carried	  out	  using	  the	  same	  
0.5	  M	  NaOH	  solution	  for	  conversion	  to	  the	  free	  acid	  as	  previous	  attempts,	  but	  at	  room	  
temperature	  overnight	  as	  opposed	  to	  80	  °C	  for	  1	  h.	   	  This	  proved	  to	  be	  successful.	   	  For	  
the	  dehydrodiacetylenic	  oxazolines,	  the	  conversion	  of	  the	  FAME	  to	  the	  DMOX	  derivative	  
remained	   substantially	   less	   efficient.	   	   The	   inherent	   issues	   described	   above	   are	  
compounded	   by	   the	   fact	   that	   the	   starting	   material	   for	   dehydrodiacetylenic	   natural	  
product	   conversions	   was	   significantly	   lower	   than	   both	   dehydrocrepenynate	   and	   the	  
diacetylene.	  
	   While	  early	  tracer	  studies	  into	  most	  basidomycetes,	  and	  F.	  hepatica	  in	  particular,	  
have	  given	  no	  cause	  to	   invoke	  biosynthetic	  steps	  other	  than	  the	  crepenynate	  pathway	  
for	   compounds	   such	   as	   those	   in	   Figure	   28,	   one	   report	   by	   Barley	   hints	   that	   the	  
biochemistry	  of	  F.	  hepatica	  may	  be	  more	  complex	  [49].	  	  Published	  incorporation	  studies	  
on	  F.	  hepatica	  with	  positionally	  verified	  [9-­‐14C]	  labeled	  crepenynic	  acid	  found	  only	  0.01%	  
incorporation	  into	  the	  tetrayne,	  but	  found	  a	  0.1%	  incorporation	  of	  labeled	  acetate	  [49].	  	  
Also,	  this	  study	  found	  a	  200-­‐fold	  increase	  in	  incorporation	  of	  labeled	  crepenynate	  into	  a	  
partially	  characterized	  trienediol,	  relative	  to	  the	  tetrayne.	   	  From	  this	  data,	  the	  authors	  
deduce	   that	   F.	   hepatica	   may	   possess	   an	   alternative,	   non-­‐crepenynic	   acid	   pathway	  
leading	   to	   polyaceteylene	   biosynthesis.	   	   Further	   incorporation	   studies	   with	   labeled	  
18:1∆9c,12a,14a	   yielded	   even	   lower	   incorporation	   than	   crepenynic	   acid	   and	   may	   be	  
indicative	   of	   diacetylenic	   precursor	   rearrangement	   or	   acyl	   chain	   degradation	   before	  




	   F.	  hepatica	  tissue	  is	  rich	  in	  oleate	  and	  linoleate,	  the	  precursors	  to	  crepenynate.	  	  
Now	   that	   we	   have	   identified	   two	   enzymes	   that	   together	   are	   capable	   of	   producing	  
18:1∆9c,12a,14a	  from	  linoleate,	  there	  is	  strong	  evidence	  that	  the	  crepenynic	  acid	  pathway	  
(Figure	  28)	  does	  exist	  and	  is	   involved	  to	  some	  extent	   in	  polyacetylenic	  natural	  product	  
biosynthesis.	   	  Our	   findings	   in	  no	  way	  discount	  or	   disprove	   the	   lack	  of	   crepenynate	  or	  
diacetylene	  incorporation	  into	  the	  tetrayne	  seen	  by	  Barley.	  	  Rather,	  our	  findings	  further	  
solidify	   Barley’s	   hypothesis	   that	   a	   non-­‐conventional	   crepenynic	   acid	   pathway	  may	   be	  
involved	  in	  tetrayne	  production.	   	  By	  coupling	  Barley’s	  results	  with	  those	  of	  the	  current	  
experiment,	   you	   could	   make	   the	   argument	   that	   the	   biosynthesis	   of	   the	   ene-­‐diyne	  
follows	   the	   proposed	   crepenynic	   acid	   pathway,	   but	   may	   function	   as	   a	   shunt	   to	   an	  
alternative	  pathway	   leading	   to	  certain	  polyacetylenic	  natural	  products.	   	  However,	   it	   is	  
also	   conceivable	   that	   Fistulina	   might	   possess	   two	   different	   and	   distinct	   polyalkyne	  
biogenesis	   pathways	   that	   act	   to	  manufacture	   different	   subsets	   of	   the	   polyacetylenes	  
found	   therein;	   the	   first	   pathway	   is	   the	   established	   crepenynic	   acid	   pathway,	   as	  
supported	   by	   this	   work,	   and	   a	   modified	   crepenynate	   derived	   pathway,	   which	   is	  




In	   conclusion,	   these	   experiments	   establish	   additional	   steps	   in	   the	   biosynthetic	  
route	  for	  the	  formation	  of	  polyacetylenes	   in	  basidiomycetes.	  Herein,	  we	  described	  the	  
functional	   characterization	   of	   two	   diverged	   desaturases	   isolated	   from	   F.	   hepatica:	   a	  
∆12-­‐acetylenase	  and	  a	  novel	  trifunctional	  desaturase	  with	  ∆14-­‐desaturase/acetylenase	  
and	  ∆16-­‐desaturase	  activities.	  	  These	  findings	  provide	  solid	  evidence	  that	  some	  Fistulina	  
polyacetylenes	  are	  biosynthesized	  via	  the	  crepenynate	  pathway,	  a	  pathway	  proposed	  by	  
Bu’Lock	  over	  half	  a	  century	  ago	  (Figure	  28).	  	  Using	  the	  knowledge	  gained	  here,	  we	  have	  
opened	  the	  door	  for	  the	  isolation	  of	  other	  diacetylenase	  gene	  homologs,	  which	  should	  
provide	  more	  concrete	  evidence	  for	  the	  involvement	  of	  the	  crepenynic	  acid	  pathway	  in	  




diverged	  desaturases	  capable	  of	  catalyzing	   later	  steps	   in	   the	  crepenynic	  acid	  pathway.	  	  
Additionally,	   this	   enzyme	   provides	   another	   variation	   on	   the	   chemo-­‐	   and	   regio-­‐	  
selectivity	   of	   the	   FAD2	   enzyme	   family	   that	  will	   be	   interpretable	  when	   structural	   data	  






CHAPTER	  3. ECHINACEA	  PURPUREA	  
3.1 Background	  
Isolation	  and	  characterization	  of	  natural	  products	  found	  in	  the	  plant	  kingdom	  has	  
uncovered	   a	   large	   diversity	   of	   unsaturated	  metabolites.	   	   However,	   the	   distribution	   of	  
acetylene-­‐containing	  metabolites	  has	  been	  shown	  to	  occur	  in	  only	  a	  limited	  number	  of	  
plant	  families	  [33,	  61,	  62].	   	  Some	  of	  the	  more	  notable	  polyacetylene	  producers	  belong	  
to	  the	  families,	  Apiaceae,	  Araliaceae,	  Asteraceae,	  Santalaceae,	  and	  Umbelliferae.	  	  As	  of	  
2006,	  32	  plant	  species	  from	  Compositae,	  Leguminosae-­‐Caesalpinioideae,	  and	  Rubiaceae	  
had	   been	   found	   to	   contain	   crepenynic	   acid	   in	   their	   seed	   oil	   at	   up	   to	   75%	   fatty	   acyl	  
content	  [62].	  	  This	  exotic	  fatty	  acid	  is	  known	  to	  be	  the	  precursor	  to	  a	  substantial	  number	  
of	   polyacetylenes	   produced	   by	   plants	   and	   fungi	   [33,	   34,	   40,	   49].	   	   Crepenynic	   acid	  
(18:1∆9c,12a)	   is	   the	   product	   of	   ∆12-­‐acetylenase	   enzymes,	   which	   further	   desaturate	   the	  
∆12-­‐double	  bond	  of	   linoleate.	   To	  date,	  most	  of	   the	  ∆12-­‐acetylenase	  genes	  have	  been	  
isolated	  from	  members	  of	  the	  families	  Apiaceae,	  Araliaceae,	  and	  Asteraceae.	  	  	  
Echinacea,	  commonly	  referred	  to	  as	  purple	  coneflower,	  is	  a	  perennial	  plant	  of	  the	  
Asteraceae	  family.	  	  Echinacea	  are	  native	  to	  North	  America	  and	  have	  an	  extensive	  history	  
as	   an	   herbal	   supplement	   and	   alternative	   medicine	   [63,	   64].	   	   For	   example,	   Native	  
Americans	  commonly	  used	  Echinacea	  to	  treat	  a	  variety	  of	  ailments	  such	  as	  snakebites,	  
fever,	   colds,	   and	  mouth	   sores.	   	   Today,	   despite	   lacking	   solid	   evidence	   for	   its	   efficacy,	  
Echinacea	  is	  used	  as	  a	  dietary	  supplement	  to	  treat	  upper	  respiratory	  tract	  infections	  and	  
the	   common	   cold.	   In	   previous	   studies,	   extracts	   have	   been	   reported	   to	   contain	   anti-­‐
inflammatory	  [65],	  anti-­‐viral	   [66,	  67],	  and	  anti-­‐bacterial	  properties	  [65].	   	   In	  addition	  to	  




extracts	  may	  contain	  anxiolytic	  properties	  [68,	  69].	   	  The	  most	  medicinally	  used	  species	  
of	  Echinacea	  are	  E.	  purpurea,	  E.	  angustifolia,	  and	  E.	  pallida.	  	  	  
In	   many	   cases,	   polyacetylenes,	   alkylamides	   (alkamides)	   and	   other	   compounds	  
have	  been	  implicated	  for	  the	  bioactivities	  of	  Echinacea	  [63,	  67,	  68,	  70].	  	  Alkamides	  make	  
up	   a	   particularly	   interesting	   class	   of	   compounds	   that	   characteristically	   contain	   a	   fatty	  
acid	   functionalized	   with	   an	   amine	   moiety,	   which	   is	   typically	   isobutylamine	   or	   2-­‐
methylbutylamine	   in	   Echinacea	   (Figure	   30).	   	   There	   have	   been	   at	   least	   20	   alkamides	  
identified	  in	  Echinacea	  which	  contain	  varying	  degrees	  of	  unsaturation	  as	  exemplified	  by	  
1-­‐5.	  	  Alkamides	  can	  be	  found	  in	  a	  wide	  range	  of	  concentrations	  in	  different	  tissues	  of	  the	  
plant.	  	  They	  have	  been	  measured	  at	  highest	  concentrations	  in	  the	  roots	  of	  E.	  purpurea	  
and	  E.	  angustifolia	  and	  are	  less	  abundant	  in	  aerial	  parts	  [71].	  	  
	  
Figure	  30:	  Examples	  of	  alkamides	  discovered	  in	  Echinacea	  [71].	  
	  
	  
Polyacetylenes	  in	  addition	  to	  acetylenic	  alkamides	  have	  been	  characterized	  from	  
Echinacea	   (Figure	  31).	   	   The	  bioactive	   role	  of	   these	   acetylenic	  metabolites	   is	   yet	   to	  be	  
determined.	  	  Nevertheless,	  given	  the	  vast	  array	  of	  biological	  activities	  exhibited	  by	  other	  




properties	   of	  Echinacea	   can	   be	   attributed	   to	   the	   presences	   of	   polyacetylenes.	   	   These	  
polyacetylenes	  6-­‐10	  have	  been	  isolated	  by	  several	  groups	  and	  are	  shown	  to	  contain	  as	  
many	  as	   five	  carbon-­‐carbon	   triple	  bonds	   (Figure	  31).	   	   For	  a	  more	   in-­‐depth	   look	  at	   the	  
structural	   nature	   of	   polyacetylenes	   from	   Echinacea	   and	   other	   members	   of	   the	  
Heliantheae	   tribe,	   readers	   are	   directed	   to	   the	   review	   by	   Christensen	   and	   Lam	   [72].	  	  
However,	   the	   goal	   of	   our	   study	   was	   not	   to	   investigate	   the	   mechanism	   or	   effects	   of	  
Echinacea	  extracts	  but	  rather	  to	  try	  to	  elucidate	  the	  pathway	  from	  which	  the	  acetylenic	  
natural	  products	  of	  the	  plant	  are	  derived.	  	  
	  
	  
Figure	  31:	  Examples	  of	  non-­‐alkamide	  polyacetylenes	  found	  in	  Echinacea	  [63,	  73,	  74].	  
	  
	  
It	   is	   proposed	   that	   the	   polyacetylenes	   and	   acetylenic	   alkamides	   formed	   by	  
Echinacea,	   as	  well	   as	   the	  vast	  majority	  of	  acetylenic	   specialized	  metabolites,	  originate	  
from	   the	   crepenynic	   acid	   pathway.	   	   To	   better	   understand	   the	   process	   of	   acetylenic	  
natural	   product	   synthesis	   in	   E.	   purpurea,	   this	   experiment	   was	   designed	   to	   test	   two	  
distinct	   expression	   systems	   for	   the	   functional	   characterization	   of	   potential	   ∆12-­‐




frequently	  employed	  eukaryotic	  expression	  systems.	   	  However,	  S.	   cerevisiae	  has	  some	  
drawbacks	   when	   used	   for	   the	   expression	   of	   plant	   FAD2	   diverged	   acetylenases.	   It	   is	  
established	  that	  Saccharomyces	  lacks	  FAD2	  activity	  and	  must	  be	  supplemented	  linoleate	  
(18:2∆9c,12c)	   in	   order	   to	   see	   ∆12-­‐acetylenase	   activity.	   	   A	   less	   trivial	   disadvantage	   of	  
Saccharomyces	   is	   that,	   upon	   the	   expression	   of	   plant	   diverged	   epoxygenases	   and	  
acetylenases,	  the	  system	  has	  provided	  little	  or	  no	  activity	  [25,	  28].	   	  The	  reason	  behind	  
this	   lack	   of	   activity	   has	   remained	   elusive.	   For	   experiments	   investigating	   the	  
multifunctional	   nature	   of	   the	   ∆12-­‐acetylenases,	   namely	   the	   ∆12-­‐desaturase	   activity	  
acting	  on	  oleate,	  control	   through	  supplementation	  of	  polyunsaturated	   fatty	  acids	   in	  S.	  
cerevisiae	  can	  be	  advantagous.	  	  
The	   second	   expression	   host	   is	   the	   oleaginous	   yeast,	   Yarrowia	   lipolytica.	   	   In	  
recent	   years,	  Y.	   lipolytica	   has	   gained	  momentum	   as	   a	   potential	   source	   for	   renewable	  
biofuels	  and	  a	  potent	  system	  for	  heterologous	  eukaryotic	  gene	  expression.	  	  This	  gaining	  
momentum	  comes	  chiefly	  due	  to	   the	  “non-­‐conventional”	  yeast’s	  ability	   to	  accumulate	  
polyunsaturated	  fatty	  acids	  and	  large	  lipid	  droplets.	  	  Experiments	  have	  shown	  both	  wild	  
type	  and	  mutant	  strains	  capable	  of	  accumulating	  TAGs	  upwards	  of	  30-­‐50%	  of	  the	  cells	  
dry	  weight	  [75].	  	  An	  additional	  advantage	  of	  this	  expression	  system	  is	  that	  Yarrowia	  has	  
a	  highly	  active	  FAD2	  allowing	  for	  the	  accumulation	  of	  linoleate	  and	  enabling	  the	  direct	  
characterization	   of	   putative	   ∆12-­‐acetylenases	   to	   be	   accomplished	   without	  
supplementation.	   	   Expression	   of	   the	   fungal	   ∆12-­‐acetylenase	   CfACET	   indicated	   that	   Y.	  
lipolytica	   can	   provide	   higher	   activity	   when	   expressing	   diverged	   FAD2	   acetylenases	  
(unpublished	  data,	  B.	  Blacklock).	  
In	  this	  project,	  we	  have	  uncovered	  the	  initial	  steps	  in	  the	  biosynthetic	  route	  for	  
the	  formation	  of	  acetylenic	  natural	  products	  in	  E.	  purpurea.	  	  Using	  sequence	  homology	  
to	   other	   functionally	   characterized	   plant	   ∆12-­‐acetylenases,	   we	   targeted	   two	   putative	  
acetylenases	   from	   Echinacea	   and,	   by	   heterologous	   expression	   in	   yeast,	   show	   their	  
ability	   to	  catalyze	   the	  production	  of	  crepenynic	  acid,	   the	   first	   step	   in	   the	   formation	  of	  





3.2 Methods	  and	  Materials	  
	  
	  
3.2.1 Isolation	  and	  Cloning	  of	  Potential	  Acetylenases	  from	  Echinacea	  purpurea	  
E.	  purpurea	  seedlings	  (accession	  #	  PI	  631307;	  courtesy	  of	  North	  Central	  Regional	  
Plant	   Introduction	   Station,	   Ames,	   Iowa)	   were	   grown	   on	   solid	   MS	   basal	   media	   with	  
Gamborg’s	  vitamins	  (0.05%	  MES,	  1.45%	  sucrose,	  0.22%	  MS	  basal	  medium,	  0.2%	  v/v	  PPM,	  
1%	   agar,	   pH	   5.75	   with	   KOH)	   until	   they	   produced	   their	   first	   true	   leaves	   (“Stage	   5	  
seedlings”),	  at	  which	  point,	  total	  RNA	  and	  mRNA	  isolation	  was	  carried	  out	  as	  described	  
in	  Chapter	  4.	  	  The	  full	  open	  reading	  frame	  of	  the	  two	  putative	  acetylenases,	  Epa955	  and	  
Epa2161,	  was	  obtained	  through	  3’-­‐	  and	  5’-­‐	  RACE	  experiments	  using	  the	  SMARTer	  RACE	  
cDNA	  Amplification	  and	  Advantage	  2	  PCR	  kits	  (Clontech,	  Mountain	  View,	  CA)	  with	  gene-­‐
specific	   primers	   (Table	   15,	   Appendix	   B).	   	   These	   gene-­‐specific	   primers	   were	   obtained	  
from	   the	   original	   E.	   purpurea	   transcriptome	   data	   publically	   available	   on	   03/21/2011.	  	  
However,	  a	  second	  version	  of	  the	  transcriptome	  was	  made	  available	  to	  the	  public	  as	  of	  
10/07/2011	  (http://medicinalplantgenomics.msu.edu/).	  	  
Once	   the	  complete	  open	   reading	   frames	  were	   identified,	   full-­‐length	   transcripts	  
containing	  a	  His6	   tag	  and	  5’-­‐BamHI	   and	  3’-­‐NotI	   restriction	   sites	  were	  obtained	  by	  Taq	  
polymerase-­‐mediated	  PCR	  (Table	  15,	  Appendix	  B).	  	  PCR	  products	  were	  TOPO	  T/A	  cloned	  
into	   pCR2.1	   and	   transformed	   into	   DH5α	   chemically	   competent	   E.	   coli.	   The	   complete	  
transcripts	  were	  subcloned	   into	  either	  pYES2	  or	  pY5	  vectors	  for	  expression	   in	  either	  S.	  
cerevisiae	  or	  Y.	  lipolytica,	  respectively.	  Bidirectional	  sequencing	  was	  employed	  to	  ensure	  
sequence	  integrity.	  	  Both	  silent	  and	  non-­‐silent	  discrepancies	  between	  the	  PCR	  products	  
and	  available	   transcriptomic	  sequences	   for	  Epa955	  and	  Epa2161	  were	  corrected	  using	  
the	   Quik	   Change	   II	   site-­‐directed	   mutagenesis	   kit	   (Stratagene,	   La	   Jolla,	   CA)	   and	  
transformed	  into	  XL1-­‐Blue	  chemically	  competent	  E.	  coli	   (Stratagene).	   	  Synthetic	  genes,	  
codon-­‐optimized	   for	   their	   respective	   expression	   systems,	   were	   purchased	   from	  




designated	  as	  EpaxxxRACE	  whereas	  those	  arising	  from	  the	  transcriptomal	  database	  are	  
named	  EpaxxxTrans.	  	  The	  extenstion	  “-­‐opt”	  is	  appened	  to	  codon-­‐optimized	  sequences.	  
	  
	  
3.2.2 Heterologous	  Expression	  of	  Echinacea	  purpurea	  Constructs	  in	  Yeast	  
Constructs	  of	  Epa955	  and	  Epa2161	  were	  subsequently	  transformed	  into	  baker’s	  
yeast	   using	   a	   standard	   lithium	   acetate-­‐polyethylene	   glycol	  method	   of	   Gietz	   [52]	   with	  
selection	  on	  complete	  minimal	  medium	  lacking	  uracil	  (CM-­‐ura+dex)	  for	  3	  days	  at	  30	  °C.	  
The	  transformation	  of	  the	  yeast	  Y.	  lipolytica	  was	  carried	  out	  using	  a	  PEG/lithium	  acetate	  
method	  with	  selection	  on	  CM-­‐leu+dex	  for	  5	  days	  at	  28	  °C	  [76].	  	  YPD	  start	  cultures	  were	  
inoculated	  with	  single	  colonies	  and	  incubated	  at	  28	  °C	  for	  24	  h.	  Expression	  cultures	  for	  S.	  
cerevisiae	   (CM-­‐ura+2%	  gal)	  and	  Y.	   lipolytica	   (CM-­‐leu+2%	  dex)	  were	   inoculated	  with	  50	  
µL	  of	  starter	  culture	  and	  grown	  at	  22	  °C	  with	  240	  rpm	  for	  24	  h,	  followed	  by	  expression	  at	  
15	   °C	   with	   240	   rpm	   for	   24-­‐72	   h.	   	   For	   feeding	   experiments,	   exogenous	   fatty	   acids	  
(provided	  as	  95%	  ethanol	  stocks)	  and	  Tergitol	  NP-­‐40	  were	  supplemented	  to	  cultures	  at	  
final	  concentrations	  of	  0.5	  mM	  and	  0.1%	  (w/v),	  respectively.	  	  
	  
	  
3.2.3 GC/MS	  of	  Lipid	  Derivatives	  
FAME	   and	   DMOX	   derivatives	   from	   yeast	   cultures	  were	   prepared	   as	   previously	  
described	  [54,	  55].	  	  In	  preparation	  for	  DMOX	  synthesis,	  the	  hexane	  solutions	  of	  FAMEs	  
were	  initially	  evaporated	  to	  dryness	  and	  then	  reacted	  with	  0.5	  M	  NaOH	  in	  90%	  aqueous	  
MeOH	  at	  80	  °C	  for	  1	  h	  followed	  by	  acidification	  with	  1	  M	  HCl	  to	  generate	  the	  free	  fatty	  
acids.	  	  The	  free	  fatty	  acids	  were	  washed	  with	  1	  mL	  of	  water	  and	  extracted	  upon	  addition	  
of	  2	  mL	  of	  1	  :	  1	  hexane	  :	  diethyl	  ether.	  	  The	  organic	  layer	  containing	  the	  fatty	  acids	  was	  
dried	   down	   under	   a	   stream	   of	   N2	   and	   the	   concentrated	   sample	   was	   used	   for	   DMOX	  
derivatization.	  	  
The	  prepared	   FAMEs	  were	   separated	   and	   analyzed	  by	   an	  Agilent	   Technologies	  
GC-­‐MS	  (7890A	  GC/	  5975C	  MS)	  using	  a	  VF-­‐23	  column	  (30	  m	  x	  250	  μm	  x	  0.25	  μm).	  	  For	  the	  




10	  °C/min	  to	  150	  °C,	  hold	  5	  min;	  ramp	  10	  °C/min	  to	  220	  °C,	  hold	  1	  min;	  ramp	  50	  °C/min	  
to	   250	   °C,	   hold	   2	   min.	   	   The	   “DMOX”	   oven	   program	   was	   the	   same	   program	   used	   to	  
analyze	  FAMEs	  with	  the	  exception	  that	  the	  hold	  time	  for	  the	  250	  °C	  step	  was	  12	  min.	  	  In	  




Transmembrane	  predictions	  were	  performed	  using	  the	  “TopPred	  0.01”	  program	  
from	   the	   Mobyle	   server	   (http://mobyle.pasteur.fr/cgi-­‐bin/portal.py?#forms::toppred).	  	  
The	  multisequence	  alignments	  and	  phylogenetic	  analysis	  were	  performed	  as	  previously	  
described	   by	   Minto	   [54].	   	   Percent	   amino	   acid	   identity	   was	   determined	   using	   the	  







3.3.1 Isolation	  of	  Putative	  ∆12-­‐Acetylenases	  
Using	   sequences	   of	   48	   known	   or	   hypothetical	   acetylenases	   and	   diverged	  
desaturases	   from	  plants	   and	   fungi,	   a	   TBlastX	   search	   against	   the	  publically	   available	  E.	  
purpurea	   transcriptome	  yielded	   two	  potential	  ∆12-­‐acetylenase	  homologs,	   Epa955	  and	  
Epa2161.	   	  Although	   the	   transcriptome	  was	   available,	   RACE	  experiments	  were	  used	   to	  
confirm	   the	   full	   extent	   of	   the	   ORF	   by	   the	   presence	   of	   a	   stop	   codon	   preceding	   the	  
anticipated	  fad2	  start	  codon	  at	  the	  5’	  end	  of	  the	  ORF	  and	  stop	  codon	  at	  the	  3’	  end	  of	  the	  
ORF	   followed	  by	   the	  poly	   (A)+	   tail	   for	  both	  diverged	  desaturases.	   	  Using	   the	   collected	  
RACE	  data,	  full-­‐length	  primers	  were	  designed	  with	  a	  His6	  tag	  and	  5’-­‐BamHI	  and	  3’-­‐NotI	  
restriction	  sites.	  	  The	  use	  of	  the	  hexahistidine	  tag	  has	  been	  found	  to	  provide	  increased	  in	  




[30,	  54].	  For	  each	  acetylenase	  construct,	  two	  His6	  fusion	  tags	  were	  used	  that	  contained	  
His	  codons	  optimized	  for	  either	  the	  S.	  cerevisiae	  (CAT)	  or	  Y.	   lipolytica	  (CAC)	  expression	  
systems.	  
Full-­‐length	   targets	   were	   obtained	   by	   PCR	   amplification	   using	   Taq	   polymerase.	  	  
Through	   comparison	   of	   the	   full-­‐length	   sequence	   data	  with	   the	   transcriptome	   data,	   it	  
was	   noticed	   that	   the	   PCR-­‐derived	   sequences	   possessed	   likely	   SNPs	   (Table	   6).	   	   These	  
variations	  are	  expected	  because	  the	  PI	  631307	  accession	  is	  maintained	  as	  a	  genetically	  
heterogenous	   population.	   SDM	  was	   used	   to	   correct	   the	   polymorphisms	   that	   result	   in	  
translated	  sequence	  differences.	  The	  resultant	  constructs	  were	  sequenced	  and	  found	  to	  
be	   in	   agreement	   with	   the	   RACE	   consensus.	   	   The	   complete	   ORF	   for	   each	   diverged	  
desaturase	  was	  subcloned	  into	  both	  pYES2	  and	  pY5	  expression	  vectors	  and	  sequenced.	  
	  
Table	   6:	   Single-­‐nucleotide	   polymorphs	   found	   in	   the	   putative	   ∆12-­‐acetylenase	   constructs	   for	   Echinacea	  
purpurea.	  





Epa	  955	   433	   ACC	  à	  CCC	   Thr	  à	  Pro	  
	   458	   GTT	  à	  GGT	   Val	  à	  Gly	  
Epa	  2161	   68	   GAT	  à	  GGT	   Asp	  à	  Gly	  




The	   targeted	   acetylenases	   Epa955	   and	   Epa2161	   contained	   1140	   and	   1134	   nt,	  
respectively.	   	  The	  predicted	  380-­‐aa	   translation	  of	  Epa955	  and	   the	  378-­‐aa	  sequence	  of	  
Epa2161	   were	   determined	   to	   share	   84%	   identity	   to	   each	   other.	   	   The	   putative	  




characterized	  ∆12-­‐acetylenases	  from	  both	  Helianthus	  annuus	  and	  Calendula	  officinalis,	  
whereas	   Epa955	   has	   83%	   sequence	   identity	   to	   the	   aforementioned	   acetylenases.	   	   A	  
sequence	  alignment	  of	  Epa955	  and	  Epa2161	  with	  the	  functionally	  characterized	  FAD2s	  
and	   diverged	   FAD2s	   established	   the	   presence	   of	   three	   highly	   conserved	   His	   motifs	  
responsible	  for	  binding	  two	  active-­‐site	  iron	  atoms	  required	  for	  catalysis	  (Figure	  32).	  The	  
conserved	  His	  box	  sequences	  for	  Epa955	  and	  Epa2161	  are:	  HECGH,	  HRNHH,	  and	  HVLHH.	  
Bioinformatics	   experiments	   predicted	   the	   presence	   of	   four	   hydrophobic	   membrane-­‐
spanning	  regions	  for	  both	  putative	  acetylenases,	  which	  are	  characteristic	  of	  membrane-­‐
bound	  desaturases.	   	  Based	  on	  these	  data,	   it	  was	  anticipated	  that	  Epa955	  and	  Epa2161	  
were	  functional	  ∆12-­‐acetylenases.	  
	  
	  
Figure	  32:	  Local	  sequence	  alignment	  of	  the	  three	  conserved	  His	  boxes	  from	  diverged	  desaturases.	  	  The	  His	  
box	  alignment	  contains	  sequences	  for	  FAD2	  desaturases	  (DES),	  epoxygenases	  (EPOX),	  conjugases	  (CONJ),	  
hydroxylases	   (12-­‐OH),	   and	   acetylenases	   (ACET).	   	   The	   GenBankTM	   accession	   numbers	   for	   the	   displayed	  
sequences	  are:	  CofACET,	  CAB64256.1;	  CofDES,	  AF343065;	  CofCONJ1,	  AF310155.1;	  CofCONJ2,	  AF310156;	  
VfoDES,	   AF525534;	   VfoCONJ,	   AF525535;	   GmaDES1,	   P48630.1;	   GmaDES2,	   P48631;	   Rco12-­‐OH,	   Q41131;	  
Pfe12-­‐OH,	  AAC32755;	  AthDES,	  P46313.1;	  HanDES,	  O24499;	  HanACET,	  AAO38032.1;	  MchCONJ,	  AF182521;	  
CalACET,	   ABC00769.1;	   DsiACET,	   AAO38036.1;	   XbrACET,	   AAO38037.1,	   RhiACET,	   AAO38035.1;	   CpaEPOX,	  
CAA76156.1;	  PgrCONJ,	  AAO37753.1;	  HheACET,	  AAO38031.1;	  TkiCONJ,	  AAO37751.1;	  PcrACET,	  AAB80697.1;	  




3.3.3 Cloning	  and	  Saccharomyces	  Expression	  of	  Epa955	  and	  Epa2161	  
The	  catalytic	  abilities	  possessed	  by	  the	  two	  Echinacea	  diverged	  desaturases	  were	  
investigated	   through	   heterologous	   expression	   in	   the	   yeast,	   S.	   cerevisiae.	   	   For	   both	  
Epa955	   and	   Epa2161,	   the	   uncorrected	   RACE-­‐	   and	   SDM-­‐derived	   transcriptomic	   ORFs	  
were	  subcloned	  into	  pYES2	  and	  transformed	  into	  S.	  cerevisiae	  InvSc1	  cells.	  For	  both	  the	  
RACE	   -­‐derived	  and	   transcriptomic	   sequences,	   the	   transgenic	   yeast	   expression	   cultures	  
gave	   no	   detectable	   activity.	   	   To	   see	   if	   codon	   bias	   was	   playing	   a	   role	   in	   the	   lack	   of	  
desaturase	  activity,	  a	  RACE-­‐derived	  Epa955	  gene	  was	  synthesized	  in	  a	  codon-­‐optimized	  
form	  for	  Saccharomyces,	   transformed	  as	  a	  pYES2	  construct,	  and	  expressed.	  Expression	  
of	  the	  codon-­‐optimized	  plant	  diverged	  desaturase	  again	  failed.	  	  These	  results	  extend	  the	  
observations	   with	   previous	   expressions	   of	   unoptimized	   plant	   acetylenases	   and	  
epoxygenases	  having	  little	  or	  no	  activity	  in	  S.	  cerevisiae	  expression	  systems	  [25,	  28].	  
	  
	  
3.3.4 Cloning	  and	  Yarrowia	  Expression	  of	  Epa955	  and	  Epa2161	  
Analogous	   to	   the	   experiments	   described	   with	   S.	   cerevisiae,	   RACE	   and	  
transcriptomic	  sequences	  for	  both	  Epa955	  and	  Epa2161	  were	  expressed	  in	  Y.	  lipolytica	  
behind	   the	   constitutive	   TEF	   promoter	   of	   the	   pY5	   expression	   vector.	   	   Initial	   four-­‐day	  
expressions	  for	  all	  pY5	  constructs	  revealed	  no	  activity	  in	  Yarrowia	  distinguishable	  from	  
the	   empty	   vector	   constructs.	   	   A	   second,	   revised	   version	   of	   the	   E.	   purpurea	  
transcriptome	   was	   subsequently	   published	   that	   had	   discrepancies	   with	   our	   original	  
RACE-­‐derived	   and	   transcriptomic	   sequences.	   	   The	   residue	   at	   376	   for	   original	   RACE-­‐
derived	  and	  transcriptome	  sequences	  was	  an	  Asp	  residue,	  while	  the	  second	  version	  of	  
the	   transcriptome	   sequence	   had	   a	   Tyr	   residue.	   	   SDM	   was	   used	   to	   correct	   the	   Asp	  
residue	   of	   the	   original	   constructs	   to	   Tyr376,	   but	   subsequent	   expressions	   of	   the	  
corrected	   constructs	   still	   yielded	   no	   activity.	   	   An	   alignment	   of	   all	   of	   the	   expressed	  
Epa955	   gene	   translations	   highlighting	   the	   variations	   in	   amino	   acid	   sequences	   can	   be	  




Figure	  33:	  Multi-­‐sequence	  alignment	  of	  all	  Epa955	  expression	  constructs.	   	  The	  differences	  marked	  by	  black	  arrows	  represent	  the	  SNPs	  resulting	   in	  non-­‐
conservative	  primary	   sequence	   substitutions	  present	   in	   the	  original	   transcriptome	  sequence	   that	  were	   repaired	  by	  SDM	  to	   codons	   consistent	  with	   the	  
RACE	  data	  and	  a	  broader	  alignment	  of	  FAD2-­‐like	  sequences.	  	  Those	  marked	  by	  blue	  arrows	  represent	  the	  SNP	  changes	  between	  the	  Race-­‐opt	  and	  Trans-­‐




Unpublished	   work	   from	   our	   lab	   has	   indicated	   that	   Yarrowia	   may	   be	   more	  
sensitive	   to	   codon	   bias	   than	   Saccharomyces	   cerevisiae.	   	   Only	   a	   synthetic,	   codon-­‐
optimized	   form	  of	   CfACET	   expressed	   in	  Yarrowia	   could	  be	   shown	   to	  have	  acetylenase	  
activity.	   	   With	   this	   information	   in	   hand,	   synthetic,	   codon-­‐optimized,	   transcriptomic	  
constructs	  of	  each	  putative	  acetylenase	  were	  obtained	  and	  expressed	  in	  Yarrowia.	  	  GC-­‐
MS	   lipid	   analysis	   of	   the	   four-­‐day,	   unfed	  Y.	   lipolytica	   expression	   cultures	   indicated	   the	  
formation	  of	  three	  new	  fatty	  acid	  products	  by	  both	  Epa955Trans-­‐opt	  and	  Epa2161Trans-­‐
opt	   (Figure	   34).	   	   As	   the	   codon-­‐optimized	   genes	   proved	   to	   be	   active,	   a	   second	   codon	  
optimized	  gene	  was	  purchased	  for	  the	  RACE-­‐derived	  Epa955	  sequence,	  Epa955RACE-­‐opt.	  	  
The	   expression	   of	   this	   gene	   in	  Y.	   lipolytica	   also	   demonstrated	   the	   production	   of	   new	  
fatty	  acids	  (Figure	  34).	  	  	  
Further	   investigation	  uncovered	  that	  each	  expression	  experiment	  produced	  the	  
same	   set	   of	   new	   fatty	   acids	   that	  were	   identifiable	   by	   their	   retention	   times	   and	  mass	  
fragmentation	   patterns.	   	   The	   first	   of	   these	   fatty	   acids	   was	   found	   to	   accumulate	   to	  
greater	  than	  1.47%	  and	  was	  identified	  as	  18:2∆9c,12t,	  based	  on	  retention	  time	  (16.4	  min)	  
and	  mass	   fragmentation	  pattern.	   	  The	  mass	  spectra	  and	  retention	  time	  of	   the	  peak	  at	  
18.3	  min	  proved	  to	  be	  identical	  to	  that	  of	  an	  authentic	  18:1∆9c,12a	  methyl	  ester	  standard	  
prepared	  from	  Crepis	  seed	  oil.	   	  The	  identity	  of	  the	  18:1∆9c,12a	  formed	  by	  the	  transgenic	  
yeast	  was	  further	  substantiated	  by	  comparison	  of	  DMOX	  derivatives	  of	  the	  analyte	  and	  
a	   crepenynate	   standard.	   	   Interestingly,	   crepenynate	   was	   found	   to	   accumulate	   to	  
essentially	  identical	  levels	  for	  both	  transcriptomic	  based	  constructs,	  ≈0.75%	  of	  the	  total	  
lipid	   pool.	   	   However,	   the	   Epa955RACE-­‐opt	   construct	   was	   found	   to	   accrue	   crepenynic	  
acid	   to	   a	   slightly	   higher	   level	   (0.91%).	   	   It	   should	   be	   noted	   that	   the	   Epa955RACE-­‐opt	  
expression	  cultures	  also	  appeared	   to	  grow	  to	  a	   lower	  cell	  density	  over	   four	  days	   than	  
the	   empty	   pY5	   control,	   Epa955Trans-­‐opt,	   and	   Epa2161Trans-­‐opt	   expressions	   and	   this	  
may	  have	  impacted	  the	  results	  of	  this	  experiment.	  	  	  
The	   third	   fatty	   acid	   product	   (retention	   time	   =	   18.9	   min)	   was	   found	   to	   be	  








Figure	  34:	  Overlay	  of	  four-­‐day	  expressions	  of	  Echinacea	  purpurea	  genes	  in	  
Yarrowia.	   	   The	   overlaid	   traces	   colored	   in	   black,	   red,	   green	   and	   blue	  
correspond	   to	   GC-­‐MS	   total	   ion	   chromatograms	   of	   total	   FAMES	   prepared	  
from	   yeast	   expression	   cultures	   of	   empty	   pY5,	   pY5-­‐(His)6Epa955RACE-­‐opt,	  









Table	  7:	  Total	  fatty	  acid	  composition	  for	  four-­‐day	  unfed	  expressions.	  	  Results	  are	  expressed	  as	  the	  mean	  %	  ±	  sd,	  n=4;	  ND	  =	  not	  detected.	  Growth	  conditions	  
were	  24	  h	  at	  22	  ˚C;	  240	  rpm	  followed	  by	  72	  h	  at	  15˚C;	  240	  rpm.	  1	  Expressed	  as	  pY5-­‐(His)6	  constructs.	  	  













Constructs	   	   	   	   	   	   	   	   	   	   	   	  
Unfed	  (4	  day)	   	   	   	   	   	   	   	   	   	   	   	  
pY5	   9.88±0.41	   4.12±0.98	   12.3±0.9	   0.12±0.09	   0.74±0.22	   43.6±0.8	   0.18±0.23	   ND	   29.0±1.7	   ND	   ND	  
Epa955Trans-­‐opt1	   10.2±0.4	   3.0±0.27	   10.5±0.4	   ND	   0.77±0.13	   50.6±0.7	   0.35±0.23	   1.72±0.21	   22.1±0.23	   0.74±0.09	   0.06±0.04	  
Epa955RACE-­‐opt1	   7.76±0.33	   3.97±0.20	   12.8±0.4	   0.33±0.02	   1.32±0.09	   32.6±2.0	   0.42±0.05	   1.47±0.03	   38.0±1.6	   0.91±0.05	   0.10±0.01	  
Epa2161Trans-­‐opt1	   10.2±0.3	   3.31±0.30	   10.8±0.9	   0.05±0.06	   0.96±0.15	   47.9±2.4	   0.10±0.19	   2.89±0.26	   23.0±1.2	   0.75±0.08	   0.06±0.05	  
	   	   	   	   	   	   	   	   	   	   	   	  











	   	  
	  
Figure	   36:	   Mass	   spectra	   of	   dimethyloxazoline	   deriviative	   of	   dehydrocrepenynic	   acid	   prepared	   from	  






This	  second	  analyte	  was	  confirmed	  to	  be	  dehydrocrepenynic	  acid	  (18:2∆9c,12a,14c)	  through	  
comparison	   of	   relative	   retention	   times	   and	   mass	   spectra	   with	   authentic	   FAMEs	   and	  
DMOX	   standards	   made	   from	   C.	   cibarius	   fruit	   bodies.	   	   The	   origin	   of	   this	   acetylenic	  
metabolite	  may	  stem	  from	  two	  potential	  sources.	  	  The	  formation	  of	  the	  conjugated	  ∆14-­‐
double	  bond	  could	  arise	  from	  endogenous	  desaturase	  activity	  possessed	  by	  Epa955	  and	  
Epa2161,	   and	  would	   therefore	   be	   a	   new	   example	   of	  multifunctional	   catalytic	   activity	  
found	   in	   diverged	   desaturases.	   	   However,	   a	   more	   probable	   explanation	   for	   the	  
biosynthesis	  of	  this	  fatty	  acid	   is	  the	  endogenous	  and	  highly	  active	  FAD2	  of	  Y.	   lipolytica	  
carrying	  out	  the	  desaturation	  at	  carbon	  14,	  consistent	  with	  the	  work	  of	  Blacklock	  [30].	  
	  
	  
3.3.5 Feeding	  Experiments	  in	  Yarrowia	  lipolytica	  
In	   an	   effort	   to	   elucidate	   the	   origin	   of	   dehydrocrepenynic	   acid,	   attempts	   were	  
made	   to	   supplement	  crepenynate	   to	   the	  Yarrowia	   expression	  cultures.	   	  However,	   this	  
task	  proved	  to	  be	  a	  daunting	  one.	  	  The	  addition	  of	  18:1∆9c,12a	  at	  0.5	  mM	  was	  surprisingly	  
toxic	  to	  Yarrowia,	  given	  that	  Saccharomyces	  liquid	  cultures	  are	  routinely	  supplemented	  
at	  the	  same	  concentration.	  	  In	  an	  attempt	  to	  identify	  the	  maximum	  amount	  of	  18:1∆9c,12a	  	  
that	   could	   be	   supplemented,	   the	   effect	   of	   exogenous	   crepenynate	   on	   liquid	   cultures	  
grown	   at	   28	   °C	   were	   observed.	   	   Acceptable	   cell	   growth	   was	   found	   with	   exogenous	  
18:1∆9c,12a	  at	  or	  below	  0.1	  mM	  (Figure	  37).	  	  Although	  the	  conditions	  for	  the	  toxicity	  curve	  
were	  different	  than	  that	  of	   the	  expression	  conditions,	   it	  was	  believed	  that	  the	  toxicity	  






Figure	  37:	  Toxicity	  curve	  for	  crepenynic	  acid	  supplementation.	  	  The	  yeast	  cultures	  (CM-­‐leu+2%	  dex+	  0.1%	  
(w/v)	  NP-­‐40)	  were	  fed	  exogenous	  fatty	  acid	  and	  grown	  at	  28	  °C	  with	  240	  rpm	  shaking	  for	  24	  h.	  
	  
	  
In	  order	  to	  circumvent	  the	  cumulative	  effects	  of	  reduced	  culture	  growth	  and	  the	  
low	   temperature	   incubations	   typically	   required	   for	   high	   FAD2	   activities,	   0.1-­‐0.5	   mM	  
crepenynic	  acid	  was	  supplemented	  to	  the	  empty	  pY5	  control	  expression	  cultures	  after	  
the	  initial	  growth	  period	  at	  22	  °C	  for	  24	  h,	  followed	  by	  24	  h	  at	  15	  °C,	  as	  opposed	  to	  the	  
original	  conditions	  of	  15	  °C	  for	  72	  h.	   	   It	  was	  discovered	  that	  18:1∆9c,12a	  accumulated	  to	  
reasonable	   levels	  at	  all	   supplemented	  concentrations,	  with	   the	  best	  being	   seen	  at	  0.5	  
mM	  (18:1∆9c,12a	  and	  18:2∆9c,12a,14c	  at	  ≈	  24%	  and	  ≈	  0.83%	  of	  total	  fatty	  acids,	  respectively).	  	  
Based	  on	  the	  observed	  results,	  18:1∆9c,12a	  feedings	  were	  setup	  and	  grown	  at	  22°C	  for	  24	  
h.	  	  At	  this	  point,	  crepenynate	  was	  supplemented	  to	  a	  final	  concentration	  of	  0.5	  mM	  and	  
gene	  expression	  was	  carried	  out	  at	  15	  °C	  for	  24	  h.	  	  Additionally,	  to	  insure	  that	  the	  unfed	  
and	  supplemented	  expressions	  were	  carried	  out	  under	  the	  same	  conditions,	  unfed	  two-­‐
day	  expressions	  were	  performed	  in	  conjunction.	  
The	  unfed	  expression	  cultures	  were	  noticeably	  less	  dense	  after	  two	  days	  relative	  
to	   the	   four-­‐day	   expressions.	   	   Furthermore,	   all	   of	   the	   expression	   cultures	   appeared	   to	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contain	   >0.69%	   18:2∆9c,12t	   for	   the	   RACE	   construct	   and	   2-­‐4.5	   times	   that	   for	   the	  
transcriptomic	   constructs	   (Table	   8).	   	   FAMEs	   analysis	   exhibited	   a	   substantially	   higher	  
accumulation	   of	   both	   crepenynate	   (2-­‐fold)	   and	   dehydrocrepenynate	   (6-­‐fold)	   for	  
Epa955Trans-­‐opt	   and	   Epa2161Trans-­‐opt,	   in	   comparison	   to	   the	   four-­‐day	   expressions	  
(Table	  8).	  	  Surprisingly	  the	  Epa955RACE-­‐opt	  sample	  demonstrated	  half	  the	  accumulation	  
of	  crepenynate	  and	  over	  a	  50%	  increase	  of	  dehydrocrepenynic	  acid	  than	  in	  the	  four-­‐day	  
expression.	  	  These	  apparently	  inconsistent	  data	  remain	  an	  unresolved	  question.	  
FAMEs	   analysis	   of	   the	   two-­‐day	   18:1∆9c,12a	   feeding	   expressions	   demonstrated	   a	  
decrease	   in	   18:2∆9c,12t	   formation	   for	   Epa955Trans-­‐opt	   and	   Epa2161Trans-­‐opt,	   but	  
Epa955RACE-­‐opt	  had	  a	   slight	   increase	   relative	   to	   the	   two-­‐day	  unfed	  expressions.	   	  The	  
build-­‐up	  of	  crepenynic	  and	  dehydrocrepenynic	  acids	  was	  detected	  in	  the	  lipid	  pool	  of	  all	  
supplemented	  cultures	  (Figure	  38;	  Table	  8).	  	  Crepenynate	  was	  found	  to	  accumulate	  >19%	  
of	  the	  total	  FAMEs,	  but	  with	  substantial	  variability,	  while	  dehydrocrepenynate	  accrued	  
to	   >0.2%,	   but	   more	   consistently.	   	   In	   all	   supplemented	   acetylenase	   expressions,	   the	  
amount	   of	   18:1∆9c,12a	   and	   18:2∆9c,12a,14c	   stockpiles	  were	   7%	   less	   than	   and	   0.1%	   greater	  
than	  the	  empty	  pY5	  control,	  respectively.	  	  	  
FAMEs	  prepared	   from	  six	  E.	  purpurea	   seeds	  were	  analyzed	  by	  GC-­‐MS	   to	   check	  
for	  the	  accumulation	  of	  any	  acetylenic	  compounds	  (Figure	  39).	  	  Although	  the	  seed	  lipid	  
pool	  contained	  a	  significant	  amount	  of	  linoleate,	  the	  known	  ∆12-­‐acetylenase	  substrate,	  








Figure	   38:	   Overlay	   of	   two-­‐day	   expressions	   of	   Echinacea	   purpurea	   ∆12-­‐acetylenases	   in	   Yarrowia.	   (A)	  
represents	   the	   unfed	   expressions	   while	   (B)	   corresponds	   to	   the	   samples	   supplemented	   with	   0.5-­‐mM	  
crepenynic	   acid.	   	   The	  overlaid	   traces	   colored	   in	   black,	   red,	   green,	   and	  blue	   correspond	   to	   total	   FAMES	  
analyzed	   by	   GC-­‐MS	   for	   yeast	   expression	   cultures	   of	   empty	   pY5,	   pY5-­‐(His)6Epa955RACE-­‐opt,	   pY5-­‐



























Figure	  39:	  GC-­‐MS	  analysis	  of	  FAMEs	  isolated	  from	  Echinacea	  purpurea	  seeds.	  	  No	  acetylenic	  fatty	  acid	  





Table	  8:	  Tabulated	  data	  for	  unfed	  and	  crepenynic	  acid	  supplemented	  two-­‐day	  Echinacea	  acetylenase-­‐expressing	  cultures.	  	  Results	  are	  expressed	  as	  the	  mean	  %	  
±	  sd,	  n=4;	  ND	  =	  not	  detected.	  	  Cultures	  were	  grown	  with	  240	  rpm	  shaking	  at	  22	  ˚C	  for	  24	  h	  followed	  by	  15	  ˚C	  for	  24	  h.	  	  (a)Fatty	  acid	  supplemented	  to	  expression	  
culture	  after	  the	  initial	  24	  h	  growth	  at	  22	  ˚C.	  	  1	  Expressed	  as	  pY5-­‐(His)6	  constructs.	  













Constructs	   	   	   	   	   	   	   	   	   	   	   	  
Unfed	  (2	  day)	   	   	   	   	   	   	   	   	   	   	   	  
pY5	   9.66±0.37	   2.21±0.29	   11.4±1.8	   0.47±0.14	   1.31±0.14	   39.1±6.0	   0.49±0.05	   0.09±0.01	   34.6±4.4	   ND	   ND	  
Epa955Trans-­‐opt1	   9.07±0.45	   2.67±0.29	   12.2±1.0	   0.39±0.07	   1.48±0.23	   38.2±2.8	   0.46±0.04	   1.69±0.15	   31.5±3.4	   1.36±0.27	   0.35±0.13	  
Epa955RACE-­‐opt1	   9.12±0.31	   2.27±0.25	   12.2±1.2	   0.39±0.06	   1.29±0.04	   38.2±2.3	   0.46±0.03	   0.69±0.03	   34.2±1.1	   0.39±0.07	   0.16±0.02	  
Epa2161Trans-­‐opt1	   8.60±0.54	   2.07±0.46	   10.5±1.8	   0.39±0.05	   1.62±0.08	   38.7±1.8	   0.55±0.03	   3.09±0.62	   31.5±0.5	   1.50±0.18	   0.38±0.03	  
+18:1∆9c,12a	  	  	  (a)	   	   	   	   	   	   	   	   	   	   	   	  
pY5	   6.84±0.67	   2.66±1.30	   4.80±0.29	   0.25±0.04	   1.25±0.13	   28.2±3.3	   0.36±0.03	   0.20±0.03	   23.8±2.0	   29.8±4.2	   0.21±0.01	  
Epa955Trans-­‐opt1	   6.71±0.32	   4.11±2.14	   4.27±0.79	   0.15±0.03	   1.46±0.25	   34.2±4.1	   0.43±0.03	   1.37±0.20	   21.6±3.8	   22.9±8.1	   0.43±0.11	  
Epa955RACE-­‐opt1	   7.33±0.10	   5.08±1.71	   3.81±0.81	   0.20±0.05	   1.62±0.08	   34.3±3.9	   0.30±0.09	   0.71±0.04	   25.0±0.8	   19.1±5.1	   0.30±0.03	  
Epa2161Trans-­‐opt1	   6.85±0.69	   5.22±1.61	   4.57±0.58	   0.17±0.03	   1.72±0.43	   33.2±3.7	   0.57±0.11	   2.38±0.27	   21.9±3.8	   21.6±5.1	   0.40±0.08	  














In	  this	  chapter,	  we	  described	  the	  cloning	  and	  functional	  characterization	  of	  two	  
diverged	  desaturases	   isolated	   from	  Echinacea	  purpurea	   seedlings,	   and	   investigated	  an	  
alternative	   yeast	   expression	   system	   for	   the	   characterization	   of	   plant	   diverged	  
desaturases.	  
Plants	   and	   higher	   fungi	   are	   some	   of	   the	  most	   prolific	   producers	   of	   acetylenic	  
metabolites.	  	  These	  bioactive	  metabolites	  have	  been	  isolated	  from	  a	  limited	  number	  of	  
plant	   families,	   and	   the	   pathway	   leading	   to	   their	   biosynthesis	   is	   not	   well	   understood.	  	  
However,	   the	   vast	   majority	   of	   acetylenic	   secondary	   metabolites	   are	   believed	   to	  
originate	   from	  the	  branchpoint	  compound	  crepenynic	  acid,	   the	  product	  of	  a	  FAD2-­‐like	  
∆12-­‐acetylenase	  that	  introduces	  an	  alkynyl	  group	  at	  C12	  of	  linoleate	  [40].	  	  To	  date,	  most	  
of	  the	  ∆12-­‐acetylenases	  have	  been	  isolated	  from	  Apiaceae,	  Araliaceae,	  and	  Asteraceae.	  	  
As	  with	  other	  Asteraceae	  species,	   flowers	   in	   the	  genus	  Echinacea	  have	  been	   found	   to	  
produce	   a	   number	   of	   acetylene-­‐containing	   compounds.	   	   In	   addition	   to	   acetylenic	  
alkamides,	  Echinacea	  manufactures	  tri-­‐,	  tetra-­‐,	  and	  pentaacetylenic	  compounds	  that	  are	  
purported	  to	  derive	  from	  crepenynate.	  
Our	  investigation	  began	  with	  a	  TblastX	  search	  through	  the	  publically	  available	  E.	  
purpurea	  transcriptome	  and	  produced	  a	  list	  of	  putative	  ∆12-­‐acetylenases.	  	  The	  top	  two	  
candidates,	  Epa955	  and	  Epa2161,	  contained	  the	  characteristic	  hydrophobic	  domains	  of	  
membrane-­‐desaturases	  and	  the	  trademark	  His	  motifs	  involved	  in	  binding	  a	  catalytically	  
active	   non-­‐heme	   di-­‐iron	   complex	   within	   the	   active	   site.	   	   Likewise,	   the	   two	   diverged	  
desaturases	  were	  believed	  to	  be	  functional	  acetylenases,	  as	  they	  possessed	  substantial	  
sequence	  identity	  (>80%)	  with	  other	  functionally	  characterized	  ∆12-­‐acetylenases	  from	  H.	  
annuus	  and	  C.	  officinalis.	  
Two	   distinct	   yeast	   expression	   systems	   were	   used	   in	   an	   effort	   to	   functionally	  
characterize	  Epa955	  and	  Epa2161.	   	  Upon	  expression	  of	  the	  anticipated	  acetylenases	  in	  
the	   first	   system,	  S.	   cerevisiae,	   no	   activity	  was	  detected.	   	   This	   result	   is	   consistent	  with	  
previous	  attempts	  of	  expressing	  plant	  acetylenases	  in	  Saccharomyces	  [25,	  28].	  	  Although	  




Initial	   expression	  of	  both	  acetylenase	   constructs	   in	  Yarrowia	   also	  proved	   to	  be	  
unsuccessful.	  	  Because	  the	  expression	  of	  a	  codon-­‐optimized	  version	  of	  the	  CfACET	  gene	  
for	  Y.	  lipolytica	  had	  higher	  activity	  than	  a	  non-­‐optimized	  transcript,	  it	  was	  surmised	  that	  
a	   critical	   parameter	   in	   Yarrowia	   may	   be	   codon	   bias.	   	   Cultures	   expressing	   codon-­‐
optimized	   versions	   of	   both	   Epa955	   and	   Epa2161	   were	   discovered	   to	   accumulate	  
18:1∆9c,12a	   and	   trace	  amounts	  of	   18:2∆9c,12a,14c.	   	  Although	   functional	   characterization	  of	  
plant	  ∆12-­‐acetylenases	  has	  been	  performed	  with	  transgenic	  plant	  seeds,	  there	  are	  many	  
advantages	  of	  using	  Y.	  lipolytica,	  such	  as	  the	  relative	  ease	  of	  transformation,	  low	  media	  
expense,	   short	   cultivation	   time,	   and	   high	   TAG	   accumulation.	   	   Coupled	   together,	   the	  
results	  obtained	  herein	  suggest	  that	  Yarrowia	  provides	  a	  suitable	  alternative	  expression	  
system	  for	  plant	  ∆12-­‐acetylenases	  and	   that	  codon	  bias	  needs	   to	  be	  considered	  during	  
construct	  design.	  
In	   contrast	   to	   the	   expression	   of	   Epa955Trans-­‐opt,	   it	   is	   important	   to	   note	   that	  
initial	   expressions	   of	   the	   Epa955RACE-­‐opt	   construct	   indicated	   no	   desaturation	   or	  
acetylenation	   activity.	   	   It	   was	   realized	   that	   the	   sequence	   for	   the	   Epa955Trans-­‐opt	  
construct	   was	   obtained	   from	   the	   second	   version	   of	   the	   published	   E.	   purpurea	  
transcriptome,	   while	   the	   sequence	   for	   the	   Epa955RACE-­‐opt	   gene	   was	   obtained	   from	  
RACE	  data	  and	  the	  original	  transcriptome.	  	  Analysis	  of	  the	  sequence	  data	  indicated	  the	  
presence	  of	  a	  non-­‐silent	  mutation	  at	  residue	  376.	  	  It	  was	  discovered	  that	  the	  RACE	  and	  
original	  transcriptome	  contained	  Asp376	  while	  the	  second	  version	  of	  the	  transcriptome	  
possessed	   Tyr376.	   	   By	   conducting	   a	   BlastX	   search	   with	   the	   Epa955	   sequence,	   the	  
conservation	  of	  Tyr376	  was	  confirmed	  by	  the	  top	  100	  hits.	  	  Furthermore,	  this	  region	  of	  
the	   gene	   has	   the	   characteristics	   of	   a	   typical	   ER	   targeting	   sequence	   (–YXXL–)	   [77,	   78].	  	  
SDM	  was	  carried	  out	  to	  convert	  both	  optimized	  and	  unoptimized	  Epa955	  constructs	  to	  
Tyr376.	   	  Expression	  of	   the	  resultant	  Epa955RACE-­‐opt	  construct	  was	  the	  only	  construct	  
to	  provide	  ∆12-­‐acetylenase	  activity.	  
The	   production	   of	   crepenynate	   and	   dehydrocrepenynate	   demonstrates	   that	  
both	  target	  genes	  contain	  ∆12-­‐acetylenase	  catalytic	  abilities.	  	  Likewise,	  another	  example	  




homologs	   have	   displayed	   ∆12-­‐desaturase	   activity	   resulting	   in	   the	   production	   of	  
16:2∆9c,12t,	   18:2∆9c,12t,	   and	   18:2∆9c,12c	   [19,	   30].	   	   In	   this	   case,	   however,	   the	   diverged	  
desaturases	  were	  observed	  to	  specifically	  convert	  oleate	   into	  18:2∆9c,12t.	   	  Although	  the	  
18:2∆9c,12c	  fatty	  acid	  is	  present	  in	  the	  transgenic	  yeast	  lipid	  pool,	  the	  accumulation	  of	  this	  
product	  in	  Epa955	  and	  Epa2161	  is	  equal	  to	  or	  below	  the	  levels	  measured	  for	  the	  empty	  
pY5	  control.	  	  The	  exception	  to	  this	  is	  the	  four-­‐day	  expression	  of	  Epa955RACE-­‐opt,	  where	  
the	   level	  of	  18:2∆9c,12c	  was	   found	  to	  accumulate	   to	  a	  substantially	  higher	  amount	   than	  
the	  control.	   	  Although,	   it	  must	  be	  stated	  that	  the	  Epa955RACE-­‐opt	  expression	  cultures	  
grew	  to	  a	  lower	  cell	  density	  than	  the	  other	  expression	  cultures.	  	  
To	   test	   for	   additional	   activities	   that	  would	  be	   consistent	  with	   the	   crepenynate	  
pathway,	   our	   functionally	   characterized	   E.	   purpurea	   ∆12-­‐acetylenases	   were	  
supplemented	   0.5	   mM-­‐crepenynic	   acid.	   	   Although,	   S.	   cerevisiae	   are	   routinely	  
supplemented	  at	  the	  same	  concentration,	  0.5	  mM-­‐crepenynate	  was	  surprisingly	  toxic	  to	  
Yarrowia.	   	   Information	   gathered	   from	   a	   toxicity	   curve	   indicated	   that	   Y.	   lipolytica	  had	  
limited	  growth	   in	   the	  presence	  of	  0.05-­‐0.1	  mM	  crepenynate,	  and	   supported	   the	  need	  
for	  pre-­‐growing	  cultures	  before	  crepenynic	  acid	   supplementation.	   	  By	   initially	  growing	  
the	  cultures	   for	  24	  h	  at	  22	  °C	  and	  then	  supplementing	  exogenous	  crepenynate,	   it	  was	  
discovered	   that	   after	   24	  h	   at	   15	   °C	   the	   yeast	   cells	   had	   taken	  up,	   and	  even	  utilize	   the	  
exogenous	  crepenynate	  to	  produce	  dehydrocrepenynate.	  	  	  
The	   finding	   that	   18:2∆9c,12a,14c	   is	   produced	   in	   the	   empty	   pY5	   Y.	   lipolytica	   cells	  
when	  they	  are	  provided	  crepenynic	  acid	  is	  consistent	  with	  the	  observations	  of	  Blacklock	  
[30].	   	  This	  further	  solidifies	  the	  catalytic	  role	  of	  FAD2	  in	  the	  formation	  of	  18:2∆9c,12a,14c.	  	  
In	   contrast	   to	   the	   similar	   accumulation	   levels	   of	   16:2∆9c,12t	   and	   18:2∆9c,12c	   described	  
above,	   there	   is	   a	   50%-­‐100%	   increase	   in	   the	   build-­‐up	  of	   dehydrocrepenynate	   found	   in	  
the	  supplemented	  two-­‐day	  acetylenase	  expression	  cultures	  in	  comparison	  to	  the	  control.	  	  
Given	  that	  the	  level	  of	  18:1∆9c,12a	  incorporation	  was	  lower	  in	  the	  acetylenase-­‐expressing	  
cultures	   than	   in	   the	  control,	  and	   the	   formation	  of	  dehydrocrepenynic	  acid	   is	  higher	   in	  
these	  cultures,	   it	  appears	  that	  Epa955	  and	  Epa2161	  also	  possess	  weak	  ∆14-­‐desaturase	  




acetylenase	   expression	   cultures	   could	   be	   due	   to	   metabolic	   channeling	   of	   de	   novo	  
18:1∆9c,12a	  to	  the	  endogenous	  FAD2	  of	  Yarrowia,	  resulting	   in	  higher	  dehydrocrepenynic	  
acid	  accumulation.	  However	  to	  confirm	  this	  activity,	  Epa955	  and	  Epa2161	  would	  need	  to	  




We	  have	  described	  the	  isolation	  and	  characterization	  of	  the	  first	  two	  bifunctional	  
∆12-­‐acetylenases	  from	  Echinacea.	  	  These	  two	  diverged	  desaturases	  contain	  the	  catalytic	  
machinery	   to	   carry	   out	   ∆12-­‐desaturation/acetylenation.	   	   Although	   further	   studies	   are	  
required	  to	  provide	  a	  direct	  link	  between	  these	  ∆12-­‐acetylenases	  and	  the	  formation	  of	  
polyacetylenes	   and	   acetylenic	   alkamides,	   our	   results	   provide	   enzymatic	   evidence	  
supporting	  E.	  purpurea	  acetylenic	  metabolite	  production	  occurs	  via	  the	  crepenynic	  acid	  
pathway	   (Figure	   40).	   	   Additionally,	   we	   have	   shown	   that	   Y.	   lipolytica	   is	   a	   suitable	  
expression	  system	  for	  plant	  diverged	  desaturases,	  and	  provide	  yet	  another	  case	  for	  the	  





Figure	  40:	  Crepenynic	  acid	  pathway	  with	  proposed	  branch	  points	  for	  the	  formation	  of	  polyacetylenic	  

















































CHAPTER	  4. MATERIALS	  AND	  METHODS	  
4.1 Materials	  
All	  yeast	  and	  E.	  coli	  media	  components	  were	  purchased	  from	  Becton	  Dickinson	  &	  
Co.	   (Franklin	   Lakes,	   NJ),	   unless	   stated	   otherwise.	   	   Tergitol	   NP-­‐40	   and	   galactose	   were	  
acquired	  from	  Sigma-­‐Aldrich	  (St.	  Louis,	  MO).	  	  NaCl	  and	  NaOH	  were	  ordered	  from	  Fisher	  
Scientific	  (Fair	  Lawn,	  NJ).	  	  All	  restriction	  enzymes	  and	  buffers	  were	  purchased	  from	  New	  
England	  Biolabs	  (Ipswich,	  MA).	  	  All	  RNA	  work	  was	  performed	  using	  RNase-­‐free	  reagents	  
and	   equipment.	   	   Water	   used	   for	   RNA	   protocols	   was	   treated	   with	   0.1%	   v/v	  
diethylpyrocarbonate	   (DEPC)	   by	   stirring	   overnight	   at	   ambient	   temperature	   and	  
subsequently	   autoclaving	   for	   20	  min	   at	   121	   °C	   to	   deactivate	   DEPC.	   	   All	   primers	  were	  
obtained	   from	   Integrated	   DNA	   Technologies	   (Coralville,	   IA)	   and	   synthetic	   genes	  were	  
purchased	   from	   GenScript	   (Piscataway,	   NJ).	   	   Fistulina	   hepatica	   fruit	   bodies	   were	   a	  
gracious	   gift	   from	   Professor	   D.	   Job	   (University	   of	   Neuchâtel,	   Switzerland).	   	   Echinacea	  
purpurea	   seedlings	   were	   provided	   by	   the	   North	   Central	   Regional	   Plant	   Introduction	  






4.2.1 Isolation	  of	  Gene	  Targets	  
	  
	  
4.2.1.1 Total	  RNA	  Isolation	  from	  Tissue	  
By	  a	  method	  similar	  to	  the	  suggested	  protocol	  for	  using	  the	  TRIzol	  (Invitrogen,	  




fruiting	   bodies	   (ATCC	   strain	   64428),	   as	   well	   as	   E.	   purpurea	   seedlings	   (accession	   #	   PI	  
631307).	  	  Fresh	  tissue	  was	  collected	  and	  ground	  to	  a	  fine	  powder	  in	  mortar	  with	  a	  pestle	  
cooled	  by	  a	  liquid	  nitrogen	  bath.	  	  Once	  ground,	  1	  mL	  of	  TRIzol	  per	  50-­‐100	  mg	  of	  tissue	  
was	   added	   to	   the	  mortar	   and	   the	   tissue	  was	   allowed	   to	   thaw	   in	   the	   presence	   of	   the	  
reagent.	   	   One	   microliter	   of	   the	   mixture	   was	   aliquoted	   into	   2-­‐mL	   screw	   cap	   vials	  
(containing	   ≈	   500	   μL	   of	   0.5-­‐mm	   glass	   beads)	   and	   disrupted	  with	   a	   Bio	   spec	   products	  
mini-­‐beadbeater-­‐8	  at	  max	  speed	  for	  90	  s.	  	  The	  solution	  was	  allowed	  to	  cool	  on	  ice	  for	  90	  
s,	  agitated	  vigorously	  as	  above,	  and	  left	  at	  room	  temperature	  for	  5	  min.	  Centrifugation	  
was	  performed	  at	  12,000×g	  for	  10	  min	  at	  4	  °C,	  and	  the	  supernatant	  was	  transferred	  to	  a	  
clean	  1.7-­‐mL	  tube.	  	  Chloroform	  (200	  μL)	  was	  added,	  the	  mixture	  was	  vortexed	  for	  30	  s,	  
and	  left	  at	  ambient	  temperature	  for	  3	  min.	  The	  solution	  was	  spun	  as	  above	  for	  15	  min	  
and	   the	   aqueous	   layer	   was	   transferred	   to	   a	   new	   1.7-­‐mL	   tube.	   	   Next,	   250	   μL	   of	  
isopropanol	  and	  250	  μL	  of	  citrate	  solution	  (0.8	  M	  Na	  citrate	  &	  1.2	  M	  NaCl)	  were	  added	  
to	   the	   aqueous	   layer	   that	   was	   inverted	   and	   centrifuged	   as	   above	   for	   15	   min.	   	   The	  
supernatant	  was	  removed	  and	  the	  pellet	  was	  washed	  with	  75%	  EtOH.	   	  The	  pellet	  was	  




4.2.1.2 Isolation	  of	  Messenger	  RNA	  from	  Total	  RNA	  
Poly	   (A)+	   RNA	   was	   isolated	   from	   total	   RNA	   using	   the	   Dynabeads	   mRNA	  
Purification	  Kit	  (Invitrogen).	   	  The	  total	  RNA	  solution	  (32-­‐75	  μg	  in	  a	  minimum	  of	  100	  μL	  
volume)	  was	  heated	  to	  65	  °C	  for	  2	  min,	  and	  immediately	  transferred	  to	  ice	  for	  3-­‐5	  min.	  	  
The	  Dynabeads	  were	  resuspended	  in	  the	  storage	  buffer	  by	  vortexing	  and	  200	  μL	  of	  the	  
slurry	   was	   transferred	   to	   a	   microfuge	   tube.	   	   The	   beads	   were	   extracted	   from	   the	  
suspension	  by	  a	  magnet	  while	  the	  supernatant	  was	  removed	  by	  a	  pipet.	  	  After	  the	  tube	  
was	  removed	  from	  the	  magnet,	  the	  beads	  were	  washed	  with	  100	  μL	  of	  Binding	  Buffer	  
(20	  mM	   Tris-­‐HCl,	   pH	   7.5;	   1.0	  M	   LiCl;	   2	  mM	   EDTA)	  with	   vortexing.	   	   Using	   the	  magnet	  




the	   starting	   solution	   volume	   of	   total	   RNA	   was	   added	   to	   the	   tube.	   	   The	   beads	   were	  
resuspended,	   and	   the	   total	   RNA	   solution	   was	   added,	   vortexed,	   and	   placed	   on	   a	  
roller/mixer	   for	   5	   min	   at	   room	   temperature.	   	   The	   Dynabeads	   containing	   the	   bound	  
mRNA	   were	   extracted	   from	   the	   solution	   with	   the	   magnet.	   	   The	   beads	   were	   washed	  
twice	  with	  200	  μL	  of	  Washing	  Buffer	  B	  (10	  mM	  Tris-­‐HCl,	  pH	  7.5;	  0.15	  M	  LiCl;	  1	  mM	  EDTA).	  	  
Finally,	  the	  Dynabeads	  were	  resuspended	  in	  20	  μL	  of	  10-­‐mM	  Tris-­‐HCl	  (pH	  7.5),	  heated	  to	  
72	   °C	   for	  2	  min,	   and	   immediately	  placed	  on	   the	  magnet.	   	   The	   supernatant	   containing	  
isolated	  mRNA	  was	  recovered	  and	  stored	  at	  -­‐80	  °C.	  
	  
	  
4.2.1.3 Synthesis	  of	  cDNA	  from	  mRNA	  
Amplification	   of	   Target	   cDNA	   from	   mRNA-­‐-­‐-­‐	   Using	   mRNA	   obtained	   from	   the	  
Dynabead	   mRNA	   Purification	   Kit,	   reverse	   transcription	   was	   performed	   using	   the	  
Superscript	   First-­‐Strand	   Synthesis	   system	   for	   RT-­‐PCR	   (Invitrogen).	   	   The	   reverse	  
transcription	  reactions	  were	  set	  up	  in	  1.7-­‐mL	  microfuge	  tubes	  according	  to	  Table	  9.	  
	  
Table	  9:	  Setup	  for	  reverse	  transcription	  reactions.	  
Component	   +RT	  
Isolated	  mRNA	   6.0-­‐8.0	  μL	  




DEPC-­‐treated	  H2O	   to	  a	  final	  volume	  of	  10	  μL	  
	  
Each	  reaction	  mixture	  was	  incubated	  at	  65	  °C	  for	  5	  min	  and	  cooled	  on	  ice	  for	  an	  
additional	  3-­‐5	  min.	  	  A	  master	  solution	  containing	  2	  μL	  of	  10x	  RT	  buffer	  (200	  mM	  Tris-­‐HCl,	  
pH	  8.4;	  500	  mM	  KCl),	  4	  μL	  of	  25	  mM	  MgCl2,	  2	  μL	  of	  0.1	  M	  DTT,	  and	  1	  μL	  of	  RNaseOUT	  
(40	  U/μL)	   	  per	   reaction	  was	  prepared.	   	   For	  each	   reaction,	  9	  μL	  of	   the	  master	   solution	  
was	  added,	  mixed,	  and	  incubated	  at	  42	  °C	  for	  2	  min.	  	  Then,	  1	  μL	  of	  SuperScript	  II	  RT	  was	  
added	  to	  the	  sample	  and	  the	  mixture	  was	  incubated	  on	  a	  heating	  block	  at	  42	  °C	  for	  ≈50	  




ice	  for	  2-­‐3	  min.	  	  After	  spinning	  briefly,	  1	  μL	  of	  RNase	  H	  was	  added	  to	  the	  sample,	  which	  
was	  then	  incubated	  at	  37	  °C	  for	  20	  min.	  
	  
	  
4.2.1.4 Generation	  of	  RACE-­‐Ready	  cDNAs	  
Using	  the	  SMARTer	  RACE	  cDNA	  Amplification	  Kit	  (Clontech,	  Mountain	  View,	  CA),	  
rapid	   amplification	   of	   cDNA	   ends	   (RACE)	   for	   both	   5’	   and	   3’	   ends	   was	   performed.	   	   A	  
master	  mix	  was	  prepared	  containing	  5	  μL	  of	  5x	  First-­‐Strand	  buffer	  (250	  mM	  Tris-­‐HCl,	  pH	  
8.3;	  375	  mM	  KCl;	  30	  mM	  MgCl2),	  2.5	  μL	  of	  20	  mM	  DTT,	  and	  2.5	  μL	  of	  dNTP	  mix	  (10	  mM	  
each).	  	  The	  synthesis	  of	  5’	  and	  3’	  first-­‐strand	  products	  were	  carried	  out	  in	  separate	  tubes.	  	  
The	  5’	  sample	  contained	  2.75	  μL	  of	  mRNA	  and	  1	  μL	  of	  5’-­‐CDS	  Primer	  A,	  where	  as	  the	  3’	  
sample	  had	  3.75	  μL	  of	  mRNA	  and	  1	  μL	  of	  3’-­‐CDS	  Primer	  A.	  The	  two	  tubes	  were	  mixed,	  
incubated	   at	   72	   °C	   for	   3	   min,	   and	   then	   cooled	   to	   42	   °C	   for	   2	   min.	   	   The	   tubes	   were	  
centrifuged	  at	  14,000×g	   for	  10	  s	  to	  collect	  the	  reaction	  mixture,	  and	  1	  μL	  of	  SMARTer	  
IIA	  oligo	  was	  added	  to	  the	  5’	  reaction	  only.	   	  Next,	  0.625	  μL	  of	  40	  U/μL	  RNase	  inhibitor	  
and	  2.5	  μL	  of	  100	  U/μL	  SMARTScribe	  reverse	  transcriptase	  was	  added	  to	  the	  master	  mix,	  
mixed,	  and	  5.25	  μL	  of	   reverse	   transcriptase	  solution	  was	  added	  to	  both	  the	  5’	  and	  3’-­‐
RACE-­‐Ready	   cDNA	   tubes.	   	   After	  mixing	  by	  pipetting	   and	   a	  brief	   centrifugation	   step	   to	  
collect	  the	  samples,	  they	  were	  incubated	  at	  42	  °C	  for	  90	  min	  followed	  by	  a	  70	  °C	  heating	  
step	  for	  10	  min.	  	  Finally,	  the	  samples	  were	  diluted	  with	  20-­‐100	  μL	  of	  Tricine-­‐EDTA	  buffer	  




4.2.1.5 Rapid	  Amplification	  of	  cDNA	  Ends	  
Rapid	   amplification	   of	   cDNA	   ends	  was	   performed	   using	   the	   RACE-­‐Ready	   cDNA	  
products	  as	  a	   template.	   	  Each	  of	   the	  5’	  and	  3’	  RACE	  samples	  were	  setup	  according	   to	  
Table	  10.	  	  The	  master	  mix	  was	  prepared	  containing	  34.5	  μL	  of	  PCR-­‐grade	  water,	  5.0	  μL	  
of	  10x	  Advantage	  2	  PCR	  buffer	  (400	  mM	  Tricine-­‐KOH,	  pH	  8.7	  at	  25	  °C;	  150	  mM	  KOAc;	  35	  




mix	  (10	  mM	  each),	  and	  1.0	  μL	  of	  50x	  Advantage	  2	  polymerase	  mix	  (50%	  glycerol;	  15	  mM	  
Tris-­‐HCl,	   pH	  8.0;	   75mM	  KCl;	   0.05	  mM	  EDTA)	  per	   reaction.	   	  Genomic	  DNA	   (75-­‐100	  ng)	  
was	  used	  for	  control	  reaction.	  
	  
Table	  10:	  RACE	  amplification	  tables.	  	  The	  top	  table	  represents	  the	  set	  up	  for	  5’	  RACE	  amplification,	  while	  
the	   bottom	   table	   shows	   the	   components	   of	   the	   3’	   RACE	   amplification.	   GSP	   corresponds	   to	   the	   gene	  
specific	  primer	  used	  for	  amplification	  while	  UPM	  is	  the	  universal	  primer	  mix.	   	  The	  components	  for	  each	  
amplification	  reaction	  were	  added	  in	  the	  order	  shown.	  










5’	  RACE	  cDNA	   2.5	   2.5	   2.5	   2.5	   2.5	  of	  gDNA	  	  
UPM	  (10x)	   5	   -­‐-­‐	   5	   -­‐-­‐	   -­‐-­‐	  
5’-­‐RACE	  Primer	  
(10	  µM)	  
1	   1	   -­‐-­‐	   1	   1	  
3’-­‐RACE	  Primer	  	  
(10	  µM)	  
-­‐-­‐	   1	   -­‐-­‐	   -­‐-­‐	   1	  
PCR-­‐Grade	  H2O	   -­‐-­‐	   4	   1	   5	   4	  
Master	  Mix	   41.5	   41.5	   41.5	   41.5	   41.5	  
	  
	  










3’	  RACE	  cDNA	   2.5	   2.5	   2.5	   2.5	   2.5	  of	  gDNA	  	  
UPM	  (10x)	   5	   -­‐-­‐	   5	   -­‐-­‐	   -­‐-­‐	  
5’-­‐RACE	  Primer	  
(10	  µM)	  
-­‐-­‐	   1	   -­‐-­‐	   -­‐-­‐	   1	  
3’-­‐RACE	  Primer	  
(10	  µM)	  
1	   1	   -­‐-­‐	   1	   1	  
PCR-­‐Grade	  H2O	   -­‐-­‐	   4	   1	   5	   4	  













RACE	   amplification	   was	   performed	   on	   an	   Eppendorf	   Mastercycler	   Gradient	   5331	  
Thermal	  Cycler	  using	  the	  following	  program:	  
RACE	  
1. 94	  °C,	  30	  s	  	  
2. 72	  °C,	  3	  min	  
3. Go	  to	  1;	  Repeat	  5	  times	  
4. 94	  °C,	  30	  s	  	  
5. 70	  °C,	  30	  s	  	  
6. 72	  °C,	  3	  min	  	  
7. Go	  to	  4;	  Repeat	  5	  times	  
8. 94	  °C,	  30	  s	  
9. 68	  °C,	  30	  s	  	  
10. 72	  °C,	  3	  min	  
11. Go	  to	  8;	  Repeat	  25	  times	  
	  
	  
4.2.1.6 Taq	  Polymerase	  Chain	  Reaction	  Amplification	  
Using	   the	   reverse	   transcription	   products,	   PCR	   reactions	   using	   the	   GoTaq	   Flexi	  
polymerase	  kit	  (Promega,	  Madison,	  WI)	  were	  developed	  to	  amplify	  the	  target	  genes	  for	  
Echinacea.	  	  Each	  of	  the	  PCR	  samples	  contained	  the	  components	  found	  within	  the	  table	  
below.	   	   PCR	   amplification	  was	   performed	  using	   an	   Eppendorf	  Gradient	   Cycler	   using	   a	  
temperature	  program	  designated	  “REMTD”.	  	  	  	  	  
	  
Table	  11:	  GoTaq	  polymerase	  meditated	  amplification	  of	  gene	  targets.	  
Component	   Volume	  (µL)	  
5x	  Green	  GoTaq	  Buffer	   4	  
25	  mM	  MgCl2	   1.6	  
10	  mM	  dNTP	   0.4	  of	  each	  dNTP	  
GoTaq	  Polymerase	  (5U/µL)	   0.1	  
10	  µM	  primer	   1.0	  
DNA	  template	   1-­‐2	  (depending	  on	  concentration)	  









1. 94	  °C,	  2	  min	  	  
2. 94	  °C,	  15	  s	  	  
3. 72	  °C,	  15	  s;	  Increment	  step	  temperature	  by	  -­‐0.5	  °C	  	  
4. 72	  °C,	  3.5	  min	  	  
5. Go	  to	  2;	  Repeat	  28	  times	  
6. 94	  °C,	  15	  s	  	  
7. 58	  °C,	  15	  s	  	  
8. 72	  °C,	  3.5	  min	  	  
9. Go	  to	  6;	  Repeat	  10	  times	  
10. 72	  °C,	  7.5	  min	  	  
	  
	  
4.2.1.7 Polymerase	  Chain	  Reaction	  Amplification	  of	  Fistulina	  hepatica	  Gene	  Targets	  by	  
Vent	  Polymerase	  
Using	  the	  reverse	  transcription	  products	  obtained	  for	  F.	  hepatica,	  PCR	  reactions	  
were	  developed	  to	  amplify	  the	  target	  genes.	  	  Each	  of	  the	  PCR	  samples	  contained	  2	  μL	  of	  
10x	  IDT	  Buffer	  (pH	  8.3;	  20	  mM	  MgCl2),	  0.4	  μL	  of	  each	  10	  mM	  dNTP	  solution,	  0.2	  μL	  Vent	  
polymerase,	  1.0	  μL	  of	  template,	  1.0	  μL	  of	  each	  of	  the	  respective	  primers	  (10	  μM),	  and	  
13.2	  μL	  of	  H2O.	   	  PCR	  amplification	  was	  performed	  using	  an	  Eppendorf	  Gradient	  Cycler	  
and	  the	  program	  “REMTD”.	  	  	  
	  
	  
4.2.1.8 Gel	  Purification	  of	  PCR	  Products	  
Using	  the	  QIAEX	  II	  Gel	  extraction	  kit	  protocol	  by	  QIAgen	  (Valencia,	  CA),	  the	  DNA	  
product	  was	  purified	  from	  the	  agarose	  gel.	  	  DNA	  bands	  were	  extracted	  from	  the	  gel	  with	  
a	   razor	  blade	  and	  Buffer	  QXI	  was	  added	   in	  a	   ratio	  of	  300	  μL	  per	  0.1	  g	  of	  gel	   slice.	  For	  
DNA	  greater	  than	  4	  kb	  in	  size,	  an	  additional	  200	  μL	  of	  water	  was	  added	  per	  0.1	  g.	  	  The	  
QIAEX	  II	  matrix	  was	  resuspended	  and	  10	  μL	  was	  added	  to	  each	  DNA	  isolation	  mixture.	  	  
The	  sample	  was	  incubated	  at	  50	  °C	  for	  10	  min	  with	  vortexing	  every	  2	  min	  to	  ensure	  that	  
the	  DNA	  and	  agarose	  were	  suspended	  in	  solution.	  After	  the	  10	  min	   incubation	  period,	  




supernatant	  was	  removed.	  	  The	  remaining	  pellet	  was	  washed	  once	  with	  500	  μL	  of	  Buffer	  
QXI	  and	  twice	  with	  500	  μL	  of	  Buffer	  PE	  by	  resuspension	  and	  centrifugation.	  	  The	  pellet	  
was	  allowed	  to	  air-­‐dry	  at	  37	  °C	  for	  5-­‐10	  min,	  followed	  by	  resuspension	  of	  the	  pellet	  in	  20	  
μL	  of	  TE	  (10	  mM	  Tris-­‐HCl,	  pH	  8.0;	  1	  mM	  EDTA)	  by	  vortexing.	  	  For	  DNA	  of	  less	  than	  4	  kb,	  
this	   elution	   period	   was	   at	   room	   temperature	   for	   5	   min.	   For	   DNA	   greater	   than	   4	   kb,	  
elution	  was	  carried	  out	  at	  50	  °C	  for	  5	  min.	  	  After	  the	  incubation,	  the	  sample	  was	  spun	  at	  
maximum	   speed	   for	   30	   s	   and	   the	   supernatant	   containing	   the	   DNA	   of	   interest	   was	  
transferred	  to	  a	  clean	  tube.	  
	  
	  
4.2.2 Cloning	  and	  Transformation	  of	  Escherichia	  coli	  
	  
	  
4.2.2.1 Topoisomerase-­‐Mediated	  Cloning	  and	  Transformation	  into	  Escherichia	  coli	  
The	   genes	   of	   interest	   were	   cloned	   into	   the	   vector	   pCR2.1	   using	   a	   TOPO	   TA	  
Expression	   kit	   (Invitrogen,	   Carlsbad,	   CA).	   	   Half-­‐size	   cloning	   reactions	   relative	   to	   the	  
manufacturer’s	  instructions	  were	  setup	  according	  to	  Table	  12.	  	  If	  Vent	  polymerase	  was	  
used	  for	  full-­‐length	  amplification,	  the	  overhangs	  required	  for	  TA	  cloning	  were	  generated	  
by	   incubating	   the	   Vent	   polymerase-­‐mediated	   PCR	   products	   with	   0.25	   µL	   of	   5	   U/	   µL	  
GoTaq	  polymerase	  at	  72	  °C	  for	  10	  min.	  	  
	  
Table	  12:	  General	  setup	  for	  TOPO	  T/A	  cloning	  reactions.	  
Components	   Component	  volume	  (μL)	   Half	  Reactions	  (μL)	  
Gene	  product	   0.5	  to	  4.0	   2.0	  
1.2	  M	  NaCl,	  0.06	  M	  MgCl2	  	   1.0	   0.5	  
pCR	  2.1	  TOPO	  TA	  Vector	   1.0	   0.5	  
MB	  H2O	   Volume	  up	  to	  6.0	   -­‐	  
	  
After	  flicking	  to	  mix	  and	  collecting	  by	  brief	  centrifugation,	  the	  cloning	  reactions	  
were	   incubated	   at	   room	   temperature	   for	   15-­‐25	   min.	   Vials	   of	   DH5α	   chemically	  
competent	  E.	  coli	  cells	  were	  thawed	  on	  ice	  and	  the	  entire	  cloning	  reaction	  was	  added	  to	  




After	   incubating,	   the	   vials	  were	  heat-­‐shocked	   for	  30	   s	   in	   a	  water	  bath	  equilibrated	   to	  
42	  °C,	  and	  then	  chilled	  on	  ice.	  Room	  temperature	  SOC	  medium	  (250	  µL)	  was	  added	  to	  
each	  sample	  followed	  by	  incubation	  at	  37	  °C	  for	  1	  h	  with	  200	  rpm	  shaking.	  	  Two	  volumes	  
(25	  µL	  and	  50	  µL)	  of	  the	  transformation	  reaction	  was	  plated	  on	  separate	  Luria-­‐Bertani	  
broth	  plates	  (LB)	  +	  ampicillin	  (amp)	  and	  grown	  overnight	  at	  37	  °C.	  Each	  of	  the	  LB	  plates	  
(1%	  tryptone,	  0.5%	  yeast	  extract,	  1%	  NaCl,	  1.5%	  agar)	  contained	  100	  µg/mL	  ampicillin	  
that	  allowed	   for	   the	  selection	  of	  positive	   transformants	  based	  on	  antibiotic	   screening.	  	  
Single	  colonies	  were	  picked	  from	  each	  plate	  and	  inoculated	  into	  5-­‐mL	  liquid	  cultures	  of	  




4.2.2.2 Subcloning	  into	  Yeast	  Expression	  Vectors	  
The	  pCR	  2.1	  constructs	  and	  circularized	  expression	  vectors,	  pY5	  and	  pYES2,	  were	  
digested	  with	  BamHI	  and	  NotI	  restriction	  enzymes.	  	  The	  digests	  were	  incubated	  at	  37	  °C	  
for	   approximately	   2	   h,	   at	   which	   point	   the	   linearized	   expression	   vectors	   were	   treated	  
with	  Antarctic	  phosphatase	  at	  37	  °C	  for	  an	  additional	  1	  h.	  	  The	  reactions	  were	  incubated	  
at	   65	   °C	   for	   15	   min	   to	   heat-­‐inactive	   the	   restriction	   and	   phosphatase	   enzymes.	   	   The	  
digest	   samples	   were	   ran	   on	   an	   agarose	   gel	   and	   the	   linearized	   products	   were	   then	  
purified	  by	  the	  QIAEX	  II	  Gel	  extraction	  kit.	  
The	   ligation	  of	  gene	   inserts	   into	  yeast	  expression	  vectors	  was	  carried	  out	  using	  
T4	  DNA	   ligase	   (Gibco	  BRL).	   	   Each	   ligation	   reaction	  contained	  4:1	  molar	  equivalence	  of	  
insert	  :	  vector,	  4	  µL	  of	  5x	  ligase	  buffer,	  2	  µL	  of	  10	  mM	  ATP,	  1	  µL	  of	  ligase,	  and	  molecular-­‐
biology	  grade	  H2O	  to	  a	   final	  volume	  of	  20	  µL.	   	  The	   reactions	  were	   ligated	   for	  1-­‐3	  h	  at	  
room	  temperature	  and	  10	  µL	  of	  each	  ligation	  reaction	  was	  transformed	  into	  XL1-­‐Blue	  E.	  






4.2.2.3 Transformation	  of	  XL1-­‐Blue	  Escherichia	  coli	  
Transforming	  DNA	  (0.5-­‐10	  µL;	  dependent	  on	  starting	  concentration)	  was	  added	  
to	  100	  µL	  of	  freshly	  thawed	  RbCl	  chemically	  competent	  XL1-­‐Blue	  E.coli	  and	  incubated	  on	  
ice	  for	  15-­‐30	  min	  [53].	  	  The	  cell	  solution	  was	  heat-­‐shocked	  in	  a	  water	  bath	  at	  42	  °C	  for	  
45	  s	  and	  then	  placed	  back	  on	  ice	  for	  an	  additional	  3	  min.	  	  LB	  media	  (1	  mL)	  was	  added	  to	  
the	   transformation	   reaction	   and	   the	   culture	   was	   incubated	   at	   37	   °C	   for	   1	   h	   with	  
occasional	  inversion	  to	  mix.	  	  The	  cells	  were	  then	  pelleted	  at	  3,000xg	  for	  1	  min	  before	  all	  
but	   150	   µL	   of	   the	   supernatant	   was	   discarded.	   	   The	   pelleted	   cells	   were	   gently	  
resuspended	  in	  the	  remaining	  supernatant	  and	  spread	  on	  LB	  +	  amp	  plates.	  
	  
	  
4.2.3 Site-­‐Directed	  Mutagenesis	  
Each	  reaction	  using	  the	  Quik	  Change	  II	  site-­‐directed	  mutagenesis	  kit	  (Stratagene)	  
contained	  the	  components	  below,	  and	  the	  components	  were	  added	  in	  the	  order	  shown.	  	  
SDM	   was	   performed	   using	   the	   MutLong	   program	   below.	   	   Once	   the	   thermocycler	  
program	  had	  finished,	  the	  template	  DNA	  was	  digested	  with	  0.5	  µL	  of	  DpnI	  (10	  U/µL)	  at	  
37	  °C	  for	  1	  h.	  	  An	  aliquot	  of	  the	  digested	  product	  (2	  µL)	  was	  then	  used	  to	  transform	  RbCl	  
competent,	  XL1-­‐Blue	  E.	  coli.	  
	  
Table	  13:	  Site-­‐directed	  mutagenesis	  reactions.	  
Components	   Component	  amount	  
10x	  Reaction	  buffer	  
(100	  mM	  KCl,	  100	  mM	  (NH4)2SO4,	  200	  
mM	  Tris-­‐HCl,	  20	  mM	  MgSO4,	  	  
1%	  Triton	  X-­‐100,	  1	  mg/mL	  BSA)	  
2.5	  µL	  
plasmid	  DNA	  	   25	  ng	  
SDM	  primer	  1	   62.5	  ng	  
SDM	  primer	  2	   62.5	  ng	  
dNTP	  mix	   0.5	  µL	  
MB	  H2O	   Volume	  up	  25	  µL	  










1. 95	  °C,	  30s	  	  
2. 95	  °C,	  30s	  	  
3. 55	  °C,	  1	  min	  	  
4. 68	  °C,	  9.5	  min	  	  
5. Go	  to	  2;	  Repeat	  16	  times	  
	  
	  
4.2.4 Yeast	  Expressions	  of	  DNA	  Constructs	  
	  
	  
4.2.4.1 Saccharomyces	  cerevisiae	  Expression	  
Gene	   products	   for	   S.	   cerevisiae	   expression	   were	   cloned	   into	   the	   expression	  
vector	  pYES2.	   	   These	   constructs	  were	   subsequently	   transformed	   into	   the	  S.	   cerevisiae	  
strain	  INVSc1	  using	  a	  standard	  lithium	  acetate-­‐polyethylene	  glycol	  method	  of	  Gietz	  [52].	  	  
The	   transformed	   S.	   cerevisiae	   was	   grown	   on	   complete	   minimal	   medium	   lacking	   the	  
nucleobase,	  uracil,	  containing	  dextrose	  (CM-­‐ura+dex)	  for	  3	  days	  at	  30	  °C	  [53].	  	  YPD	  liquid	  
starter	   cultures	   (1%	   Bacto	   Yeast	   Extract,	   2%	   Bacto	   peptone,	   and	   2%	   dextrose)	   from	  
single	   transformant	   colonies	   were	   grown	   at	   30	   °C	   overnight	   with	   240	   rpm	   shaking.	  	  
Expression	  cultures	  for	  the	   INVSc1	  transformants	  were	  generated	  by	   inoculating	  50	  μL	  
of	   the	  YPD	   start	   cultures	   into	  5-­‐mL	  of	  CM-­‐ura+2%	  galactose.	   	   The	  expression	   cultures	  
were	  grown	  at	  22	  °C	  with	  240	  rpm	  for	  24	  h	  followed	  by	  expression	  at	  15	  °C	  with	  240	  rpm	  
for	  72	  h.	  	  In	  the	  event	  that	  exogenous	  fatty	  acids	  were	  fed,	  the	  5-­‐mL	  expression	  culture	  
contained	  0.1%	  w/v	  Tergitol	  NP-­‐40	  and	  the	  fed	  fatty	  acid	  at	  a	  final	  concentration	  of	  0.5	  
mM.	  	  All	  fatty	  acid	  feeding	  stocks	  were	  prepared	  as	  10	  mg/mL	  solutions	  in	  95%	  ethanol.	  	  
	  
	  
4.2.4.2 Yarrowia	  lipolytica	  Expression	  
In	   preparation	   for	   Yarrowia	   expression,	   the	   full-­‐length	   target	   transcripts	   were	  
subcloned	   into	   the	   pY5,	   a	   Y.	   lipolytica	   expression	   vector	   containing	   the	   Leu2	  marker.	  	  




using	  a	  PEG/lithium	  acetate	  method	  [76].	   	  The	  transgenic	  yeast	  was	  cultivated	  on	  CM-­‐
leu+2%	  dextrose	   for	  3-­‐5	  days	  at	  28	   °C,	  and	  single	   transformant	  colonies	  were	  used	   to	  
innoculate	   YPD	   start	   cultures.	   	   Expression	   of	   the	   gene	   constructs	   was	   carried	   out	   as	  
before	  in	  CM-­‐leu+2%	  dex	  and	  were	  grown	  at	  22	  °C	  with	  240	  rpm	  for	  24	  h,	  followed	  by	  
expression	  at	  15	  °C	  with	  240	  rpm	  for	  24-­‐72h.	  	  For	  feeding	  experiments,	  exogenous	  fatty	  




4.2.4.3 Fatty	  Acid	  Derivatization	  of	  Transgenic	  Yeast	  Expressions	  
	  
	  
4.2.4.3.1 Fatty	  Acid	  Methyl	  Esters	  (FAMEs)	  
FAMEs	   from	   both	   transformed	   yeast	   species	   were	   prepared	   by	   incubation	   of	  
resuspended	   cell	   pellets	   in	   2%	   H2SO4	   in	   methanol	   (1	   mL)	   at	   80	   °C	   for	   1-­‐2h.	   If	   the	  
transformants	  were	  fed	  exogenous	  fatty	  acids,	  the	  cells	  were	  first	  washed	  with	  1%	  (w/v)	  
Tergitol	  NP-­‐40	  (2	  x	  5	  mL),	  followed	  by	  two	  washes	  of	  H2O	  (5	  mL)	  before	  the	  addition	  of	  
acidic	   methanol.	   The	   FAMEs	   were	   extracted	   into	   hexanes	   (2	   mL)	   and	   concentrated	  




4.2.4.3.2 Fatty	  Acid	  Pyrrolidides	  (FAPys)	  
Fatty	  acid	  pyrrolidides	  were	  developed	  by	  a	  reacting	  250	  µL	  of	  pyrrolidine	  and	  25	  
µL	  of	  glacial	  acetic	  acid	  with	  a	  dried	  FAMEs	  sample	  at	  100	  °C	  for	  1	  h.	   	  The	  pyrrolidides	  
were	  recovered	  by	  adding	  1	  mL	  of	  water	  and	  2	  mL	  of	  hexane	  :	  diethyl	  ether	  (1	  :	  1).	  	  The	  
products	  were	  then	  washed	  twice	  with	  2	  mL	  of	  H2O,	  and	  the	  organic	  phase	  was	  dried	  
down	  under	  a	  nitrogen	  atmosphere	  to	  concentrate	  the	  fatty	  acid	  pyrrolidide	  derivatives.	  	  






4.2.4.3.3 Fatty	  Acid	  Dimethyloxazolines	  (DMOX)	  
FAMEs	  samples	  were	  concentrated	  under	  a	  stream	  of	  N2	  and	  then	  reacted	  with	  
0.5	  M	  NaOH	  in	  MeOH	  :	  H2O	  (90	  :	  10)	  at	  80	  °C	  for	  1	  h	  followed	  by	  acidification	  with	  1	  M	  
HCl.	  	  As	  derivatizations	  of	  higher	  unsaturated	  fatty	  acids	  were	  performed,	  this	  step	  was	  
carried	   out	  with	   the	   0.5	  M	  NaOH	   solution	   at	   room	   temperature,	   overnight.	   	   The	   free	  
fatty	  acids	  were	  extracted	  with	  2	  mL	  of	  hexanes	  and	  concentrated	  under	  N2.	  	  
The	   concentrated	   free	   fatty	   acids	  were	   reacted	  with	   750	  µL	   of	   distilled	  DCM	   :	  
DMF	  solution	  (1000	  :	  1)	  and	  500	  µL	  of	  oxayl	  chloride	  under	  nitrogen	  to	  generate	  the	  acid	  
chloride.	  	  Once	  the	  reaction	  stopped	  bubbling,	  the	  solvent	  was	  dried	  down	  and	  the	  acid	  
chlorides	  were	  reacted	  with	  500	  µL	  of	  10	  mg/mL	  2-­‐amino-­‐2-­‐methylpropanol	  in	  distilled	  
DCM.	  	  The	  mixture	  was	  allowed	  to	  react	  for	  1	  h	  at	  room	  temperature	  under	  a	  nitrogen	  
atmosphere.	   	  The	  solution	  was	  dried	  down	  and	  reacted	  with	  1000	  µL	  of	  trifluoroacetic	  
acid	  at	  40	  °C	  for	  1	  h	  to	  generate	  fatty	  acid	  DMOX	  derivatives.	  	  The	  derivatized	  fatty	  acids	  
were	  dried	  down	  and	  recovered	  by	  addition	  of	  1	  mL	  of	  H2O	  and	  extraction	  with	  hexane	  
(2	  x	  2	  mL).	  	  The	  organic	  layer	  was	  then	  washed	  twice	  with	  H2O,	  and	  concentrated	  under	  
a	  stream	  of	  nitrogen.	  	  Subsequently,	  the	  DMOX	  derivatives	  were	  dissolved	  in	  50-­‐200	  µL	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Appendix	  A Fistulina	  Primers,	  Sequences,	  and	  Mass	  Spectra	  
Table	  14:	  List	  of	  all	  primers	  used	  in	  Fistulina	  hepatica	  gene	  isolation.	  
Primer	  Name	   Amplification	  Use	   Sequence	  (From	  5’	  to	  3’)	  
Fhe04128-­‐5	  RACE	  1	   5’	  RACE	   CAG	  TGG	  TTG	  GCA	  AGG	  ATG	  TAC	  GGG	  AC	  
Fhe04128-­‐3	  RACE	  1	   5’	  RACE	   CTT	  TAT	  TTC	  GTC	  CCG	  TAC	  ATC	  CTT	  GCC	  
Fh04128s	   Full	  length	   ATG	  CTC	  TCC	  ATC	  TTC	  GAA	  GAC	  AGC	  C	  
Fh04128a_NotI	   Full	  length	   TTT	  GCG	  GCC	  GCT	  TAC	  TCT	  GGT	  GTC	  GGA	  
CGA	  TTG	  TTG	  TC	  
BamHI-­‐H6(Sc)-­‐Fh04128s	   Hexahistidine	  tagging	  of	  
full	  length	  gene	  
AAA	  GGA	  TCC	  AAA	  ATG	  CAC	  CAC	  CAC	  CAC	  
CAC	  CAC	  CTC	  TCC	  ATC	  TTC	  G	  
Fh10752-­‐5’C	   5’	  RACE	   GTC	  AGA	  GTA	  CGC	  GTA	  GTG	  CTC	  GCC	  GAT	  
G	  
Fh10752-­‐3’C	   5’	  RACE	   TCC	  TCT	  GGA	  CAC	  CGT	  ACT	  TCT	  CAT	  GGA	  G	  
Fh10752ORFs	   Full	  length	   ATG	  GTT	  TCG	  ACT	  AAA	  GAA	  TAC	  CGC	  
Fh10752-­‐NotI	   Full	  length	   GTG	  GCG	  GCC	  GCT	  TAC	  TCG	  GCT	  TTG	  GTC	  
TTC	  TTG	  AC	  
BamHi-­‐H6(Sc)-­‐Fh10752s1	   Hexahistidine	  tagging	  of	  
full	  length	  gene	  
AAA	  GGA	  TCC	  AAA	  ATG	  CAT	  CAT	  CAT	  CAT	  




































































































































































































Figure	   41:	   Mass	   spectral	   analysis	   of	   crepenynic	   acid	   pyrrolidide.	   	   Shown	   are	   mass	   spectra	   of	   (A)	  
pyrrolidides	  synthesized	  from	  an	  expression	  culture	  of	  Fhe10752	  and	  (B)	  the	  authentic	  standard	  purified	  










Figure	  42:	  Stacked	  comparison	  of	  mass	  spectra	  of	  methyl	  dehydrocrepenynate.	  	  Provided	  is	  the	  (A)	  mass	  
spectrum	   obtained	   from	   FAMEs	   prepared	   from	   Fhe04128	   expression	   cultures	   supplemented	   with	  












Figure	   43:	   Comparison	   of	   GC-­‐MS	   data	   for	   dehydrocrepenynoyl	   DMOX	   derivatives.	   	   Mass	   spectra	  
corresponding	   to	   (A)	   dehydrocrepenynoyl	   DMOX	   from	   18:1∆9c,12a-­‐supplemented	   Fhe04128-­‐expressing	  












Figure	  44:	  GC-­‐MS	  analysis	  of	  18:1∆9c,12a,14a	  FAMEs.	  	  (A)	  Mass	  spectrum	  of	  the	  diacetylenic	  FAME	  developed	  
from	  Fhe04128	  expression	  cultures	  supplemented	  with	  crepenynic	  acid.	  	  (B)	  Mass	  spectrum	  of	  synthetic	  










Figure	   45:	   Mass	   spectral	   identification	   of	   18:1∆9c,12a,14a	  dimethyloxazolines.	   	   (A)	   Mass	   spectrum	   for	   the	  
diacetylenic	  DMOX	  derivative	   prepared	   from	   transgenic	   yeast	   expressing	   Fhe04128	   supplemented	  with	  










Figure	  46:	  Mass	  fragmentation	  data	  for	  methyl	  18:2∆9c,12a,14a,16	  isomers.	  	  (A)	  (16Z)-­‐dehydrodiacetylenic	  and	  
(B)	   (16E)-­‐dehydrodiacetylenic	   fatty	   acid	   methyl	   esters	   prepared	   from	   Fhe04128	   transgenic	   yeast	  











Figure	  47:	  Mass	  spectra	  of	  18:2∆9c,12a,14a,16	  DMOX	  derivatives.	  	  Shown	  are	  the	  mass	  fragmentation	  patterns	  











Appendix	  B Echinacea	  Primers,	  Sequences,	  and	  Mass	  Spectra	  
Table	  15:	  A	  comprehensive	  list	  of	  primers	  used	  for	  the	  isolation	  of	  Echinacea	  purpurea	  gene	  targets.	  
Primer	  Name	   Amplification	  Use	   Sequence	  (From	  5’	  to	  3’)	  
Epa955-­‐5’A	   5’	  RACE	   TGA	  GAT	  CAG	  ATG	  ATG	  CAA	  GAC	  ATG	  AGT	  A	  
Epa955-­‐3’A	   3’	  RACE	   GAA	  ATA	  CAG	  TCA	  TCG	  TAA	  TCA	  CCA	  TGC	  C	  
Epa955-­‐5’B	   5’	  RACE	   GCT	  CAC	  CCA	  ACA	  CCG	  GCT	  TGA	  TGG	  CGT	  C	  
Epa955-­‐3’B	   3’	  RACE	   GTT	  TTG	  TCA	  AGG	  TAG	  TAT	  CCT	  AAC	  AGG	  T	  
Epa955s	  (RACE)	   Full	  length	  	   ATG	  GGT	  GCG	  GGT	  GGC	  CGG	  ATG	  ACC	  A	  
Epa955s	  (Illum)	   Full	  length	   ATG	  GGT	  GCT	  GGT	  GGG	  CGG	  ATG	  ACC	  A	  




Hexahistidine	  tagging	  of	  full	  
length	  gene	  
AAA	  GGA	  TCC	  AAA	  ATG	  CAT	  CAT	  CAT	  CAT	  
CAT	  CAT	  GGT	  GCG	  GGT	  GGC	  CGG	  ATG	  AC	  
BamHI-­‐H6-­‐Epa955	   Hexahistidine	  tagging	  of	  full	  
length	  gene	  
AAA	  GGA	  TCC	  AAA	  ATG	  CAC	  CAC	  CAC	  CAC	  
CAC	  CAC	  GGT	  GCT	  GGT	  GGG	  CGG	  ATG	  AC	  
YlHis6Epa955repair_s	   Site-­‐directed	  mutagenesis	   GCC	  AAC	  ACC	  AAC	  TCT	  CTC	  GAT	  AAC	  GAT	  
GAG	  GTT	  TAC	  AT	  
YlHis6Epa955repair_a	   Site-­‐directed	  mutagenesis	   ATG	  TAA	  ACC	  TCA	  TCG	  TTA	  TCG	  AGA	  GAG	  
TTG	  GTG	  TTG	  GC	  
Epa2161-­‐5’A	   5’	  RACE	   ACG	  CCT	  AGC	  ACA	  GGA	  ACT	  CCA	  TAC	  ATG	  C	  
Epa2161-­‐3’A	   3’	  RACE	   ACG	  CTA	  AGT	  GAT	  CTA	  AAG	  AAA	  GCT	  ATC	  C	  
Epa2161s	  	   Full	  length	   ATG	  GGC	  GCA	  GGT	  GGT	  CGC	  ATG	  TCG	  G	  
Epa2161-­‐NotI	   Full	  length	   GTG	  GCG	  GCC	  GCT	  TAC	  ATT	  TTA	  TGG	  TAC	  
CAA	  TAG	  
BamHI-­‐H6-­‐Epa2161	   Hexahistidine	  tagging	  of	  full	  
length	  gene	  
AAA	  GGA	  TCC	  AAC	  ATG	  CAC	  CAC	  CAC	  CAC	  
CAC	  CAC	  GGC	  GCA	  GGT	  GGT	  CGC	  ATG	  TC	  
YlHis6Epa2161repair_s	   Site-­‐directed	  mutagenesis	   CCC	  GGT	  TGA	  TCC	  ACC	  GTT	  CAC	  GCT	  AAG	  
TGA	  TCT	  AAA	  G	  
YlHis6Epa2161repair_a	   Site-­‐directed	  mutagenesis	   CTT	  TAG	  ATC	  ACT	  TAG	  CGT	  GAA	  CGG	  TGG	  





























































































































































































































































































































































































Figure	  48:	  Mass	  spectral	  identification	  of	  crepenynoyl	  DMOX.	  	  DMOX	  mass	  spectra	  demonstrating	  the	  presence	  of	  crepenynate	  in	  yeast	  expressing	  Epa955	  




Figure	  49:	  Mass	  spectral	  identification	  of	  dehydrocrepenynoyl	  DMOX.	  	  DMOX	  mass	  spectra	  demonstrating	  the	  presence	  of	  dehydrocrepenynate	  in	  yeast	  
expressing	  Epa955	  and	  Epa2161.	  	  Standard	  prepared	  from	  methyl	  dehydrocrepenynate	  isolated	  from	  C.	  cibarius	  is	  shown	  in	  the	  upper	  left	  panel.	  
